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SUMMARY 
Due to strict requirements regarding quality control of pharmaceuticals and with the aim of 
obtaining maximal efficacy and safety of drug therapy for patients, there is a constant demand 
for developing new reliable analytical methods to determine drug concentrations in complex 
samples. Electroanalytical techniques, especially voltammetric, represent a powerful 
analytical tool. Electrochemical nanosensors have recently found extensive applications in 
pharmaceutical analysis. Therefore, the aim of this doctoral thesis was to develop new 
electroanalytical methods for the determination of selected pharmaceuticals in dosage forms 
and biological fluids using novel sensors based on multi-walled carbon nanotubes dispersed in 
Nafion matrix, as well as their combination with zirconium oxide nanoparticles. 
Electrochemical behaviour of selected drugs was examined by cyclic voltammetry to get an 
insight into their redox mechanism at modified electrodes. Experimental conditions and 
instrumental parameters that could affect the electroanalytical performance of proposed 
sensors were carefully optimised. New methods were validated according to ICH guidelines. 
Direct pulse voltammetric techniques (square-wave or differential pulse) were used to 
determine the content of ropinirole, L-dopa, mesalazine and nebivolol in tablets, except for 
ondansetron in which case adsorptive stripping procedure was employed. The good recoveries 
indicated that excipients did not interfere with the assay of active ingredient in any case. In 
comparison to the high performance liquid chromatographic methods, there were no 
significant differences regarding the accuracy and precision; however voltammetric 
techniques offer high sensitivity, rapid response and simplicity. Finally, nanosensors were 
applied for the simultaneous quantification of selected pharmaceuticals with other co-
administered drugs in therapy (such as ondansetron with morphine and ropinirole with L-
dopa) or their metabolites (mesalazine and N-acetylated metabolite) in human serum samples 
using adsorptive stripping voltammetry. Integration of the nanoparticles in the sensor 
improved notably the determination of therapeutic concentrations of nebivolol in serum. 
Excellent recoveries in the range of 98.7 – 102.6 % were obtained in all cases, without the 
need for sample pretreatment. A considerable enhancement effect on voltammetric responses 
of selected drugs is due to synergy of remarkable properties of nanomaterials and cation-
exchange polymer that enhanced the preconcentration of positively charged drug molecules.  
KEYWORDS: multi-walled carbon nanotubes, zirconium oxide nanoparticles, Nafion, 
voltammetry, electrochemical nanosensors, ondansetron, morphine, ropinirole, L-dopa, 
mesalazine, metabolite of mesalazine, nebivolol 
  
SAŽETAK 
Uvod: S obzirom na sve složenije zahtjeve u kontroli kvalitete lijekova, a s ciljem 
osiguravanja maksimalne učinkovitosti i sigurnosti terapije za pacijente, postoji neprestani 
zahtjev za razvojem novih analitičkih metoda za određivanje lijekova u farmaceutskim 
dozirnim oblicima i biološkim tekućinama. Elektroanalitičke tehnike su jako osjetljive, 
selektivne, točne i precizne, a istodobno jednostavne i relativno jeftine s kratkim vremenom 
analize. Zahvaljujući svojim brojnim prednostima, u posljednje vrijeme pronalaze sve 
značajniju primjenu u analitici lijekova. Među njima se ističu voltametrijske tehnike, kao 
najčešće korištene u području kvalitativnih i kvantitativnih ispitivanja lijekova. Razvoj 
elektroanalitičkih tehnika usmjeren je ponajprije na razvoj novih elektrokemijskih senzora, 
među kojima se posebno ističu nanosenzori. Ugljikove nanocjevčice, zbog svoje jedinstvene 
strukture i izvanrednih svojstava, privukle su veliku pozornost u pripremi elektrokemijskih 
senzora. Stoga su u sklopu ove doktorske disertacije razvijene nove voltametrijske metode za 
određivanje odabranih elektroaktivnih lijekova slabo bazičnih svojstava primjenom 
elektrokemijskih senzora s ugljikovim nanocjevčicama. Ugljikove nanocjevčice dispergirane 
su u polimernom matriksu Nafiona, a u nekim ispitivanjima i dodatno obogaćene 
nanočesticama cirkonijeva dioksida (ZrO2). Nakon validacije u skladu s ICH smjernicama, 
metode su primijenjene za određivanje lijekova u gotovim farmaceutskim oblicima, kao i za 
simultane analize zajedno primjenjivanih lijekova u terapiji ili lijekova i metabolita u 
biološkim tekućinama. 
 
Metode: Različite voltametrijske tehnike korištene su u svrhu kvalitativnog i kvantitativnog 
ispitivanja odabranih lijekova. Cikličkom voltametrijom ispitano je elektrokemijsko 
ponašanje lijekova radi stjecanja uvida u mehanizam i kinetiku redoks procesa koji se odvijaju 
na modificiranim elektrodama. Pravokutnovalna voltametrija primijenjena je za određivanje 
sadržaja ondansetrona, ropinirola, levodope i mesalazina u tabletama. Diferencijalna pulsna 
voltametrija primijenjena je za određivanje sadržaja nebivolola u tabletama. Tablete su 
nabavljene u ljekarnama u Republici Hrvatskoj. Kao usporedna tehnika za evaluaciju točnosti 
i preciznosti novorazvijenih metoda korištena je tekućinska kromatografija visoke 
djelotvornosti (HPLC) primjenom statističkih alata. Adsorptivna pravokutnovalna tehnika 
korištena je za simultanu analizu ondansetrona s morfinom i ropinirola s levodopom te 
mesalazina s glavnim N-acetiliranim metabolitom, dok je adsorptivna diferencijalno pulsna 
  
metoda primijenjena za određivanje nebivolola u uzorcima seruma. Uzorci seruma prikupljeni 
su od zdravih dobrovoljaca koji nisu uzimali nikakvu drugu terapiju u vrijeme davanja krvi te 
su potpisali informirani pristanak i bili upoznati sa svrhom korištenja dobivenih uzoraka 
seruma. Predloženi elektrokemijski senzori pripremljeni su dispergiranjem nanomaterijala u 
Nafionu te nanošenjem odgovarajućih volumena suspenzije na površinu prethodno ispolirane 
elektrode od staklastog ugljika, nakon čega je uslijedila evaporacija otapala. Morfologija 
površine pripremljenih senzora ispitana je elektronskom mikroskopijom (scanning electron 
microscopy, SEM) te cikličkom voltametrijom. U svrhu obrade podataka za potrebe ovog 
doktorskog rada korišteni su programski paketi GPES 4,9 μ-Autolab potenciostata te 
Microsoft office Excel 2010 i OriginPro 7,5 i 9,0. 
 
Rezultati:  
Elektrokemijsko ponašanje antiemetika ondansetrona ispitano je prvi put u sklopu 
ovog doktorskog rada na nemodificiranoj i modificiranoj elektrodi od staklastog ugljika. U 
odnosu na nemodificiranu elektrodu, modifikacija elektrode ugljikovim nanocjevčicama u 
polimernom matriksu dovela je do izvanrednog poboljšanja voltametrijskog odgovora 
ondansetrona zahvaljujući sinergističkom učinku modifikatora. 0,1 M sumporna kiselina 
odabrana je kao optimalni elektrolit, a najveća osjetljivost dobivena je nanošenjem 5 μL 
suspenzije koja je sadržavala ugljikove nanocjevčice i Nafion u omjeru 1:1. Razvijena metoda 
primijenjena je za određivanje sadržaja ondansetrona u tabletama metodom standardnog 
dodatka. Dobivena vrijednost analitičkog prinosa od 99,7 % ukazuje na dobru točnost metode 
te prikladnost predloženog senzora za ovu svrhu. Analitički prinos dodane otopine standarda u 
prethodno analiziranu otopinu tableta od 98,1 % pokazuje da pomoćne tvari u formulaciji ne 
interferiraju s određivanjem aktivne tvari te nije potreban separacijski korak. Rezultati su 
uspoređeni s rezultatima razvijene HPLC metode te je statističkom analizom pokazano da 
nema značajne razlike u izvedbi ovih dviju metoda što se tiče točnosti i preciznosti. 
Predloženi senzor uspješno je primijenjen i za simultanu analizu s analgetikom morfinom u 
uzorcima seruma s kojim se nerijetko primjenjuje u terapiji. Dobivena je linearna ovisnost 
njihovih voltametrijskih odgovora u području koncentracija 1,0 x 10-7 – 5,0 x 10-6 M za 
ondansetron i 1,0 x 10
-7
 – 4,0 x 10-6 M za morfin nakon akumulacije pri optimalnim 
vrijednostima Eacc = -0,5 V i tacc = 360 s. Razlika potencijala od 430 mV između strujnih 
vrhova ondansetrona i morfina te niska granica detekcije (3,1 x 10
-8
 za ondansetron i 3,2
-8
 M 
  
za morfin) omogućili su simultano određivanje vrlo niskih koncentracija ondansetrona i 
morfina kakve se mogu naći u biološkim tekućinama nakon primjene uobičajenih terapijskih 
doza s vrijednostima analitičkih prinosa 98,7 % ± 1,5 % za ondansetron i 102,6 % ± 2,7 % za 
morfin. 
Nanosenzor predložen u sklopu ovog doktorskog rada pokazao je izvrsnu osjetljivost i 
selektivnost te je primijenjen u razvoju nove analitičke metode za simultanu analizu ropinirola 
i levodope. Iako se ropinirol i levodopa vrlo često koriste zajedno u terapiji Parkinsonove 
bolesti, dosad u literaturi nije bilo analitičke metode za njihovu simultanu analizu. Za 
optimalnu izvedbu nanosenzora primijenjeno je 5 μL suspenzije koncentracije 1 mg/mL, pri 
čemu je uzeta 0,5 % etanolna otopina Nafiona. Sva mjerenja u svrhu kvantifikacije provedena 
su u 0,1 M sumpornoj kiselini. Pri optimalnim uvjetima postignut je linearan odgovor za 
ropinirol u širokom području koncentracija 1,0 x 10-7 – 1,0 x 10-5 M te 2,5 x 10-7 – 1,0 x 10-5 
M za levodopu. Velika razlika potencijala od 720 mV omogućila je simultanu analizu 
ropinirola i levodope uz optimalnu akumulaciju pri Eacc = 0 V i tacc = 240 s prije samog 
voltametrijskog mjerenja. Dobivene su vrijednosti analitičkih prinosa 99,6 % ± 2,2 % za 
ropinirol i 98,8 % ± 2,3 % za levodopu u složenom matriksu poput seruma bez kompliciranog 
postupka ekstrakcije prije analize. Nadalje, predloženi senzor primijenjen je i za individualno 
određivanje sadržaja ropinirola i levodope u gotovim farmaceutskim oblicima. Dobiveni 
rezultati pokazuju slaganje s deklariranim sadržajima u tabletama. Vrijednosti analitičkih 
prinosa od 99,2 % za ropinirol i 99,4 % za levodopu ukazuju da pomoćne tvari ne 
interferiraju, a t-test i F-test da nema statistički značajne razlike u pogledu točnosti i 
preciznosti između novorazvijenih voltametrijskih i HPLC metoda. 
U sklopu ovog doktorskog rada razvijena je prva elektroanalitička metoda za 
simultanu analizu mesalazina i N-acetiliranog metabolita. Po prvi put ispitano je 
elektrokemijsko ponašanje metabolita mesalazina. Zahvaljujući svojim odličnim svojstvima 
predloženi nanosenzor omogućio je selektivno određivanje strukturno vrlo sličnih spojeva kao 
što su lijek i njegov metabolit zajedno u serumu bez prethodne separacije. Razlika potencijala 
na senzoru s ugljikovim nanocjevčicama u polimernom matriksu bila je 200 mV. Senzor je 
pripremljen nanošenjem 3 μL suspenzije ugljikovih nanocjevčica u omjeru 1:1 s 0,3 % 
etanolnom otopinom Nafiona. Britton-Robinson pufer pH 2,0 pokazao se kao optimalan za 
simultanu kvantifikaciju. Bilo je potrebno svega 30 sekundi za simultano određivanje 
mesalazina i metabolita u složenom matriksu poput seruma s visokom osjetljivošću (2,33 x 
10
7
 za mesalazin i 8,37 x 10
6
 μA M-1 za metabolit) i bez interferencija s endogenim biološkim 
  
tvarima, što se vidi po vrijednostima analitičkih prinosa 100,1 % ± 2,7 % za mesalazin i 99,3 
% ± 2,8 % za N-acetilirani metabolit. Direktnom pravokutnovalnom voltametrijom određen je 
sadržaj mesalazina u dva različita farmaceutska oblika dostupna na tržištu Republike 
Hrvatske. Dobivene vrijednosti analitičkih prinosa u vrijednosti 100,7 % te 99,8 %  
omogućuju usporedbu njihove kvalitete i ukazuju na slaganje s deklariranim sadržajima u oba 
slučaja. Ispitan je utjecaj pomoćnih tvari na voltametrijski odgovor mesalazina i ustanovljeno 
je da nema interferencije (analitički prinos u rasponu 98,4 – 101,6 % za oba farmaceutska 
proizvoda). Usporedbom točnosti i preciznosti s postojećim HPLC metodama u literaturi, 
zaključeno je da nema statistički značajne razlike u njihovim izvedbama. 
U sklopu razvoja nove voltametrijske metode za određivanje kardioselektivnog beta 
blokatora nebivolola u farmaceutskom dozirnom obliku i serumu, senzor predložen u ranijim 
istraživanjima dodatno je obogaćen nanočesticama ZrO2 kako bi se integracijom učinaka 
dvaju nanomaterijala na elektrokatalitičku aktivnost postigao još bolji voltametrijski odgovor 
lijeka i veća osjetljivost metode za praćenje terapijskih koncentracija lijeka u serumu. Posebna 
pažnja pridodana je optimizaciji samog nanosenzora. S ciljem dobivanja maksimalne 
osjetljivosti sinergističkim djelovanjem ugljikovih nanocjevčica, ZrO2 nanočestica i Nafiona, 
ispitan je utjecaj omjera koncentracija dvaju nanomaterijala, koncentracije Nafiona u 
etanolnoj otopini te volumena konačne suspenzije na elektrokemijsko ponašanje nebivolola. 
Na inovativnom nanosenzoru dobiven je linearni odgovor nebivolola u području koncentracija 
1,5 x 10
-6
 – 1,0 x 10-4 M bez akumulacije te u području koncentracija 1,0 x 10-7 – 6,0 x 10-6 M 
s akumulacijom od 240 sekundi neposredno prije voltametrijskog mjerenja. Diferencijalno 
pulsnom voltametrijom određen je sadržaj nebivolola u tabletama i pokazano je slaganje 
dobivenih rezultata s deklariranim sadržajem (analitički prinos 98,3 %). Nema statistički 
značajne razlike u odnosu na rezultate dobivene prethodno razvijenom HPLC metodom. 
Utjecaj pomoćnih tvari ispitan je metodom standardnog dodatka i ustanovljeno je da nema 
interferencija (analitički prinos 98,1 %). Očekivane koncentracije nebivolola u serumu nalaze 
se unutar linearnog područja metode nakon kratke akumulacije na površinu elektrode te je 
adsorptivna diferencijalno pulsna voltametrija korištena za određivanje nebivolola u uzorcima 
seruma. Srednja vrijednost analitičkog prinosa 100,8 % ukazuje na odličan potencijal 
predloženog nanosenzora za praćenje nebivolola u biološkim tekućinama. 
 
 
  
Zaključak: Razvoj novih elektroanalitičkih metoda predstavlja važan znanstveni doprinos u 
analizi onih lijekova za koje ovakve metode nisu dosad uopće razvijene ili nisu razvijene na 
inovativnim elektrokemijskim senzorima. Nanosenzori predloženi u sklopu istraživanja ovog 
doktorskog rada znatno su utjecali na poboljšanje osjetljivosti, selektivnosti i 
reproducibilnosti novorazvijenih metoda zahvaljujući sinergističkom učinku modifikatora. S 
druge strane, predloženi nanosenzori pokazuju dobru stabilnost u duljem vremenskom 
razdoblju, a njihova priprema i regeneracija su vrlo jednostavne i brze. Suvremene 
elektroanalitičke metode temeljene na ovakvim inovativnim elektrokemijskim senzorima 
imaju velik potencijal za primjenu u složenom matriksu, kao što su farmaceutski dozirni 
oblici i biološke tekućine, ne samo za istraživanja u akademske svrhe, već i u rutinskim 
analizama lijekova. Predloženi nanosenzori mogu stoga doprinijeti u procjeni kvalitete 
gotovih farmaceutskih proizvoda te poslužiti u kliničkoj medicini i farmaciji za praćenje 
terapijskih koncentracija lijekova u biološkim uzorcima s ciljem postizanja što boljeg 
farmakološkog učinka i manje toksičnih nuspojava. 
 
KLJUČNE RIJEČI: ugljikove nanocjevčice, nanočestice cirkonijeva dioksida, Nafion, 
voltametrija, elektrokemijski nanosenzori, ondansetron, morfin, ropinirol, levodopa, 
mesalazin, N-acetilirani metabolit mesalazina, nebivolol 
 
 
 
 
  
ABBREVIATIONS AND SYMBOLS 
 
A                   electrode area 
Ac-5-ASA    N-acetylated metabolite of mesalazine 
AdDPV        adsorptive differential pulse voltammetry 
AdSV           adsorptive stripping voltammetry 
AdSWV       adsorptive square wave voltammetry 
API              active pharmaceutical ingredient 
BDD            boron-doped diamond  
BDDE          boron-doped diamond electrode 
BR                Britton-Robinson 
C                  concentration 
CE                cappilary electrophoresis 
CEC             capillary electrochromatography 
CMEs           chemically modified electrodes 
CNTs            carbon nanotubes 
CP                 carbon paste 
CV                cyclic voltammetry 
CVD             chemical vapor depostition 
D                  diffusion coefficient 
DMF            dimethylformamide 
DNA            deoxyribonucleic acid   
DPV             differential pulse voltammetry 
Emax              maximum peak potential   
Emin              minimum peak potential  
Ep,a                    anodic peak potential 
Ep,c               cathodic peak potential 
  
EDXS          energy dispersive x-ray spectroscopy 
Esw               square-wave amplitude 
f                    frequency 
FIA              flow injection analysis 
GC               glassy carbon, gas chromatography  
GCE             glassy carbon electrode 
HOPG          highly oriented pyrolytic graphite  
HPLC           high performance liquid chromatography 
Ip,a                 anodic peak current 
Ip,c                  cathodic peak current 
L-dopa          levodopa 
LC                 liquid chromatography 
MALDI         matrix-assisted laser desorption ionization 
MOR             morphine 
MWCNTs     multi-walled carbon nanotubes 
n                    number of electrons 
na                            number of electrons in the rate-determining step 
NBV             nebivolol 
NPs               nanoparticles 
NPV              normal pulse voltammetry 
OND             ondansetron 
Ph.Eur.          European Pharmacopoeia 
ROP              ropinirole 
RVC              reticulated vitreous carbon 
SEM              scanning electron microscopy 
SPAB            2-hydroxy-5-[(4-sulfophenyl)azo]benzoic acid 
SPC               screen-printed carbon strips 
  
SPE               solid phase extraction 
SPME           solid phase micro extraction 
SV                 staircase voltammetry, stripping voltammetry 
SWCNTs      single-walled carbon nanotubes 
SWV             square-wave voltammetry 
XRD             X-ray diffraction 
5-ASA          5-aminosalicylic acid, mesalazine 
α                   charge transfer coefficient 
ν                   scan rate 
τ                   duration of a potential cycle 
ΔE               step potential 
ΔI                difference in current 
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1.1. The importance of pharmaceutical analysis  
 
In recent years, there has been extraordinary progress in the discovery, synthesis, 
sensitive analysis and means of delivery of pharmaceutically active compounds used in the 
diagnosis, prevention and treatment of human diseases [1]. During the development of a new 
drug product from the discovery stage to the commercial market, analytical chemistry plays a 
great role [2]. The pharmaceutical and biomedical analysis is among the most important 
branches of applied analytical chemistry [3]. Drug analysis is essential in various stages of 
drug design and development, such as quality control, stability testing, preclinical and clinical 
trials [4,5]. All these investigations require sensitive and reliable analytical methods in order 
to measure drugs in pure and formulated forms as well as in complex media such as biofluids 
[5] with the aim of obtaining data that can contribute to the maximal efficacy and safety of 
drug therapy and maximal economy of the production of pharmaceuticals [6]. The increased 
level of regulatory scrutiny under which the pharmaceutical industry should operate has also 
fostered the continued development of analytical methods [4].  
1.2. Electroanalytical techniques in pharmacy 
 
Electrochemistry is a fast-growing field with a number of possible applications in 
pharmacy. The great diversity of electroanalytical methods allows the application of 
electrochemistry in various stages of drug research and development [7]. Oxidation and 
reduction of functional groups are also important transformations in organic synthesis [8] and 
therefore, electroorganic synthesis of pharmacologically interesting molecules can be used in 
the early stages of drug research [9]. It represents a cost-efficient and sustainable ''green-
chemistry'' method [8,10,11] with possibility of easily scaling up many electrochemical 
reactions [12]. Furthermore, electroorganic synthesis can provide outstanding selectivity and 
reactivity due to accurate potential control [7] and in some cases the formation of products 
that are not accessible via conventional methods [10]. In recent years, there have been several 
examples of electrochemical synthesis of potential pharmaceuticals, such as novel 1,3-
indandione derivatives as possible antiplatelet agents [13], phenoxazine and diphenoxazine 
derivatives which were shown through previous examinations to be effective antitumor, 
antileukemia and antimicrobial material [14], benzoxazoles that represent an important 
structure of several natural products, pharmaceuticals and biologically active compounds [15] 
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and benzofuranoquinone derivatives [16] with triad structures of catechol, benzofuran and 
quinone that were shown to be useful from the point of view of pharmaceutical properties. 
In addition to the synthetic approach, electrochemistry can be used at an early stage of 
drug research for screening the pharmacological activity of a homologous series of newly 
synthesized molecules [9]. The screening is based on correlation between oxidation or 
reduction potential of investigated group of compounds with their molecular structure and 
pharmacological activity [7]. For example, the relationship between antioxidant activity of 
natural phenolic compounds and their voltammetric behaviour was investigated using 
electroanalytical approach [17]. Antioxidant capacity of several drug products with 
acetylsalicylic acid was also evaluated using voltammetry [18]. In early screening of new 
analogues of clozapine, oxidation potential was correlated with their potential for 
hematotoxicity. It was shown that only the compounds that did not easily oxidise could be 
promising antipsychotic candidates with low side effects [19]. 
Electroanalytical methods can be quite useful to directly measure the stability of 
certain pharmaceuticals in aqueous solution [20]. Depending on the compounds involved it 
can be used to monitor either the decomposition of a drug [21–24] or the formation of a 
decomposition product [25,26].  
Electron transfer reactions have an important role in biochemical processes and hence 
in biotransformation of drugs [7]. Due to similarity in the electrochemical and biological 
reactions, it can be assumed that the oxidation/reduction mechanisms taking place at the 
electrode and in the body share similar principles [27]. In such cases, when a relationship 
between voltammetry and drugs exists, the knowledge of the mechanism of their electrode 
reactions can help us to elucidate the mechanism of their interaction with living cells [28] and 
their metabolic fate [29,30] in the human body after administration of the dosage form [31].  
Using modern electroanalytical techniques, interactions of drugs with biologically 
important macromolecules can be studied [7]. The extent to which a drug is bound to plasma 
proteins may influence its distribution, onset of activity and rate of metabolism and excretion 
[20]. In pharmacology, the free drug concentration, as opposed to the total drug concentration, 
is suggested to reflect therapeutic efficacy. Banis et al. examined sensing performance of 
clozapine using fundamental electrochemical methods with respect to the impact of protein 
binding, showing lack of significant electrochemical activity resulting from bound clozapine 
in protein complexes [32]. The decay in the current of paracetamol, after the addition of 
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protein, also confirmed a decrease in free drug concentration and formation of electroinactive 
biocomplex [33]. Since the discovery of the electrochemical activity of nucleic acids, 
interaction of anticancer drugs and other DNA targeted molecules with DNA has been the 
focus of many electrochemical investigations [34]. Electrochemical approach can provide new 
insight into rational drug design and would lead to further understanding of the interaction 
mechanism between anticancer drugs and DNA [35–37]. The interaction mechanism can be 
investigated in three different ways, by using DNA modified electrode, drug-modified 
electrode and interaction in solution [38]. Moreover, DNA modified electrodes have recently 
been often used in developing novel electrochemical biosensors for selective drug 
determination [39–41]. 
Although there is an increase in utility of electrochemical methods in different parts of 
pharmaceutical field, most publications dealing with electrochemistry describe its use in 
solving analytically oriented pharmaceutical problems [9]. It can be used as an alternative or 
complementary technique to spectrophotometric and separation chromatographic techniques 
due to their many advantages [1,4]. Nevertheless, those methods are still commonly employed 
for the determination of the drug in bulk form, pharmaceutical formulations and biological 
fluids despite their many disadvantages, such as the need for derivatization, time-consuming 
extraction procedures, consumption of large solvent volumes, expensive instrumentation and 
running costs [27].  
On the other hand, electroanalytical methods are a powerful and versatile analytical 
tool that offers high sensitivity, selectivity, accuracy and precision, often in spectacularly 
reproducible way [6] with relatively simple and inexpensive instrumentation [31] and rapid 
analysis time [4]. It only requires very small sample volumes, often in microliter range. For 
these reasons, electrochemistry is suited for the analysis of pharmaceuticals in biological 
samples for clinical investigations, where small volumes of blood or urine are analysed for 
low concentrations of drug products and metabolites [1]. Besides in biological fluids, 
electroanalytical methods are well suited for the determination of drugs in various samples, 
such as raw material and different pharmaceutical dosage forms, even those involving a 
complex matrix, due to their very large useful linear concentration range [31].  
They are, of course, restricted to determination of compounds, which can undergo 
electrochemical oxidation or reduction in the available potential range, which depends on the 
structure of the analysed species [42]. Most of the pharmaceutical active compounds were 
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found to be as electrochemically active and readily oxidised or reduced in contrast to the 
excipients of pharmaceutical dosage forms [1]. The principal advantage is that electroanalysis 
of pharmaceuticals in their dosage forms or biological samples is usually not affected from 
the possible interferences depending on their oxidation or reduction potentials [1] and 
generally the separation and extraction procedure is not necessary [43]. 
They can also be used as electrochemical detectors as they can very well adapt to 
hydrodynamic conditions such as those encountered in liquid chromatography (LC), in 
capillary electrophoresis, or in flow injection analysis (FIA) applied to drug compound 
analysis [42]. Some of them are already implemented in European Pharmacopoeia (Ph. Eur.), 
such as potentiometry, voltammetry, conductometry or amperometric titration in the 
determination of water in pharmaceutically active compounds by Karl-Fischer titration [44]. 
The application of electrochemical techniques in the analysis of pharmaceuticals has 
greatly increased over the few years [31] and there are many examples demonstrating 
applicability of these methods in pharmaceutical and biomedical area, with only few selected 
ones presented here, seeing that the extent of this doctoral thesis makes it impossible to quote 
all papers dealing with various electrochemical, especially voltammetric determination of 
drugs [45–66]. Examples include mainly innovative electrode materials and techniques, 
similar to those used for the research in this doctoral thesis and described in the following 
chapters. 
1.3. Voltammetry  
 
Among the variety of electrochemical techniques available for drug analysis, 
voltammetry has become the most important and widespread technique [42]. The term 
voltammetry refers to a group of electroanalytical methods in which information about 
analyte is aquired by measuring current in an electrochemical cell as a function of applied 
potential [67]. A plot of potential vs. current is called a voltammogram. Analysis of 
voltammograms can yield analytical, kinetic and thermodynamic information as well as 
information on other phenomena such as adsorption on the electrode surface [42]. Some of the 
most important types of voltammetry, which are used for gaining both qualitative and 
quantitative information about investigated drugs in this doctoral thesis, are discussed in the 
following sections. 
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1.3.1. Cyclic voltammetry 
In cyclic voltammetry (CV) the current response of a small stationary electrode in an 
unstirred solution is excited by a triangular voltage waveform [42], which is shown in Figure 
1, a). 
 
Figure 1. One cycle of the triangular potential-excitation signal (a). The resulting cyclic 
voltammogram (b). From [68]. 
 
The starting potential value is usually selected so that the chemical species under 
investigation is not initially oxidised or reduced. The potential is then swept to a voltage Emax 
or Emin (positive or negative sweep, respectively), at which point the scan direction is reversed 
back to the original or to a different potential value. The potential window is selected so that 
includes the oxidation or reduction process of interest. The current vs. applied potential curve 
is recorded over one sweep (linear sweep), one cycle or multiple cycles [42]. The rate of 
change of potential with time is referred to as the scan rate [1]. 
CV is the most widely used technique for acquiring qualitative information about 
electrochemical reactions [11] of new systems and has also proven very useful in obtaining 
information about fairly complicated electrode reactions particularly in the field of organic 
chemistry and pharmaceutical compounds [42]. It is perhaps the most versatile 
electroanalytical technique in pharmaceutical analysis [27] and often the first experiment 
performed in an electrochemical study [27,42]. The power of CV results from its ability to 
rapidly determine formal redox potentials of electroactive species, determine number of 
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electrons transferred and number of protons involved in redox reaction [9], detect chemical 
reactions that precede or follow electron transfer or evaluate electron transfer kinetics [11,27]. 
The important parameters in CV are the magnitudes of the peak currents, Ip,a and Ip,c 
and the potentials at which peaks occur, Ep,a and Ep,c (Figure 1, b)) that provide the basis for 
analysing the cyclic voltammetric response [11]. A redox couple in which both species 
rapidly exchange electrons with electrode, i.e. the potential-current profile which is governed 
solely by diffusion and by Nernst equation, is termed an electrochemically reversible couple. 
For a reversible couple, the anodic peak current, Ip,a , is given by the Randles-Sevcik equation 
(T = 25 ºC): 
Ip,a = 2,69 x 10
5
 n
3/2 
A D
1/2
 ν1/2 C 
where Ip,a is the anodic peak current (in amperes), ν is the scan rate (V s
-1
), n is the 
number of electrons transferred per species, A is the electrode area (cm
2
), D is the diffusion 
coefficient of the electroactive species (cm
2
s
-1
) and C is the concentration of analyte in bulk 
solution (mol cm
-3
). For a cathodic peak, Ip,c is given by the same expression but with a 
negative sign [42].  
Moving towards irreversible CV systems, when the kinetics has a successively greater 
effect in slowing the electron transfer, the current peaks become more widely separated. In the 
irreversible limit, no reverse reaction is observed, which happens with the oxidation of the 
most pharmaceutical compounds (38). For an irreversible system the peak current is: 
Ip = 2,99 x 10
5
 n(αna)
1/2 
A D
1/2
 ν1/2 C 
where na is the number of electrons in the rate-determining step of the electrode 
process and α is the charge transfer coefficient. The detection limit of CV is usually about 10-6 
M and it is not sensitive enough to determine drugs in body fluids after therapeutic doses [43], 
but it can be very useful in optimising analytical conditions [3]. 
1.3.2. Pulse voltammetric techniques 
Many limitations of CV, such as slowness and poor detection limits, were overcome 
by the development of pulse methods [67]. The potential step is the basis of various pulse 
techniques and sequence of such potential steps, each with a duration between 20 and 50 ms, 
is applied to the working electrode [11,42]. Due to the short pulse duration, great increase in 
sensitivity is achieved when compared to sweep or similar voltammetric methods. By 
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substantially increasing the ratio between the faradaic and non-faradaic currents compared to 
sweep techniques and increasing sensitivity, pulse techniques may permit a limit of 
quantitation at about 10
-8
 M concentration level, and, with correctly chosen parameters, the 
measured current consists almost solely of the faradaic current [42].  
The difference between the various pulse voltammetric techniques is the excitation 
waveform and the current sampling regime [11]. After developing more sensitive pulse 
methods, the electroanalytical methods are more regularly used on the drug analysis in their 
dosage forms and especially in biological samples [1]. The most common types are staircase 
(SV), normal pulse (NPV), differential pulse (DPV) and square wave (SWV) voltammetric 
techniques, the most widely used being DPV and SWV [42]. 
1.3.2.1. Differential pulse voltammetry 
Application of fixed-magnitude pulses superimposed on a linear potential waveform to 
the working electrode results in differential pulse voltammetric techniques [69]. The 
minimisation of charging current is achieved by sampling the current twice [1,42], before 
pulse application and at the end of the pulse (Figure 2, a)). The difference in current (ΔI) per 
pulse is recorded [67] as a function of the linearly increasing excitation voltage (Figure 2, b)). 
 a)                                                                           b) 
 
 
 
 
 
 
Figure 2. Potential program for differential pulse voltammetry (a). From [69]. Voltammetric 
profile of ΔI versus staircase potential in DPV (b). From [70]. 
A consequence of double sampling and representing ΔI against potential is that the 
DPV curves are peak-shaped and thus are well suited to analytical purposes [43]. Peak height 
is directly proportional to the concentration of electroactive species [42]. Because of the 
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derivative shape of differential pulse voltammograms, the resolution of two compounds with 
similar redox potentials is improved. Individual peak maxima without overlapping can be 
observed for substances with a small potential difference such as 40-50 mV. In contrast, 
normal-pulse voltammetry requires a potential difference of about 200 mV for resolving 
waves [67]. Due to its high sensitivity and the availability of low-cost instruments, DPV is 
often the choice for the determination of drug-active compounds in their dosage forms and in 
body fluids [42]. 
1.3.2.2. Square-wave voltammetry 
SWV is a powerful electrochemical technique suitable for analytical application, 
mechanistic study of electrode processes and electrokinetic measurements. Nowadays it is 
considered as one of the most advanced voltammetric techniques, which unifies the 
advantages of pulse techniques (enhanced sensitivity), cyclic voltammetry (insight into the 
electrode mechanism) and impedance techniques (kinetic information of very fast electrode 
processes) [71]. In SWV, a waveform composed of a symmetrical square wave and 
superimposed on a base staircase potential is applied to the working electrode [11] (Figure 3, 
a)). 
  
Figure 3. Potential waveform (a) and one potential cycle (b). From [72]. 
 
The main parameters of a potential cycle composed of two neighbouring pulses 
(Figure 3, b)) are the height of the pulses (reffered as the SW amplitude, Esw), SW frequency 
(f, defined as f =1/τ, where τ is the duration of a potential cycle) [72] and height of the 
staircase waveform (potential increment, step potential, ΔE) [73].  
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The current is sampled twice during each square-wave cycle, once at the end of the 
forward pulse and once at the end of the reverse pulse (Figure 3, b)). The difference between 
the two measurements is plotted versus the base staircase potential [11]. Similarity with DPV 
lies in the fact that the current is sampled at two different times in the waveform [1] and that 
detrimental effects of charging current are reduced [42], however SWV has few advantages 
over DPV and other pulse techniques which is why it is employed more often than others in 
pharmaceutical analysis [1]. The main advantage of SWV is its speed. The analysis time is 
drastically reduced; a complete voltammogram can be recorded within a few seconds, where 
in DPV it takes about 2-3 minutes [11]. 
 
Figure 4. Square-wave voltammetry (SWV): (a) reversible and (b) irreversible 
reaction. From [42]. 
The values of the forward and reverse current are subtracted so that the plot of current 
difference vs. staircase potential yields a peak-shaped voltammogram [42]. The two 
components of the SWV response, the current response of the forward and reverse series of 
pulses, can be displayed as well as the net current (Figure 4). Excellent sensitivity arises from 
the fact that net current is larger than either the forward or reverse components (since it is the 
difference between them) which is why the peak height is usually quite easy to measure with 
greater accuracy than in DPV. The sensitivity is usually higher than that of DPV (in which the 
reverse current is not used) [11], but detection limits for SWV can also be similar to the 
detection limits for DPV (10
-7
 – 10-8 M) [42]. Due to the outstanding resolution of the 
voltammetric response, SWV is applied for simultaneous determination of compounds with 
close redox potentials. SWV method was applied to numerous drug active compounds 
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because of its sensitivity and rapidity and it is very useful for drug analysis in their dosage 
forms and biological samples because of the low LOD and LOQ values achieved with it [1]. 
1.3.2.3. Stripping voltammetry 
Growing concerns about trace amounts of pharmaceutically active compounds and 
heavy metal combinations have led to an increase in the monitoring of their low amounts in a 
variety of matrices such as biological fluids or wastewater samples and environment [42,74]. 
In the analysis of such dilute samples, it is often necessary to employ some type of 
preconcentration step prior to the actual quantification. This happens when the analyte 
concentration is below the detection limit of the instrumental technique applied [43]. 
Stripping voltammetric (SV) forms a subdivision of voltammetry and constitutes one of the 
most important groups of electroanalytical techniques [1].  
There are different types of SV, classified primarily by the nature of the 
preconcentration steps and scan direction of the stripping steps: anodic, cathodic, adsorptive 
(AdSV) or potentiometric stripping voltammetry [42]. Even though those techniques have 
their own unique features, they all have two steps in common [4]. First, the analyte is 
accumulated or deposited on the electrode surface at open curcuit or under controlled applied 
potential. During this accumulation step, the solution is usually stirred to increase solution 
flow and thus also increasing the deposition rate. After equilibration, if needed, and after stop 
stirring, the measurement (stripping) step is carried out [42]. Depending on the nature of 
analyte, different modes of stripping analysis are used, such as linear sweep, NPV, DPV SWV 
or potentiometric methods [1]. Pulse voltammetric waveforms are especially useful for the 
stripping step as they effectively correct for background current contributions [4]. Using DPV 
and SWV in the determination step, following the preconcentration, the detection limits can 
be lowered down to 10
-10
 – 10-12 M [42]. Because of that, SV represents an extremely 
sensitive electroanalytical technique [11] and can also increase in many cases the selectivity 
of the method as it is less sensitive to matrix effects from excipients (in drug dosage forms) or 
endogenous substances (in biological media) [27]. 
Numerous pharmaceuticals and biomolecules have a strong tendency to be adsorbed 
from solutions onto an electrode surface [9] so the application of AdSV in the determination 
of pharmaceuticals in biological fluids and drug dosage forms have been widely reviewed. 
The primary difference between AdSV and other stripping methods is that preconcentration 
step of the analyte is accomplished by adsorption on the electrode surface or by specific 
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reactions at chemically modified electrodes rather than accumulation by electrolysis. To 
achieve maximum sensitivity with AdSV, optimum conditions for maximum adsorption 
should be utilized during the accumulation step [4]. The main disadvantage of AdSV is 
interference from other substances in the sample solution. Such compounds are usually 
organic but can also be inorganic. Interference effects can often be minimised by applying the 
right accumulation potential, shorter accumulation time and appropriate electrolyte parameter 
(e.g. pH, buffer, ionic strength). AdSV techniques are well established and represent a large 
area with many possible applications in the analysis of pharmaceutically active compounds in 
their dosage forms or in biological media. AdSV with pulse techniques is highly selective, 
sensitive and precise for detecting ultra-trace amounts of pharmaceutically active compounds, 
important in research into drug design, bioavailability and safety [42].  
1.4. Electrodes in voltammetry 
Modern electroanalytical analyses are usually performed in a vessel containing a three 
electrode cell system [31], immersed in a solution containing the analyte and also an excess of 
a nonreactive electrolyte called a supporting electrolyte [67]. The performance of the 
voltammetric procedure is strongly influenced by the material of the working electrode [11]. 
As voltammetric methods continue to develop, the range of working electrode materials 
continues to expand [75]. A great challenge for high-quality electroanalytical determinations 
is reproducibility, a low background current, an easily renewable electrode surface and a fast 
electron transfer rate for target analyte [42]. 
Mercury used to be a very attractive choice of electrode material because it provides a 
clean, reproducible surface for each determination with every new drop [3]. It also has a high 
hydrogen overpotential that greatly extends the cathodic potential window (compared to solid 
electrode materials). Disadvantages of the use of mercury are its limited anodic range (due to 
the oxidation of mercury at low positive potentials) and its toxicity. The limited anodic 
potential range of mercury electrodes has precluded their utility for monitoring oxidizable 
compounds [11]. Moreover, at present time, in many countries the mercury electrodes are 
considered as undesirable due to the toxic character of mercury and related salts. 
Accordingly, solid electrodes with extended potential windows have attracted 
considerable analytical interest [11]. Despite the difficulty of controlling their surfaces in a 
reproducible manner, solid electrodes have distinct advantages over the mercury electrode 
[76]. They have much larger positive potential range and are more mechanically stable and 
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environmentally friendly. The performance of an electroanalytical method depends on the 
geometry and material composition of the solid electrode. In the selection of the solid 
material, the redox behavior of the analyte, the nature of the supporting electrolyte, the pH 
and the potential region required for the measurement of the redox processes of electroactive 
drugs have to be considered [42]. Many different solid materials can be used as working 
electrodes. The most often used are carbon-based and metal electrodes [76]. 
1.4.1. Carbon-based electrodes 
Carbon, in different forms, is the most widely used solid electrode material. The most 
popular carbon electrode materials are those involving glassy carbon (GC), carbon paste (CP), 
carbon fiber, screen-printed carbon strips (SPC), reticulated vitreous carbon (RVC), highly 
oriented pyrolytic graphite (HOPG), carbon films, pencil lead graphite, boron doped diamond 
(BDD), etc. [42]. Electrochemical reactions on carbon-based electrodes are often slower than 
at noble metal electrodes [11], the electron transfer kinetics being dependent on structure and 
surface preparation [11,42], but they have a wider useful potential range than metal electrodes 
in the negative and particularly so in the positive direction, due to slow kinetics of carbon 
oxidation [75]. 
 The high degree of delocalisation of π electrons, together with weak van der Waals 
forces, provide good electrical conductivity and influence the electrical double layer, 
molecular adsorption and electrode polarity [76]. The high surface activity of carbon materials 
explains their susceptibility to electrode fouling by adsorption of organic compounds and 
especially by electroactive pharmaceutical compounds. Many pretreatment cleaning 
procedures have been developed, depending on the type of carbon, both renewing the surface 
and activating carbon-based electrodes [42], and play a role in increasing the π electron 
transfer rates [75]. The successful application of carbon electrodes in electroanalytical studies 
of electroactive pharmaceutical compounds is due to the high chemical and electrochemical 
stability of carbon materials, relatively high hydrogen and oxygen overpotential in different 
electrolytes, a broad working potential range and availability of different carbon materials 
[42], as well as their low background current, rich surface chemistry and low cost [11].  
1.4.1.1. Glassy carbon electrode 
Glassy carbon electrode (GCE) represents the most commonly used carbon electrode 
in electroanalysis since the 1980s. The structure of GCE consists of graphitic planes randomly 
organised as tetrahedral domains in a complex topology linked by short oxygen-containing 
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bridges, closely related to that of a vitreous material, with high lustre and glass-like fracture 
characteristics, hence the designations of glassy carbon, vitreous carbon or pyrolytic carbon 
[42]. GCE has remarkable physico-chemical properties, such as high strength, high thermal 
and electrical conductivity [76] and also high chemical inertness [11] making it probably the 
most inert carbon-based material [42]. It is mechanically polishable, extremely impermeable 
to gases and liquids and compatible with all common solvents [75]. It is well known that the 
GCE electrode possesses six-membered aromatic ring structures (sp
2
 hybridized carbon) in 
which functional groups such as benzoquinone/ hydroquinone, phenolic and carboxylic acids 
are present [77]. These influence reactivity, and thence also chemical derivatisations that are 
possible on GCE [42]. The formation of these oxygen-containing functional groups is 
common for almost all carbon surfaces of sp
2
 hybridized materials due to their reaction with 
oxygen and water [78]. This surface chemistry can be very complex and has to be considered 
during the study of the structure-function relationships at carbon-based electrodes [42].  
1.5. Chemically modified electrodes  
As far as solid electrodes are concerned, their perfection consists of the development 
of electrochemical sensors, searching for and using new electrode materials [76]. Chemically 
modified electrodes (CMEs) consist of conducting or semiconducting materials modified 
using different reagents with the objective of obtaining specific surface properties for 
electroanalytical applications [42]. For electroanalytical purposes, such deliberate alteration of 
electrode surfaces aims at improving sensitivity, selectivity and/or stability [79]. It also very 
often enables preferential accumulation of analyte or acceleration of electron transfer 
reactions [11]. The unmodified electrodes are called ''bare'', ''native'' or ''virgin'' electrodes 
[42] .  
1.5.1. Carbon nanotubes-based electrochemical sensors 
Nano-sized materials, also called nanostructured materials, have been shown to have a 
number of novel and interesting physical and chemical properties which led to rapid growth 
of using nanotechnology in the sensor fields [80]. Among them various families of novel 
carbon materials with unique properties and advanced electrochemical performances emerged 
and rapidly established themselves as reliable alternatives in electroanalysis due to their nano-
sizes and/or special structures [81]. Electrochemical nanosensors have recently found 
extensive applications in pharmaceutical and biomedical industries with some great 
advantages such as lower detection limits, wider linear response range, sensitivity, good 
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stability and reproducibility when compared with other sensors and techniques. Carbon 
nanotubes (CNTs) represent an increasingly important group of nanomaterials  and they have 
recently received enormous attention in the preparation of electrochemical sensors [80] and 
biosensors [82].  
CNTs are built from sp
2
 carbon units arranged in graphene sheets, which have been 
rolled up to form a seamless hollow tube [83]. Based on the number of layers, structures of 
CNTs are classified into two types (Figure 5): single-walled carbon nanotubes (SWCNTs) and 
multiwalled carbon nanotubes (MWCNTs) [84,85]. SWCNTs, as the name suggests, consist 
of a single hollow tube with diameters between 0.4 and 2 nm while MWCNTs are composed 
of multiple concentric nanotubes 0.38 nm apart where the final MWCNT has diameters of 2–
100 nm [84]. At present, the three main methods employed for CNTs synthesis are arc-
discharge, laser ablation, and chemical vapor deposition (CVD) [86].  
 
 
 
 
 
 
Figure 5. Rolling a sheet of graphene to form SWCNT (a) and MWCNT (b). From 
[87]. 
CNTs, a novel carbon form, has been exploited as an electrode material in 
electroanalysis as a result of its unique structure [83] and extraordinary electronic, chemical 
and mechanical properties. Their impressive structural, mechanical and electronic properties 
are due to their small size and mass, their incredible mechanical strength [84],  high surface-
to-volume ratio [88], chemical stability [89] and their high electrical and thermal conductivity 
[84]. The conductivity of the tubes, as a consequence of their electronic properties, is 
important for the role of these unique nanomaterials in electrochemistry. MWCNTs are 
regarded as metallic conductors, a highly attractive property for an electrode. The situation is 
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not so clear for SWCNTs which can be metallic or semiconducting depending on their 
chirality [81] and diameter [80].  
 
Figure 6. Carbon nanotube structures of armchair, zigzag and chiral configurations. 
From [84]. 
 
The chirality of SWCNTs relates to the angle at which the grafene sheets roll up and 
hence the alignment of the π-orbitals [80]. There are three distinct ways for the molecule to do 
the rolling, depending upon its direction: armchair, zigzag, and chiral (Figure 6.). Thus, 
metallic nanotubes are achiral and in arm-chair configuration, while chiral and achiral zigzag 
tubes are semi-conducting [84].  
CNTs are have been proved to possess distinct electrochemical behaviour from other 
carbon-based electrode materials because of which they are intensively exploited in 
electrochemistry [90]. CNTs-based electrodes have been reported with various advantages, 
such as negligible surface fouling [81,90], increased heterogenous electron transfer (ET) rates 
[81] and consequently decreased over-potential [90], enhanced electroanalytical signals [91] 
shown as increased voltammetric currents [84] and also increased sensitivity and therefore 
lowered detection limits [90]. Analytical methods based on voltammetric stripping techniques 
have also benefited from the unique properties of CNTs-modified electrodes, mainly due to 
the stronger adsorption of many organic compounds on CNTs in comparison with 
conventional working electrode materials [91].  
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An important part of the impressive success of the use of CNTs for electroanalytical 
applications is probaby due to the ability of this nanomaterial to promote electron transfer in 
electrochemical reactions [91]. CNTs are closed structures that represent two well defined 
regions with clearly different properties, the tube and the cap (the tips and sidewalls), which is 
half-fullerene-like molecule with topological defects that in this case are mainly pentagons 
[92] (Figure 7).  
 
 
 
 
Figure 7. A carbon nanotube with closed ends. From [84]. 
 
The electrocatalytic effect of CNTs has been attributed to the activity of edge-plane-
like graphite sites at the CNTs ends. MWCNTs have a sidewall structure similar to graphite 
basal plane of HOPG, and the open-end is similar to the edge plane of HOPG. Accordingly, 
electron transfer rates similar to a graphite edge-plane electrode can be expected [91]. The 
presence of pentagonal defects produce regions with charge density higher than those 
observed in the region of hexagonal graphite, either in planar or in tubular structures 
demonstrating the connection between topological defects and CNTs electroactivity. It was 
proposed by Compton's group that the reason for enhanced electrocatalytic activity of CNTs 
is due to the presence of edge-plane like sites located at the end and in the ''defects'' areas of 
the tubes [93]. 
It has been demonstrated that the electrocatalytic activity of MWCNTs strongly 
depended on the CNTs fabrication mode [91] and a higher electrochemical reactivity of CNTs 
was achieved when they were produced in CVD manner [94]. With carbon electrodes the rate 
of electron transfer has been shown many times to be very surface dependant hence the 
electrochemical activity is also influenced by the electrode preparation  [90]. The protocols of 
pretreatment are typically based on the oxidation of CNTs under different conditions. 
Activation by treatment in acidic solutions has been widely used [92]. Modified electrodes 
with CNTs which were pretreated with concentrate acids in order to open nanotubes and to 
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create carboxylic groups (Figure 8), exhibited an intense catalytic activity towards the 
electrochemical oxidation [91]. 
 
 
Figure 8. Functionalisation of CNTs with strong acids. From [95]. 
 
Besides improving the electron transfer properties, this type of acidic purification is 
also used for eliminating metallic impurities [92]. Most widely used method in commercial 
preparation of CNTs is CVD in the presence of metal catalysts [81] which can usually cause 
for CNTs to have metallic, nanographitic and amorphous carbon-based impurities. These 
impurities can dramatically influence the electrochemical properties of CNTs and influence 
the electrochemical responses of a large number of substances on CNTs-based electrodes 
[96].  
Electrocatalytic activity of CNTs also depends on the dispersing agent used to 
immobilize them on the electrode surface [91], however one of the problems for the 
preparation of sensors based on the use of carbon nanotubes is to achieve a homogenous 
dispersion in usual solvents [92]. Before application to analytical assays, CNTs first must be 
modified to facilitate homogenous dispersion [97]. First step in the modification of CNTs 
with aim to improve their dispersion in various solvents has already been achieved upon 
purification of the nanotubes, mentioned above [80]. The ends of CNTs, being terminated in 
oxygenated species are quite hydrophilic but the walls, which comprise the vast majority of 
the tube, are highly hydrophobic. This hydrophobicity presents a major challenge when it 
comes to dispersing and manipulating CNTs to give controlled modification of electrode 
surface. In aqueous solution or in polar solvents tubes have a tendency to rapidly coagulate 
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(agglomerate). As a consequence, dispersing tubes is usually performed in non-polar organic 
solvents such as dimethylformamide (DMF) or with the aid of surfactants or polymers [92]. 
Using a polymer/CNTs composite is one way of improving the adhesion properties and the 
film reproducibility since CNTs poor adhesion to the electrode surface and the CNTs 
dispersion difficulty in most solvents results in the inconsistent electrocatalytic reaction at the 
electrode [90]. The preparation of hybrid composite materials, based on integration of CNTs 
with other materials possessing well-known electrochemical significance, has led to modified 
electrode surfaces that exhibit special properties due to the synergistic effect from the 
individual components. Materials used for such purposes mostly include polymers and metal 
nanoparticles, but composites with cyclodextrines, microparticles or more recently ionic 
liquids, have also been reported [91]. 
1.5.1.1. Carbon nanotubes/Nafion composite film 
The polymer that has been often used as dispersing agent for CNTs is Nafion [90]. 
CNTs can be homogeneously dispersed in Nafion solution because of the hydrophobic side 
chains and polar head groups of Nafion. CNTs/Nafion composite thin film modified 
electrodes have their attractive effects in electroanalytical applications [98]. In general, 
Nafion is the most extensively investigated ion-exchange polymer used for preparing CMEs 
 
[20]. It is generated by copolymerization of a perflourinated vinyl ether comonomer with 
tetrafluoroethylene [99] (Figure 9). Perfluorinated sulfonated cation exchanger has been 
widely used as an electrode modifier due to its attractive permselective, ion-exchange and 
antifouling properties [11].  
 
 
 
 
Figure 9. Chemical structure of Nafion. From [100]. 
 
Nafion is chemically and thermally inert, non-electroactive, conductive and insoluble 
in water and is, therefore, particularly suitable for the modification of electrodes [101]. 
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Previously reported results have shown that Nafion membrane can enrich metal cations, 
improve voltammetric signal-to-noise ratios, and increase the electrode’s resistance against 
fouling by surface-active compounds effectively [102]. The modification of GCE by Nafion is 
a quite simple and almost standardized way of enhancing electrode performances. After usual 
polishing procedures of the GCE electrode, the modification is typically obtained by dropping 
few microliters of alcoholic solution of Nafion onto the electrode surface, and by some 
subsequent drying procedure [103].  
One important reason for the application of Nafion modified electrodes in 
electroanalytical chemistry is their ability to preconcentrate positively charged molecules, 
which increases the sensitivity of the method. The accumulation mechanism of Nafion can be 
explained through an electrostatic interaction due to the hydrophilic negatively charged 
sulfonate groups in the polymer structure, whereas its ionic selectivity for hydrophobic 
organic cations is achieved through hydrophobic interactions with the hydrophobic 
fluorocarbons of the film. These two factors give Nafion selectivity for cations, and especially 
high selectivity for hydrophobic organic cations [104].  
In recent years, CNTs/Nafion-based electrodes have been increasingly used to solve 
demanding electrochemical problems and often offer advantages over other types of electrode 
materials [80]. The nano-hybridization by polymers is regarded as an effective technology for 
obtaining the stable colloidal dispersion while simultaneously preserving the inherent 
properties of carbon [105]. It is well known that homogeneous CNT dispersion and strong 
interfacial adhesion with the matrix are critical issues in the development of polymer/CNTs 
composites in order to attain improved properties. The combination of polymers with carbon 
nanomaterials for the preparation of chemical sensors is opening up exciting areas of research 
due to their biocompatibility, excellent sensitivity and selectivity [106].  
1.5.1.2. Metal nanoparticles and carbon nanotubes-based nanohybrids  
Nowadays, due to the fast development of nanotechnology, various nanomaterials, 
including carbon nanotubes, nanoparticles of metals and metal oxides, as well as their hybrids 
have been introduced to construct electrochemical sensors [107]. In recent years, metal 
nanoparticles (NPs) have attracted much more attention in electroanalysis because of their 
unusual physical and chemical properties [108]. These unique properties can often be 
advantageous in electroanalytical techniques [109] and can result in an enhanced mass 
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transport, high surface area and high electrocatalytic activity [110]. This is all owing to their 
nanosize and is not typical for the corresponding bulk material [111]. 
Generally, metal nanoparticles have excellent conductivity and catalytic properties, 
which make them suitable for enhancing the electron transfer rate [111] for compounds which 
have sluggish redox process at bare electrodes. The introduction of nanoparticles with 
catalytic properties into electrochemical sensors and biosensors can decrease overpotentials of 
many analytically important electrochemical reactions, and even realize the reversibility of 
some redox reactions, which are irreversible at common unmodified electrodes [108]. 
Incorporation of nanoparticles to CNTs electrode matrices has demonstrated to 
enhance the electrocatalytic efficiency of many electrochemical processes [91]. An interesting 
class of carbon nanotube derivatives results from deposition of metal nanoparticles on the 
tubular surfaces. Furthermore, uniform dispersion of metal nanoparticles decorated on CNTs 
surfaces can yield ideal nanocatalysts for application in chemically modified electrodes [110]. 
Recently, there have been a growing number of electrochemical sensors that incorporate 
different metal nanoparticles together with CNTs, solubilized in Nafion to form 
nanocomposites for electrochemical detection [91]. 
1.5.1.3. Other analytical applications of carbon nanotubes in pharmacy and medicine 
Although CNTs application in voltammetric techniques is especially favorable and 
numerous publications in literature discuss about the use of CNTs as electrode materials or 
modifiers of conventional working electrodes in analytical voltammetry [86], CNTs have also 
contributed in different areas of drug analysis. In the field of analytical chemistry, 
nanomaterials and especially CNTs can be used as matrices in matrix-assisted laser desorption 
ionization (MALDI), as stationary phases in gas chromatography (GC), high performance 
liquid chromatography (HPLC) or capillary electrochromatography (CEC), as 
pseudostationary phases in capillary electrophoresis (CE) and as new solid-phase extraction 
(SPE) materials [112]. Due to their strong interaction with other molecules, particularly with 
those containing benzene rings, CNTs surfaces possess excellent adsorption ability. 
Nonfunctionalized or functionalized CNTs have been successfully employed in extraction 
techniques, such as SPE and solid phase micro-extraction (SPME) alone or in conjugation 
with classical SPE sorbents for the analytical extraction of drugs in different media such as 
biological fluids or drug preparations [84]. Due to their chirality they can be used also as 
chiral selectors, with or without further modification, for the enantioseparation of 
  
22 
 
pharmaceuticals [113]. The excellent electroanalytical capabilities of CNTs modified 
electrodes have also found important application in electrochemical detection systems 
coupled with separation techniques such as liquid chromatography (LC) and capillary 
electrophoresis [91]. Furthermore, CNTs have attracted great attention as suitable electrode 
materials to be applied for the construction of biosensing platforms for in vivo and in vitro 
diagnostics and therapeutic monitoring [89]. 
As a new and emerging nanomaterial, the use of CNTs as drug delivery carriers has 
brought great attention in recent years [114]. The main applications of CNTs in pharmacy and 
medicine include drug, biomolecule and gene delivery to cells or organs, tissue regeneration, 
and biosensor diagnostics and analysis. Many studies have demonstrated that when bonded to 
CNTs, these molecules are delivered more effectively and safely into cells than by traditional 
methods [84]. Moreover, CNTs have been recently revealed as a promising antioxidant. It was 
observed that the presence of –COOH groups would increase the free radical scavenging 
activity of SWCNTs and that carboxylated SWCNTs are at least as good as, or even better, 
free radical scavengers than their nonfunctionalized partners. Their antioxidant property has 
been used in anti-aging cosmetics and sunscreen creams to protect skin against free radicals 
formed by the body or by UV sunlight [84]. As with any new technology, there are concerns 
over the application of nanomedicine, stemming from the lack of proper knowledge and the 
need for the establishment of regulatory measures [114]. Identification of pharmacological 
and toxicological profiles is of critical importance for the use of nanoparticles as drug carriers 
in nanomedicine [115]. Despite a large number of studies performed in the past several years 
to explore the potential toxic effects of CNTs, the results are still often contradictory [116] .  
  
  
23 
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The electrochemical behavior of ondansetron was studied on the multi-walled carbon nanotubes/Naﬁon
polymer composite modiﬁed glassy carbon electrode (MWCNTs–Naﬁon/GCE). The oxidation peak
potential was shifted from 1.32 V to 1.18 V compared to the bare electrode indicating excellent
electrocatalytic activity of immobilized ﬁlm toward drug molecule. The modiﬁed electrode exhibited a
remarkable enhancement effect on voltammetric response due to the synergistic effect of nanomaterial
and cation-exchange polymer on the electron transfer rate, the effective electrode area and the
accumulation capability. After optimizing the experimental parameters, adsorptive stripping procedure
was used for the determination of ondansetron in pharmaceutical formulation. The results were satisfactory
in comparison with those obtained by high-performance liquid chromatography. In addition, the
MWCNTs–Naﬁon/GCE exhibited high selectivity in the voltammetric measurements of ondansetron and
co-administrated drug morphine with potential difference of 430 mV. The response peak currents had linear
relationship with drug concentration in the range of 1.0107–5.0106 M and 1.0107–4.0106 M
with detection limits 3.1108 and 3.2108 M for ondansetron and morphine, respectively. The electrode
was successfully applied for simultaneous electrochemical sensing of both drugs in human serum samples
after selective accumulation at the electrode surface.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Ondansetron (OND) is a selective 5-HT3 receptor antagonist
widely used in the treatment of emetogenic side effects accom-
panying cancer chemotherapy or radiotherapy (Scheme 1). It has
also become the ﬁrst line therapy for the prevention of post-
operative nausea and vomiting [1]. In addition, OND is used to
ameliorate pruritus, irritable bowel syndrome, diarrhea associated
with cryptosporidiosis or diabetes, chronic refractory diarrhea,
anxiety and sleep disorders, alcohol dependency, opiate with-
drawal syndrome, vertigo, Tourette's syndrome and psychosis in
advanced Parkinson's disease [2]. The studies on the use of OND in
new indications continue and, therefore, the development of a
sensitive analytical method to evaluate the quality of its pharma-
ceutical product or to determine drug concentration in biological
ﬂuids is highly required.
At present, several analytical methods have been employed for
the determination of OND in biological samples or pharmaceutical
preparations, such as HPLC combined with mass spectrometry [3–5]
or UV detection [6–8], supercritical ﬂuid chromatography/tandem
mass spectrometry [9], HPTLC [10], spectrophotometry [11], radio-
immunoassay [12] and capillary zone electrophoresis [13]. However,
most of these methods are time-consuming, solvent-usage intensive,
expensive and involve tedious sample preparations or, on the other
hand, suffer from poor selectivity.
Morphine (MOR) is a widely used and highly effective analgesic
agent for the treatment of acute and chronic pain associated with
cancer, recommended by the World Health Organization. OND
often coexists with MOR in biological ﬂuids as these drugs are
co-administered for control of pain, nausea and vomiting in
patients undergoing surgical procedure and chemotherapy. To
prevent overdose-induced toxicity, monitoring of the therapeutic
levels of OND and MOR concentrations in biological samples of
patients is a critical issue in clinical medicine. Therefore, it is
necessary to establish simple, rapid and sensitive analytical
methods for detection and quantitation of OND and MOR in
biological matrix for clinical, toxicological and pharmacological
studies. Recently, some new electrochemical methods have been
proposed for morphine detection [14–19]. However, up to now,
only one analytical method has been reported in the literature
on the simultaneous determination of OND and MOR [20].
Two analytes were separated within 20 min and determined in
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pharmaceutical dosage form by HPLC method with UV detection.
Consequently, a cheap, highly sensitive and selective method is of
great demand for simultaneous determination of both drugs.
Electrochemical detection of an analyte is a very elegant
method in pharmaceutical analysis due to its high sensitivity,
rapid response, simple operations and low cost [21,22]. In spite of
that, the redox behavior and electrochemical determination of
OND in pharmaceutical formulation or human ﬂuids have not been
reported in the literature to this date. Our preliminary results
showed that the voltammetric response of OND at the glassy
carbon electrode (GCE) was not satisfactory because of slow
heterogeneous electron transfer. In the light of these ﬁndings, it
was a challenge to ﬁnd a new electrode material for determination
of OND using voltammetric technique.
In recent years, carbon nanotubes (CNTs) have attracted
increasing attention in the electrode preparation due to their
unique structure and extraordinary electronic properties [23].
CNTs have huge surface area, signiﬁcant mechanical strength, high
electrical conductivity and efﬁcient electrocatalytic activity. On the
other hand, Naﬁon has been extensively applied as an electrode
modiﬁer due to its excellent antifouling capacity, high permeabil-
ity to cations and strong adsorption ability. The hydrophilic
negatively charged sulfonate group in Naﬁon ﬁlm enables selective
preconcentration of positively charged drug molecules through
electrostatic interaction, whereas, the hydrophobic ﬂuorocarbon
network of the polymer gives a selectivity for the hydrophobic
part of the molecule [24].
Based on the above advantages of nanomaterial and cation-
exchange polymer, a simple and sensitive electrochemical sensor
was developed for simultaneous trace analysis of OND and MOR.
To take advantage of the remarkable properties of MWCNTs in
electrochemical sensing application, the MWCNTs should be
properly functionalized and uniformly immobilized at electrode
surface. However, the MWCNTs are inclined to form agglomerates
due to strong Van der Waals interactions when they are dispersed
in water or organic solvents [23]. To overcome this difﬁculty,
Naﬁon was selected as the binder in electrode fabrication proce-
dure. In the presence of Naﬁon, the MWCNTs were homoge-
neously dispersed into ethanol via ultrasonication. Consequently,
a stable and uniform ﬁlm was easily achieved at the electrode
surface after organic solvent evaporation.
The electrochemical behavior of OND on the multi-walled
carbon nanotubes/Naﬁon polymer composite modiﬁed glassy
carbon electrode (MWCNTs–Naﬁon/GCE) strongly revealed selec-
tive interfacial accumulation of positively charged drug molecule
and excellent electrocatalytic activity toward target, thus improv-
ing the sensitivity and voltammetric signal-to-noise ratios as well
as the stability of the resulting ﬁlm. The proposed method was
applied for the quantiﬁcation of OND in real drug samples. The
ability of the modiﬁed electrode for voltammetric response of
MOR was also evaluated. Finally, the MWCNTs–Naﬁon/GCE was
successfully used as an electrochemical sensor for the simulta-
neous determination of OND and MOR at trace levels in biological
samples.
2. Experimental
2.1. Apparatus
Voltammetric measurements were performed using a μ-Autolab
potentiostat (Eco Chemie, Utrecht, The Netherlands) controlled by
GPES 4.9 software. A conventional three-electrode system was
employed, comprising a bare GCE (3-mm diameter, Metrohm,
Switzerland) or MWCNTs/Naﬁon ﬁlm modiﬁed GCE as a working
electrode, a platinum wire as a counter electrode and an Ag/AgCl/
3 M KCl (Metrohm) as the reference electrode. All electrochemical
experiments were carried out at room temperature (2371 1C).
When required, stirring was applied using a computer-controlled
stirrer at ca. 300 rpm.
Scanning electron microscopy (SEM) measurement was per-
formed on a Jeol JSM-7000 F microscope (Jeol Ltd., Tokyo, Japan).
High-performance liquid chromatographic experiments were car-
ried out using an Agilent 1100 Series LC system equipped with a
diode array detector (Agilent Technologies, Waldbronn, Germany).
2.2. Chemicals
OND, kindly donated by Pliva (Zagreb, Croatia), was used as
received without any further puriﬁcation. Ondantors (Sandoz)
ﬁlm-coated tablets, containing ondansetron hydrochloride dihy-
drate equivalent to 8 mg of OND, were supplied by local pharmacy.
MOR was obtained from the Agency for Medicinal Products and
Medical Devices (Zagreb, Croatia). Multi-wall carbon nanotubes
(498%, O.D. 6–13 nm, length 2.5–20 mm) and Naﬁon (5 wt%
solution in a mixture of lower aliphatic alcohols and water) were
from Sigma-Aldrich (Steinheim, Germany). All other chemicals
were of analytical grade quality. Ultra-pure water used for the
preparation of standard solutions and buffers was obtained by a
Milli-Q system (Millipore, Bradford, USA).
2.3. Preparation of MWCNTs/Naﬁon electrode
Before use, the received MWCNTs were sonicated in concen-
trated HNO3 for 4 h to generate carboxylic acid-functionalized
MWCNT surface. The suspension was ﬁltered through a cellulose
nitrate membrane with a 200 nm pore size. The solid powders
were washed thoroughly with double distilled water to remove
any residual acid and then dried under vacuum at room tempera-
ture. The immobilizing suspension was prepared by dispersing
1 mg of functionalized MWCNTs in 1 mL of 0.5% (m/v) Naﬁon
solution prepared in ethanol. The mixture was then sonicated for
Scheme 1. Chemical structures of ondansetron (OND) and morphine (MOR).
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30 min to get a stable and well-distributed MWCNTs–Naﬁon
suspension. Prior to modiﬁcation, the GCE was polished with
aqueous slurry of 0.05 μm alumina powder on a smooth polishing
cloth, thoroughly rinsed with water and then ultrasonically
cleaned in water for 30 s. Finally, the electrode was washed with
puriﬁed water and dried. The cleaned GCE was uniformly coated
with 5 mL of the MWCNTs–Naﬁon suspension and air-dried at
room temperature. Then, the modiﬁed electrode was carefully
rinsed with puriﬁed water. At the beginning of experiment, the
modiﬁed electrode was scanned by two successive cyclic voltam-
metric sweeps between 0 and 1.4 V at 100 mV/s in a blank solution
of 0.1 M H2SO4. The relative electrochemical surface areas of the
MWCNTs–Naﬁon/GCE and bare GCE were determined by cyclic
voltammetry (CV) between 0.2 and 0.7 V in 1103 M ferri-
cyanide solution as a redox probe in 0.1 M KCl electrolyte at
different scan rates (v). From the slope of the plot of anodic peak
current versus v1/2, the electro active area was calculated. The
modiﬁed MWCNTs–Naﬁon/GCE showed a surface area 5.2 times
greater than the bare GCE. The MWCNTs–Naﬁon/GCE can be stored
in air or kept in distilled water for several weeks without the loss
of activity. For comparison, a Naﬁon modiﬁed GCE was prepared
using the same procedure described previously, but without
MWCNTs, and denoted as Naﬁon/GCE.
2.4. Electrochemical measurement procedures
Stock solution of OND (1103 M) was prepared in puriﬁed
water and stored under refrigeration. Stock solutions of MOR
(1103 M) were freshly prepared for daily use with puriﬁed
water. The working standard solutions of OND and MOR were
obtained by serial dilution of stock solutions with a supporting
electrolyte just before voltammetric measurements. The studies
were carried out in 0.1 M H2SO4 solution and Britton–Robinson
buffer (0.04 M in each of acetic, phosphoric and boric acids)
adjusted to the desired pH with 0.2 M sodium hydroxide solution.
The oxidative behavior of OND was investigated by CV in the scan
range from 0.0 V to 1.5 V. Square-wave voltammetry (SWV) was
used for the determination procedures of OND and MOR. The
sensor was immersed in the sample solution and preconcentration
of both analytes was carried out at potential 0.5 V with a 360 s
accumulation step. After 5 s equilibrium period, the voltammo-
gram was recorded in the SWV mode (frequency, 75 Hz; potential
step, 8 mV; amplitude, 25 mV) from 0.7 to 1.4 V. Following each
measurement, the MWCNTs–Naﬁon/GCE was transferred to the
solution of supporting electrolyte to regenerate the electrode
surface by applying single positive-going SWV potential scan from
0.7 to 1.4 V.
2.5. Pharmaceutical dosage form assay procedure
To prepare the solutions of OND commercial pharmaceutical
product, ten tablets were weighted and crushed to a ﬁne powder.
An accurately weighted powdered sample of the drug formulation
equivalent to 3.6 mg of active ingredient was transferred into a
10.0 mL calibrated ﬂask and dispersed in water. The tablet solution
was sonicated for 15 min to provide complete dissolution of the
active ingredient. After soniﬁcation, the sample was ﬁltered
through 0.45 μm Acrodisc GHP ﬁlters (Gelman, Ann Arbor, USA).
An aliquot of ﬁltrate was then transferred into a calibrated ﬂask
and diluted with water to yield a ﬁnal drug concentration of
1.0104 M. A series of dilutions were made with the supporting
electrolyte to cover the working concentration range. Solutions
were subjected to voltammetric measurements as previously
described and the content of OND in the pharmaceutical prepara-
tions was determined by the standard addition method. For
recovery studies, aliquots of the OND standard solutions were
added to real samples prepared from tablets.
For the comparison study, HPLC experiments were carried out
using a chromatographic column Zorbax C18, 2504.1 mm, par-
ticle size 5 mm (Agilent Technologies, Waldbronn, Germany). The
mobile phase, consisted of acetonitrile, ultra-pure water and
tetraethylammonium hydroxide at the ratio of 50:50:1 (v/v/v),
was ﬁltered through cellulose nitrate ﬁlter (0.45 μm, Sartorius,
Goettingen, Germany). The HPLC analyses were carried out at
constant temperature (25 1C) with a ﬂow-rate of 0.7 mL/min under
isocratic conditions. For chromatographic analysis, standard solu-
tions of OND were made by dilution with the mobile phase and
ﬁltered through a 0.2 μm Acrodisc GHP ﬁlters (Gelman, Ann Arbor,
USA). The 10 μL aliquots were injected into the HPLC system for
analysis. The DAD detector recorded UV spectra in the range from
190 to 400 nm and chromatogram was obtained at 248 nm. All
chromatographic data acquisition and processing was performed
using ChemStation software (Agilent Technologies, Waldbronn,
Germany).
2.6. Determination of OND and MOR in biological samples
Human serum samples were obtained from healthy volunteers
abstained from any medications during the week preceding the
study and were stored frozen until assay. Serum samples were
fortiﬁed with the appropriate aliquot volume of OND and MOR
standard solutions to achieve ﬁnal concentrations (5.0107 and
1.0107 M) that are found in serum after the treatment with
therapeutic daily doses of 16 and 80 mg for OND and MOR,
respectively [25,26]. An aliquot of serum sample containing OND
and MOR was mixed with acetonitrile (1:1) to remove serum
proteins effectively. After vortexing for 60 s, the mixture was then
centrifuged for 6 min at 6000 rpm. Appropriate volumes of this
supernatant were transferred into the volumetric ﬂask and diluted
with the supporting electrolyte and analyzed in the voltammetric
cell. Quantitations in biological ﬂuids were performed using the
standard addition method by adding three successive aliquots of
drug standard solutions.
3. Results and discussion
3.1. Electrochemical response of OND at GCE
In this paper, the redox behavior of OND was studied for the
ﬁrst time and initially, we started with the investigation of the
electrochemical oxidation of drug molecule at a bare GCE by cyclic
voltammetry. A poorly deﬁned anodic current response was
observed during the scanning from 0 to 1.5 V (Fig. 1, curve a).
On the reverse potential scan, there was no corresponding reduc-
tion peak, suggesting that the electrode reaction of OND is totally
irreversible. The voltammetric response was broad due to slow
electron transfer. In addition, the peak potential of OND obtained
at GCE had a relatively high value, close to þ1.32 V in 0.1 M H2SO4
solution, which resulted in the merging of the signal current with
the background current. Therefore, the effect of pH on the
electrochemical response of OND was studied over the pH range
of 2.0–9.0 in BR buffer. However, the peak potential of the
oxidation process remained almost constant in the pH interval
2.0–7.0 (Ep (V)¼1.37–0.009 pH). As the pH value was increased
above 7, the oxidation peak shifted to less positive potentials, but it
was split into two broad and overlapped waves, together with a
decrease in peak currents.
The effect of scan rate on the oxidative peak currents was also
evaluated. Variation of the scan rate in the range of 20–500 mV/s
resulted in a linear relationship between the anodic peak current
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and the square-root of a scan rate. This indicates that the electrode
process was controlled by diffusion rather than adsorption. Addi-
tionally, a plot of logarithm of peak current versus logarithm of
scan rate gave a straight line log i¼0.456 log v –0.326 (r¼0.993)
with a slope very close to the theoretical value of 0.5, an expected
value for an ideal reaction of solution species [27]. Therefore, the
preliminary results clearly revealed that the voltammetric
response of OND at bare GCE was not satisfactory for the analytical
application due to slow electron transfer reaction, reduced sensi-
tivity since the adsorption of drug molecule could not be purpo-
sely used as a preconcentration step, electrode fouling problems
and unstable analytical signal.
3.2. Electrochemical behavior of OND on modiﬁed electrode
To improve the electrochemical response of OND, the electrode
was modiﬁed with nanomaterial and cation-exchange polymer.
The surface morphology of MWCNTs–Naﬁon/GCE was character-
ized by SEM. As shown in Fig. 2, the MWCNTs were well dispersed
in the Naﬁon and entrapped in the polymer matrix. The nano-
composite ﬁlm deposited at the surface of the GCE formed a three-
dimensional structure and reticular formation revealing a much
larger surface area than electrode geometric area.
The cyclic voltammograms of 1.0104 M drug solution in
0.1 M H2SO4 obtained at the MWCNTs–Naﬁon/GCE, Naﬁon/GCE
and a bare GCE with a scan rate of 100 mV/s are presented in Fig. 1.
When the bare GCE surface was coated with 0.5% Naﬁon ﬁlm, a
well-shaped oxidationwave (ip¼9.6 mA) appeared at 1.29 V (inset of
Fig. 1). Naﬁon as a cation-exchanger attracted positively charged
drug molecules from the bulk solution to enhance the anodic signal.
However, the electroanalytical performance of the MWCNTs–Naﬁon
/GCE for measuring OND was advantageous over that observed
at the Naﬁon/GCE and bare GCE. Compared with Naﬁon/GCE, the
voltammetric response of OND intensively increased at MWCNTs–
Naﬁon/GCE with a current of 30.5 mA and a peak potential of 1.18 V.
The oxidation peak potential of OND was shifted to less positive
values by 140 mV compared with that of using a bare GCE indicat-
ing faster electron transfer reaction at the electrode surface and
excellent electrocatalytic activity of immobilized ﬁlm toward drug
molecule. The experimental results clearly indicated a remarkable
enhancement effect on the electrochemical response of OND
obtained from the combined contribution of Naﬁon and CNTs. This
is due to the larger surface area of the modiﬁed electrode as well as
the synergistic effect of the electronic conductivity and electroca-
talytic activity of MWCNTs with ionic conductivity and ion-
exchange capacity of Naﬁon. OND is a weak basic compound with
pKa 7.4 and therefore, the molecule is completely protonated in the
experimental conditions under which voltammetric measurements
were performed. It is evident that Naﬁon enhances the preconcen-
tration of drug molecules through electrostatic interaction with
negatively charged sulfonate group in Naﬁon polymer structure,
leading to a considerable improvement in the analytical sensitivity.
Another effect of Naﬁon observed here was ﬁxing CNTs onto GCE
surface tightly and enhancing the stability of the electrochemical
sensor. On the other hand, the sensor exhibited a higher sensitivity
for OND determination owing to the excellent properties of
MWCNTs, thus indicating an improvement in the electrode kinetics
and a decrease in the oxidation potential substantially. The OND
oxidation observed at the high potential using GCE was more facile
at the MWCNTs–Naﬁon/GCE due to the shift in peak potentials to
less positive values, thus placing the electrochemical oxidation
outside of the solvent window.
For evaluating the reaction character of OND at the MWCNTs–
Naﬁon/GCE, cyclic voltammetry was performed in a 5.0105 M
OND solution with different scan rates. The peak potential was
positively shifted from 1.116 to 1.241 V when increasing the scan
rates from 20 to 500 mV/s. The dependence of the peak potential
is linear with logarithm of the scan rate, which could be expressed
as a regression equation: Ep (V)¼0.0927 log v (mV/s)þ0.989
(r¼0.996), allowing the calculation of αn¼0.638 (inset of Fig. 3).
Using the value of the charge transfer coefﬁcient (0.66) obtained
from the difference between the peak potential (Ep) and the half
wave potential (Ep/2), taking the equation α¼(47.7/Ep–Ep/2) [28], the
number of electrons exchanged was calculated to be n¼0.96. The
voltammetric response of OND at the modiﬁed electrode is probably
initiated by one-electron transfer to form the cation radical at
nitrogen atom in the imidazole ring. On the other hand, peak
currents were linearly increased with the scan rates from 20 to
200 mV/s, and their relationship obeyed the following regression
equation ip (mA)¼0.227 v (mV/s)þ7.838 (r¼0.997). This result
indicated that the electrochemical reaction of OND at the
MWCNTs–Naﬁon/GCE was a surface-controlled process [27]. There-
fore, to obtain the highest sensitivity of the method, the adsorption
of OND at the modiﬁed electrode surface was purposely used in
subsequent analytical measurements as an effective accumulation
step prior to the voltammetric quantitation of the drug.
3.3. Selection of the experimental conditions
The electrochemical oxidation of OND was examined in differ-
ent electrolyte solutions using CV. Various types of the supporting
Fig. 1. Cyclic voltammograms of ondansetron (1104 M) at a bare GCE (a) and
the MWCNTs–Naﬁon/GCE (b) together with corresponding background recording
(c) in 0.1 M H2SO4. Inset: cyclic voltammograms of ondansetron at a bare GCE
(a) and the Naﬁon/GCE (d). Scan rate: 100 mV/s.
Fig. 2. The surface image of MWCNTs–Naﬁon/GCE produced by scanning electron
microscopy. Scale bar: 100 nm.
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electrolytes, including BR buffer pH 2.0–6.0, H2SO4, HCl and
CH3COOH, were tested for the electroanalytical measurements,
as shown in Fig. 3. The comparison of voltammograms showed
that only in lower pH values OND could exhibit higher peak
current. The drug molecule is completely protonated on the
nitrogen atom in the imidazole ring and could be more effectively
attracted to the modiﬁed electrode surface. A lower peak potential
and highest peak current was achieved in 0.1 M H2SO4 and,
therefore, this solution was selected as the suitable supporting
electrolyte for the drug determination using the MWCNTs–Naﬁon/
GCE.
To improve the sensitivity, SWV was employed for measuring
OND due to the most favorable response compared to other
voltammetric modes such as differential pulse voltammetry and
linear-sweep voltammetry. Variation of the peak current for OND
recorded at the MWCNTs–Naﬁon/GCE was monitored while chan-
ging instrumental parameters, i.e. frequency (25 Hzr fr100 Hz),
pulse amplitude (5 mVrar50 mV) and potential step (2 mVr
ΔEsr10 mV). The most favorable response was achieved using a
combination of a frequency of 75 Hz, a pulse amplitude of 25 mV
and a potential step of 8 mV.
The thickness of the cast ﬁlm on the GCE surface, which was
determined by the amount of MWCNTs–Naﬁon suspension, had
certain effects on the current response of OND. The volume of
MWCNTs–Naﬁon suspension coated on the electrode changed the
properties and functions of the electrode surface. When the
volume of MWCNTs–Naﬁon suspension added to the GCE surface
increased from 3 to 5 μL, the oxidation peak current enhanced
notably, but with further increase of the amount of MWCNTs–
Naﬁon suspension to 9 μL, the oxidation peak current conversely
showed gradual decline. The Naﬁon ﬁlm became thicker and
lowered the electrical conductivity of MWNTs and, consequently,
retarded the electron transfer rate of OND oxidation as well as the
mass transportation between the drug and the electrode resulting
in the higher electric resistance. In the beginning, on increasing
the amount of the modiﬁer, the sites of electron exchange
increased and the adsorption of OND was enhanced. However,
the accumulation capacities of the ﬁlm depend on the amount of
Naﬁon, leading to an increment of the ion-exchange capacity of
the ﬁlm up to a certain limit, which is determined by the nature
of the analyte and its diffusion through the ﬁlm. The voltammetric
signal increased up to 0.5% of Naﬁon concentration in the
immobilizing suspension. The SWV response of OND reached
the maximum when the composite ﬁlm was uniformly coated on
the electrode surface using 5 μL of homogenous MWCNTs–Naﬁon
suspension.
3.4. Adsorption characteristics of OND on modiﬁed electrode
Since the modiﬁcation of the electrode surface with a MWNTs–
Naﬁon layer led to a strong interfacial accumulation of OND, the
possibility of the analyte preconcentration before voltammetric
measurement was investigated in order to obtain lower detection
limits. Fig. 4 shows square-wave voltammograms for 2.5106 M
solutions of OND without accumulation and after a 360 s accumu-
lation step at the MWCNTs–Naﬁon/GCE. To achieve the maximum
sensitivity and the optimum conditions for the maximum adsorp-
tion, the inﬂuence of accumulation potential on the stripping peak
current was evaluated from 1.0 to 0.9 V using SWV mode. When
the accumulation potential shifted from 0 to 0.9 V, the stripping
peak current greatly decreased. The results showed that the
oxidation peak current increased as the accumulation potential
became more negative. The optimum deposition potential of
0.5 V was selected for subsequent sensitive determination of
OND. Square-wave voltammograms with increasing accumulation
times (between 30 s and 480 s) were recorded for solutions
containing OND at concentration level of 1106 M. The accu-
mulation time signiﬁcantly affected the voltammetric response of
OND at the MWCNTs–Naﬁon/GCE. The oxidation peak current
enhanced greatly with the increase of the accumulation time
within 360 s (Fig. 5). The linear relationship between the voltam-
metric response and the deposition time pointed to a constant
adsorption of positively charged drug molecules attracted on the
surface of the MWCNTs–Naﬁon/GCE. Further increment of accu-
mulation time period showed a deviation of the peak current from
linearity, thus indicating surface adsorption saturation. Therefore,
the value of 360 s was considered as optimum to achieve the
highest possible sensitivity in acceptable analysis time.
3.5. Simultaneous determination of OND and MOR
To develop a new electroanalytical method for simultaneous
determination of OND and MOR, the voltammetric response of
MOR was also studied at the MWCNTs–Naﬁon/GCE. Fig. 6 shows
the SWV responses from the electrochemical oxidation of OND
and MOR in 0.1 M H2SO4 solution following preconcentration for
360 s at 0.5 V. The proposed sensor exhibited potent electron
mediating behavior followed by well-separated oxidation peaks
towards OND and MOR at 1.17 and 0.74 V, respectively. The large
Fig. 4. Square-wave voltammograms of ondansetron (2.5106 M) at the
MWCNTs–Naﬁon/GCE in 0.1 M H2SO4 after accumulation time of 360 s (a), without
accumulation (b) and blank solution (c). SWV settings: frequency of 75 Hz,
amplitude of 25 mV and potential step of 8 mV, Eacc¼0.5 V.
Fig. 3. Inﬂuence of supporting electrolyte on ondansetron oxidation at the
MWCNTs–Naﬁon/GCE: 0.1 M H2SO4 (a), 0.5 M H2SO4 (b), Britton–Robinson buffer
pH 2 (c) and pH 4 (d), 0.1 M CH3COOH (e) and 0.01 M HCl (f). Scan rate: 100 mV/s;
c¼1105 M. Inset depicts peak potential vs. logarithm of scan rates from 20 to
500 mV/s in 0.1 M H2SO4.
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separation of the peak potentials allows simultaneous determina-
tion of OND and MOR in their mixture.
On the basis of previous investigation of MOR oxidation
mechanism using GCE, the anodic voltammetric signal of MOR at
the MWCNTs–Naﬁon/GCE can be ascribed to oxidation of phenolic
group which involves one electron transfer [29]. The tertiary
amine of MOR has a pKa of 8.4, and the phenolic group has a
pKa of 9.4. Therefore, MOR was also completely in the cationic
form under used voltammetric condition and MOR molecule, like
OND, showed adsorption at the MWCNTs–Naﬁon/GCE. As shown
in Fig. 5, the accumulation time of 120 s provided for MOR the
largest peak current in the linearity range indicating faster
adsorption of MOR then OND on the surface of the modiﬁed
electrode. However, the value of 360 s was used as the optimum
for simultaneous quantiﬁcation of both drugs because the peak
current of MOR increased up to a maximum at tacc¼360 s which
was selected previously as the optimal value for OND.
The oxidation peak of OND at 1.17 V in 0.1 M H2SO4 solution
after 360-second accumulation time showed a linear response at
the MWCNTs–Naﬁon/GCE for concentration in the range of
1.0107–5.0106 M. The calibration plot is described by the
following regression curve: ip (μA)¼3.38107c (M)–0.43, r¼
0.999. Since the presence of MOR may affect the quantiﬁcation
of OND due to its competitive adsorption, the variation of
adsorptive stripping SWV peak current versus OND concentration
in the presence of MOR (1.5106 M) was also checked using
MWCNTs–Naﬁon/GCE (Fig. 6). The sensitivity of the modiﬁed
electrode towards the oxidation of OND in the presence of MOR
is 3.27107 mA M1, which is very close to the value observed in
the absence of MOR (3.38107 mA M1), indicating that the
oxidation of OND and MOR at the MWCNTs–Naﬁon/GCE, as well
as their adsorption at electrode surface in the accumulation step,
are independent. The detection limit (LOD) and the quantiﬁcation
limit (LOQ) estimated from the calibration curve as LOD¼3s/b and
LOQ¼10s/b, where s is the standard deviation of the intercept and
b is the slope of the calibration curve, were calculated to be
3.1108 M for LOD and 9.6108 M for LOQ. Compared with
other methods, the linearity range obtained at proposed electro-
chemical sensor for OND was in the similar concentration range as
for HPLC methods with UV detection and HPTLC [6,8,10]. The LOD
and LOQ values are better than those obtained in capillary
electrophoresis and spectrophotometry [11,13], but are higher
than LODs reported for chromatographic methods coupled to mass
spectrometry [3–5]. However, the LC–MS analytical procedures
demand expensive and sophisticated equipment that is not avail-
able in many laboratories. The proposed voltammetric method
using the MWCNTs–Naﬁon/GCE offers several advantages over
chromatographic techniques applied only to the quantitative
determination of a drug, including short analysis time, simplicity
of operation and lower running cost. It should be mentioned once
again that in the literature there are no studies on electrochemical
behavior of OND or its voltammetric determination.
Fig. 7 shows the square-wave voltammograms for the solutions
containing various concentrations of MOR and constant concen-
tration of OND (1.5106 M). It can be seen that the related peak
currents increased by increasing MOR concentration, while there
are no signiﬁcant changes in the peak current and potential of
OND. The calibration graph obtained for anodic peak current of
MOR at the MWCNTs–Naﬁon/GCE was linear within the concen-
tration range of 1.0107–4.0106 M (inset of Fig. 7). The
regression equation was expressed as ip (μA)¼2.90107c (M)þ
11.99 with a correlation coefﬁcient of 0.999. The calculated LOD
and LOQ values were found to be 3.2108 and 9.8108 M,
respectively.
Fig. 6. Adsorptive stripping square-wave voltammograms of ondansetron at the
MWCNTs–Naﬁon/GCE recorded in 0.1 M H2SO4 at different concentrations (1
107–5106 M) in the presence of morphine (1.5106 M). SWV settings and
accumulation conditions same as in Fig. 4. Inset shows a calibration graph for the
quantiﬁcation of ondansetron.
Fig. 7. Adsorptive stripping square-wave voltammograms of the mixture contain-
ing morphine at different concentrations (1107–5106 M) and ondansetron
(1.5106 M) recorded at the MWCNTs–Naﬁon/GCE in 0.1 M H2SO4. SWV settings
and accumulation conditions same as in Fig. 4. Inset shows a calibration graph for
morphine.
Fig. 5. Effect of the accumulation time on the oxidation peak current for ondansetron
(1106 M) (circles) and morphine (1106 M) (squares). SWV settings and
accumulation conditions same as in Fig. 4.
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In comparison to HPLC–UV procedure developed for the simul-
taneous quantiﬁcation of MOR and OND mixtures in 0.9% sodium
chloride injection, the MWCNTs–Naﬁon/GCE showed wider linear
range for the quantiﬁcation of both drugs [20]. The detection and
quantiﬁcation limits of OND and MOR obtained at this sensor are
of the same order as for the HPLC method, but the proposed
electroanalytical method is simpler, cheaper and faster. In HPLC
method the separation time of 20 min was necessary for the
analysis. In addition, the HPLC method requires a high percentage
of organic solvent making it less environmental friendly.
3.6. Stability and reproducibility of the modiﬁed electrode
The stability of the MWCNTs–Naﬁon/GCE was checked by
measuring the adsorptive stripping SWV response in 2.5
106 M OND and MOR solution over a period of four weeks.
Before measurements, the modiﬁed electrode was scanned
between 0.5 and 1.4 V in the solution of supporting electrolyte
until the SWV response was stable. When the nanocomposite
modiﬁed electrode was stored in the air at room temperature for
10 days, the peak potential of both drugs was unchanged and the
current response of OND and MOR decreased by about 2.6% and
3.2%, respectively. The high mechanical strength of the MWCNTs-
interspersed in the polymer ﬁlm could be the reason for the high
stability of the proposed electrochemical sensor. Repeating the
experiment after a longer time period, it was found that the
current responses decreased about 15% in three weeks for both
drugs.
To evaluate the repeatability of the electrode response, the same
modiﬁed electrode was used for six successive measurements of
1.0106 M OND and MOR solution. After each measurement, the
surface of the MWCNTs–Naﬁon/GCE was regenerated by applying
single positive-going SWV potential scan from 0.5 to 1.5 V in a blank
solution of 0.1 M H2SO4. The recorded oxidation peak potentials
for OND (mean Ep¼1.17 V) and MOR (mean Ep¼0.74 V) were
unchanged. The RSD values of the peak current for OND (mean
ip¼35.4 μA) and MOR (mean ip¼36.9 μA) were 1.9% and 1.2%,
respectively. These results indicated that the MWCNTs–Naﬁon/GCE
was stable in repeated measurements for selective determination of
OND and MOR compounds. The reproducibility of the modiﬁed
electrode was characterized by three replicate measurements of
1106 M OND and MOR over three days using freshly prepared
standard solutions. The RSDs of the anodic peak current for OND
and MOR were not greater than 2.5% and 1.7%, respectively.
Additionally, a series of ﬁve sensors prepared repeatedly in the
same manner were also tested and the RSDs of peak potentials and
currents for both drugs were in the range 0.5–0.7% and 2.5–3.1%,
respectively, indicating good fabrication reproducibility.
All experiments conﬁrmed that the prepared MWCNTs–Naﬁon
composite ﬁlm has good durability, homogeneity in deposition,
reproducibility, more active sites and strong adherence to elec-
trode surface. These characteristics are suitable for long-term
electrochemical sensing applications.
3.7. Interference
The inﬂuence of potential interfering species, which are likely
to be in biological samples or are co-formulated with the active
pharmaceutical ingredient, on the voltammetric responses of OND
and MOR was examined. A ﬁxed amount of 1106 M OND and
MOR, spiked with various excess amounts of interfering species,
was evaluated under optimized experimental conditions described
previously. The tolerance limit was deﬁned as the maximum
concentration of the interfering substance that caused an error
less than 75% in the determination of both drugs. The presence of
Naþ , Cl (2000 fold), Kþ , NO3 , SO42 , HPO42 (1000 fold), Zn2þ ,
Ca2þ , Mg2þ , Cu2þ , Fe3þ , Na2EDTA, manitol (500 fold), L-alanine,
L-glycine, L-aspartic acid, L-glutamic acid, citric acid (400 fold),
lactose, sucrose, starch (300 fold) and L-cysteine (200 fold), had no
inﬂuence on the peak current of both drugs. Also, nitrite (400 fold)
did not interfere with voltammetric response of both drugs
although nitrite ions were oxidized at þ0.75 V, very close to
MOR potential. However, the MWCNTs–Naﬁon composite ﬁlm
allows facile accumulation of the positively charged MOR mole-
cule, while prevent accumulation of negatively charged oxidizable
nitrite ions onto the electrode surface. The experiments displayed
that the oxidation peak current of OND and MOR at the MWCNTs–
Naﬁon/GCE did not change after adding 400-fold concentration of
ascorbic acid and 300-fold of glucose indicating that the selectivity
of the method could be satisfactory for the quantiﬁcation of both
drugs in biological ﬂuids where these endogenous substances are
always present. When 200-fold concentration of uric acid was
added into the solution containing 1106 M OND and MOR, no
obvious interference was observed for OND quantiﬁcation, but the
current response of MOR increased signiﬁcantly due to the oxida-
tion of uric acid at þ0.65 V. Selectivity of the developed procedure
was also investigated by observing any interference encountered
from dopamine. The results showed that dopamine is oxidized at
potential þ0.49 V, however, in the presence of equal concentra-
tion do not cause a competitive adsorption onto the surface of
modiﬁed electrode since a decrease in the currents of both drugs
was not greater than 5%.
3.8. Applications of electrochemical sensor
The applicability of the MWCNTs–Naﬁon/GCE was examined
via quantitation of OND in pharmaceutical dosage form. OND was
analyzed in commercial ﬁlm-coated tablets using the standard
addition method in order to eliminate matrix effects. The results
obtained using the proposed sensor are in good agreement with
the claimed amount (Table 1). The analysis of OND in its pharma-
ceutical formulation exhibited the mean recovery of 99.7% with
the relative standard deviation of 1.3% indicating good accuracy
and precision as well as the suitability of the proposed sensor for
this purpose. To evaluate possible interactions with excipients,
recovery experiments were carried out by spiking the formulation
solution samples with known amount of standard OND solution.
The mean recovery of 98.1% indicated that excipients have no
interference effect on the analysis of OND, therefore a separation
step can be avoided.
The ﬁlm-coated tablets were also analyzed by the reverse-phase
HPLC method. The developed HPLC method with UV-detection was
validated according to standard procedure [30]. The results obtained
Table 1
Analysis of ondansetron in ﬁlm-coated tablets by the proposed adsorptive stripping
SWV and HPLC methods.
Technique AdSWV HPLC
Stated content (mg) 8.00 8.00
Detected content (mg)a 7.97 8.02
RSD % 1.25 0.39
Added (mol L1) 5.00107 2.00105
Found (mol L1) b 4.91107 1.97105
Recovery % 98.1 98.5
RSD % 3.46 0.24
F c 0.10 –
t c 0.37 –
a Each value is the mean of ﬁve experiments.
b Each value is the mean of three experiments.
c The theoretical values of F and t-test at 95% conﬁdence limit are 6.39 and 2.31,
respectively.
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with the proposed sensor were compared to those obtained by the
HPLC method (Table 1). Statistical analysis of the results obtained
using voltammetric and HPLC procedures showed no signiﬁcant
difference between the performance of the two methods regarding
accuracy and precision, as revealed by the student t-test and
variance ratio F-test. However, the electroanalytical method does
not require separation, degassing and expensive solvents that are
needed for an HPLC procedure.
Finally, the MWCNTs–Naﬁon/GCE was applied for simultaneous
determination of OND and MOR in biological samples. The
sensitivity of the proposed method complies with the expected
serum concentration level for both drugs after the treatment with
the therapeutic daily dose. However, the quantitation of OND and
MOR in human serum at the therapeutic concentration range
could not be feasible without accumulation of protonated drug
molecules on the MWCNTs–Naﬁon/GCE surface. Furthermore, the
MWCNTs–Naﬁon ﬁlm contains sulfonate groups and such surface
layer prevents accumulation of negatively charged oxidizable
substances found in biological ﬂuids onto the electrode surface.
The recovery studies of both drugs in serum samples were
performed using the standard addition method to nullify any
remaining interference. The mean recovery of 98.771.5% for
OND and 102.672.7% for MOR was achieved in this type of
matrix. From the experimental results, it is obvious that the
proposed electrochemical sensor has great potentials for practical
analysis of biological samples.
4. Conclusions
The paper describes, for the ﬁrst time, the oxidative behavior
and electrochemical determination of OND. A simple, but power-
ful, approach was applied for the fabrication of stable CNT-based
electrochemical sensor. The MWCNTs–Naﬁon/GCE exhibited a
remarkable enhancement effect on the voltammetric response of
OND due to excellent electrocatalytic activity and adsorption
capability of the immobilized ﬁlm toward the drug molecule. This
work provides a new and convenient electroanalytical method for
direct quantitation of OND in ﬁlm-coated tablets. In comparison to
HPLC method, the proposed sensor possesses numerous advan-
tages such as high sensitivity, rapid response, low cost and simpli-
city. In addition, the MWCNTs–Naﬁon/GCE exhibited high selectivity
in the voltammetric measurements of OND and co-administrated
drug MOR with potential difference of 430 mV. The electrode was
successfully applied for the simultaneous determination of both
drugs in human serum samples after selective accumulation at the
electrode surface.
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a b s t r a c t
A nanostructured electrochemical sensor was developed to establish an innovative way to measure
ropinirole and levodopa in real pharmaceutical and biological samples, which offers a high selectivity
derived from the stable carbon nanotubes-Naﬁon polymer ﬁlm. The surface morphology of the modiﬁed
electrodes was characterized by scanning electron microscopy. The effect of surface modiﬁcations,
supporting electrolyte, amount of carbon nanotubes suspension, accumulation time and potential were
investigated. A sensitive electroanalytical methodology for the simultaneous determination of both drugs
co-administrated in advanced Parkinson’s disease patients using adsorptive stripping square-wave vol-
tammetry is presented. Under the optimized conditions, ropinirole and levodopa gave a linear response
in the range 1  107–1  105 M and 2.5  107–1  105 M with detection limits 1.6  108 M and
5.2  108 M, respectively. The method was successfully utilised for their quantiﬁcation in human serum
samples and good recoveries were obtained without interference from endogenous dopamine, uric and
ascorbic acid. In addition, the proposed sensor was successfully applied in the independent determina-
tion of ropinirole and levodopa content in pharmaceutical formulations, whose accuracy was attested
by good agreement of the results with those, obtained using high performance liquid chromatography.
The proposed sensor is characterized by high sensitivity and reproducibility, simple fabrication proce-
dure, easy handling, resistance against surface fouling and low cost.
 2014 Elsevier B.V. All rights reserved.
1. Introduction
Parkinson’s disease is one of the most common neurodegenera-
tive disorders in humans leading to progressive deterioration of
motor function due to loss of dopamine-producing brain cells.
Ropinirole (ROP) is a novel nonergoline dopamine agonist indi-
cated for the treatment of early and advanced Parkinson’s disease
(Scheme 1). It is used as monotherapy in the ﬁrst stages of the dis-
ease [1]. When used as an adjunct to dopamine precursor levodopa
(L-dopa) in advanced Parkinson’s disease patients with motor
ﬂuctuations, ROP reduces daily off time and allows a reduction of
L-dopa dose. ROP is also one of the four medications approved by
the FDA for the treatment of primary restless legs syndrome affect-
ing up to ten percent of the population [2].
To date, only a few analytical methods have been described for
the determination of ROP, such as liquid chromatography-mass
spectrometry methods for quantiﬁcation of ROP in biological ﬂuids
[3,4], HPLC with UV detection for drug impurity proﬁling [5,6] and
stability-indicating assays [7], high performance thin layer chro-
matography [8], capillary zone electrophoresis [9], spectrophotom-
etry [10], spectroﬂuorimetry [11] and ultra-performance liquid
chromatography [12,13]. The ofﬁcial method for quantiﬁcation of
ROP has not yet been approved in European Pharmacopoeia [14].
The literature has only one report for electroanalytical determina-
tion of ROP employing glassy carbon electrode (GCE) [15]. How-
ever, due to the surface-active properties of drug oxidation
product, the adsorption of ROP on the electrode surface could not
be used as an effective preconcentration step prior to voltammetric
quantiﬁcation of the drug. Consequently, the obtained concentra-
tion range with the GCE was sufﬁcient for measurements of ROP
in pharmaceutical formulation, but not in biological samples.
Therefore, the development of electrochemical sensors for ROP
determination with lower quantiﬁcation limit without time-
consuming surface cleaning as in the case of GCE is of great
importance. On the other hand, ROP often coexists with L-dopa
in biological ﬂuids as these drugs are co-administrated in advanced
Parkinson’s disease patients. Surprisingly, up to now, no study has
http://dx.doi.org/10.1016/j.jelechem.2014.09.020
1572-6657/ 2014 Elsevier B.V. All rights reserved.
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been published in the literature reporting the simultaneous deter-
mination of ROP and L-dopa. The monitoring of the therapeutic
level concentrations of both drugs in serum samples is a critical
subject in clinical medicine to prevent overdose-induced toxicity.
The development and application of electrochemical sensors for
L-dopa quantiﬁcation in pharmaceuticals and biological ﬂuids has
received considerable interest in recent two years [16–26].
In continuation to our work on analysis of ROP [15], the aim of
this study was to construct a simple, stable and sensitive electro-
chemical sensor for ROP determination. Carbon nanotubes (CNTs)
have embarked a new epoch as novel electrode material in phar-
maceutical analysis. CNTs can be homogenously dispersed in Naf-
ion (NAF) solution due to hydrophobic side chains [27], while the
hydrophilic negatively charged sulfonate group in NAF ﬁlm enables
selective preconcentration of positively charged drug molecules
through electrostatic interaction [28,29]. Therefore, the adsorption
characteristic of ROP molecule was investigated at the surface of
glassy carbon electrode modiﬁed with carbon nanotubes and Naf-
ion as cation exchange polymer (CNT-NAF/GCE). The analytical
performance of the modiﬁed electrode for ROP quantiﬁcation in
the presence of L-dopa was also evaluated. Thus, here we reported
for the ﬁrst time, the development of analytical method for simul-
taneous determination of ROD and L-dopa. The adsorptive strip-
ping voltammetric method was applied for trace analysis of both
drugs in human serum samples. To achieve a better medicinal
effect and lower toxicity, it is very important to control the content
of ROP and L-dopa in pharmaceutical dosage forms. Therefore, the
modiﬁed electrode was also used to develop simple, inexpensive,
fast and accurate method for direct voltammetric quantiﬁcation
of ROP and L-dopa individually in commercial pharmaceutical for-
mulations. The HPLC was selected as the comparative methods for
evaluating the proposed new electroanalytical method.
2. Experimental
2.1. Instrumentation
Voltammetric experiments were carried out using a l-Autolab
potentiostat (Eco Chemie, Utrecht, The Netherlands). The experi-
mental conditions were controlled by General Purpose Electro-
chemical System (GPES) software, version 4.9. A three-electrode
conﬁguration was used with a bare or modiﬁed GCE (3-mm diame-
ter, Metrohm, Switzerland) as working electrode, Ag/AgCl (KCl 3 M,
Metrohm) reference electrode and a platinum counter electrode.
When required, stirring was applied using a computer-controlled
stirrer at ca. 300 rpm. All measurements were performed at room
temperature (23 ± 2 C) in a 20 mL electrochemical cell. HPLC anal-
ysiswere performedusing anAgilent 1100 Series LC system (Agilent
Technologies, Waldbronn, Germany) equipped with a diode array
detector, controlled by ChemStation software. The scanning elec-
tron microscope employed for surface characterisation of the elec-
trodes was a Jeol JSM-7000F model (Jeol Ltd., Tokyo, Japan) with
an operating voltage of 5 or 10 kV.
2.2. Chemicals
Ropinirole hydrochloride (99.4%), kindly donated by Pliva
(Zagreb, Croatia), was used as received without any further puriﬁ-
cation. L-dopa was purchased from Fluka (Laramie, USA). The pur-
ity of L-dopa was high enough to comply with the European
Pharmacopoeia. Requip ﬁlm-coated tablets (GlaxoSmithKline,
London, United Kingdom) containing 2.28 mg of ropinirole hydro-
chloride, equivalent to 2 mg of ROP, and Madopar tablets (Hoff-
mann-La Roche, Basel, Switzerland) containing 100 mg of L-dopa
and 25 mg of benserazide, were supplied from local pharmacy.
Multi-wall carbon nanotubes (purity more than 98%) with o.d.
between 6 and 13 nm and tube length from 2.5 to 20 lm as well
as Naﬁon (5 wt% solution in a mixture of lower aliphatic alcohols
and water) were from Sigma–Aldrich (Steinheim, Germany). All
solutions were prepared from analytical grade chemicals and
ultra-pure water obtained by a Milli-Q system (Millipore, Bradford,
USA).
Stock solutions of ROP and L-dopa for voltammetric measure-
ments were prepared in ultra-pure water at a concentration of
1.0  103 M and stored at 4 C in a refrigerator. Both ROP and
L-dopa standard solutions were prepared by appropriate dilution
of these stock solutions with the selected supporting electrolyte
just before use. The supporting electrolytes were sulfuric acid,
hydrochloric acid, acetic acid and Britton-Robinson buffer adjusted
to the desired pH with 0.2 M sodium hydroxide solution.
2.3. Preparation of the modiﬁed electrodes
A mass of 50 mg of the multi-wall carbon nanotubes was dis-
persed in 20 mL of concentrated nitric acid. The mixture was then
sonicated for 4 h to generate carboxylic acid-functionalized sur-
face. The suspension was ﬁltered through a 200 nm membrane
and washed with double distilled water to reach neutral pH. The
solid powders were dried under vacuum at room temperature.
Then, 1 mg of the functionalized CNTs was dispersed in 1 mL of
0.5% (m/v) Naﬁon ethanol solution and sonicated for 30 min to
form homogenous suspension. The CNT-NAF/GCE was prepared
by casting 5 lL of the immobilizing suspension on the polished
GCE surface allowing the solvent to evaporate at room tempera-
ture. Finally, the modiﬁed electrode was carefully rinsed with puri-
ﬁed water and scanned by two successive cyclic voltammetric
sweeps between 0 and 1.5 V at 100 mV s1 in a blank solution of
0.1 M H2SO4 prior to ﬁrst electrochemical measurements. The sur-
face areas of modiﬁed electrodes were obtained by cyclic voltam-
metry (CV) using 1.0  103 M K3Fe(CN)6 as a probe in 0.1 M KCl
electrolyte at different scan rates (v). From the slope of the anodic
peak current versus v1/2 plot, the surface areas of the GCE and the
CNT-NAF/GCE was calculated to be 0.057 and 0.298 cm2, respec-
tively. For comparison, the carbon nanotubes modiﬁed GCE (CNT/
GCE) and the Naﬁon modiﬁed GCE (NAF/GCE) were also prepared
in the same way as described but without the addition NAF and
CNTs, respectively.
2.4. Electrochemical measurements
CV was carried out from 0 to 1.5 V with the scan rate varying
from 10 to 500 mV s1. Square-wave voltammetry (SWV) was used
for the determination procedures of ROP and L-dopa. The
voltammograms were recorded in the SWV mode from 0.4 to
1.5 V either immediately in quiescent solution or after adsorptive
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Scheme 1. Chemical structures of ropinirole (ROP) and levodopa (L-dopa).
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accumulation for selected time at the predetermined potential in
stirred solution. The preconcentration of both analytes was carried
out at 0 V with a 240 s accumulation step. After an equilibrium
period of 5 s the potential scan was started. Operating instrumen-
tal conditions for SWV were: pulse amplitude of 25 mV, frequency
of 50 Hz and scan increment of 8 mV. After each measurement, the
sensor was transferred to the solution of 0.1 M H2SO4 to regenerate
the electrode surface by applying single positive-going CV poten-
tial scan from 0 to 1.5 V.
2.5. Determination in samples
Ten tablets of each analyzed pharmaceutical formulation were
weighed and separately powdered in a mortar. An adequate
amount of prepared powders, equivalent to a stock solution of con-
centration 1.0  103 M, was weighed and individually dispersed
in puriﬁed water in a 10.0 mL volumetric ﬂask. The mixtures were
sonicated for 10 min to provide complete dissolution of active
ingredients and ﬁltered through 0.45 lm Acrodisc GHP ﬁlters (Gel-
man, Ann Arbor, USA). To obtain ﬁnal concentrations in the range
of calibration curve, the sample solutions of both drugs were suit-
ably diluted with supporting electrolyte and subjected to direct
SWV measurements as previously mentioned. The content of ROP
and L-dopa in formulated products was determined by standard
addition method.
The ROP determination by HPLC was carried out using a chro-
matographic column XBridge C18, 3.0  50 mm, particle size
2.5 lm (Waters, Miliford, Mass., USA). The mobile phase composed
of acetonitrile, ultra-pure water and ammonium hydroxide (25%)
at the ratio of 400:600:0.04 (v/v/v) were ﬁltered through cellulose
nitrate ﬁlter (0.45 lm, Sartorius, Goettingen, Germany). The chro-
matography was carried out at constant temperature (25 C) with
a ﬂow-rate of 1 mL/min under isocratic conditions. The standard
solutions and the appropriate tablet solutions for HPLC analysis
were prepared in mobile phase and ﬁltered through a 0.2 lm Acro-
disc GHP ﬁlters (Gelman, Ann Arbor, USA). The injection volume
was 5 lL. The UV spectra were recorded from 190 to 400 nm and
the chromatogram was obtained at 250 nm. The nominal content
of ROP tablet amounts were calculated from the corresponding
regression equations of previously plotted calibration plots. The
ofﬁcial HPLC method described in USP was used for comparative
analysis of L-dopa tablets [30].
Serum samples were obtained from healthy volunteers and
stored frozen until assay. A 500 lL aliquot of human serum sam-
ples was fortiﬁed with the appropriate aliquot volume of ROP
and L-dopa standard solutions to achieve ﬁnal concentrations
(1.0  107 and 5  107 M) that are found after the treatment
with therapeutic daily doses of 6 and 100 mg for ROP and L-dopa,
respectively [31,32] and mixed with acetonitrile (1.5 mL) to
remove serum proteins effectively. The mixture was vortexed for
5 min. After centrifugation of sample for 10 min at 6000 rpm the
supernatant was separated. Appropriate volumes of clear superna-
tant solution were transferred into the volumetric ﬂask and diluted
with the supporting electrolyte and analyzed in the voltammetric
cell. To reduce the matrix effect the standard addition method
was employed in direct analysis of human serum samples.
3. Results and discussion
3.1. Electrochemical behaviour of ROP and L-dopa
The cyclic voltammograms of 5  105 M ROP solution in 0.1 M
H2SO4 were recorded at the CNT-NAF/GCE, the CNT/GCE, the NAF/
GCE and a bare GCE using a scan rate of 100 mV s1. A single anodic
peak was observed showing that the oxidation of ROP molecule is a
totally irreversible process. As seen in Fig. 1, moving from the GCE
to CNT-NAF/GCE, the oxidation peak was found to be extremely
well-deﬁned with enhanced peak current. ROP is completely in
cationic form (pKa 9.5) in experimental conditions used in the vol-
tammetric measurements. When the bare GCE surface was coated
with 0.5% Naﬁon ﬁlm, an oxidation wave (ip = 26.6 lA) at 1.36 V
was increased due to electrostatic attraction of positively charged
drug molecules. However, compared with NAF/GCE, the voltam-
metric response of ROP was remarkable increased at the CNT-
NAF/GCE with a current of 91.7 lA and a peak potential of
1.24 V. The oxidation peak potential was shifted to less positive
values by 120 mV indicating faster electron transfer at the elec-
trode surface and excellent electrocatalytic activity of immobilized
CNTs toward ROP molecule. Therefore, it can be concluded that the
synergistic effect of CNTs and NAF combination leads to a consid-
erable improvement in the analytical sensitivity.
To characterize the modiﬁed electrode, the surface morphology
of the NAF/GCE, the CNT/GCE and the CNT-NAF/GCE was studied
using scanning electron microscopy (SEM). The SEM image of the
NAF/GCE showed a smooth ﬁlm of cation-exchange polymer
(Fig. 2). On the other hand, the ﬁlm of the CNT/GCE showed plenty
of tubes irregularly placed in thread-like formations revealing a
much larger surface area. The SEM image of the CNT-NAF compos-
ite ﬁlm offers a uniform coating with higher accessible surface area
forming bundle structures. The CNTs were embedded into the
polymer matrix making the composite ﬁlm surface rough. This
unique surface morphology of CNT-NAF/GCE gave a high accessible
area improving the preconcentration of ROP molecules through
electrostatic interaction with negatively charged sulfonate group
in NAF polymer structure. Furthermore, the CNTs were tightly
ﬁxed in the NAF matrix onto GCE surface in a reproducible way
enhancing the stability of CNT-NAF/GCE.
The inﬂuence of the scan rate on the electrochemical response of
ROP was investigated by CV at the CNT-NAF/GCE. A plot of the ano-
dic peak current versus the scan rate in the range of 10–200 mV s1
gave the linear relationship ip (lA) = 0.23 v (mV s1) + 9.85
(r = 0.996), indicating that the electrooxidation of drug molecule
at the modiﬁed electrode was a adsorption-controlled process.
The oxidation peak potential was shifted to more positive poten-
tials as the scan rate increased from 10 to 500 mV s1. The depen-
dence of the peak potential is linear with logarithm of the scan
rate with a slope of 63.5 mV/decade (inset of Fig. 1), allowing the
calculation of an = 0.93. Using the value of the charge transfer coef-
ﬁcient (a = 0.53) obtained from the difference between the peak
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Fig. 1. Cyclic voltammograms of ropinirole (5  105 M) at a bare GCE (a), the NAF/
GCE (b), the CNT/GCE (c) and the CNT-NAF/GCE (d) in 0.1 M H2SO4. Scan rate:
100 mV s1. Inset: plot of peak potential vs. logarithm of scan rates from 10 to
500 mV s1 at the CNT-NAF/GCE.
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potential (Ep) and the half wave potential (Ep/2) by the equation
Ep–Ep/2 = (47.7/a) mV, the number of electrons exchanged was
calculated to be n = 1.76. Our earlier investigation of ROP
electrooxidation mechanism at bare GCE over a wide pH range
(1.0–12.0) in buffered aqueous media indicated that the voltam-
metric signal in strong acid media was assigned to an over-all
2e/2H+ oxidation process involving indol-2-one ring [15]. The oxi-
dation pattern of ROP molecule observed at the CNT-NAF/GCE in
0.1 M H2SO4 solution was well-consistent with that obtained at
the bare GCE, thus, we can corroborate that the oxidation of ROP
at the CNT-NAF composite ﬁlm occurs at indol-2-one moiety. How-
ever, at the surface of the CNT-NAF/GCE not only the sensitivity was
increased in comparison with the GCE, but the fouling effect of ROP
and its oxidation product was also decreased.
In order to develop electrochemical sensor for simultaneous
determination of ROP and L-dopa co-administrated in advanced
Parkinson’s disease patients, the oxidation of L-dopa was also stud-
ied at the CNT-NAF/GCE, the CNT/GCE, the NAF/GCE and a bare GCE
using CV. A single reversible oxidation peak at +0.52 V was
observed at the CNT-NAF/GCE, which can be assigned, in accor-
dance with previous studies [19], to a 2e/2H+ oxidation of L-dopa
to corresponding quinone form (inset of Fig. 3). The L-dopa mole-
cule has positively charged nitrogen atom (pKa 8.7) in 0.1 M
H2SO4 solution [33] and NAF as ion exchange polymer also
attracted cationic form of L-dopa from bulk to electrode surface,
thus facilitating the electrode process. The experimental results
clearly indicated a higher current response of L-dopa at the CNT-
NAF/GCE in comparison with that of using a bare GCE or other
two modiﬁed electrodes. This remarkable current enhancement
can be undoubtedly attributed to the unique structure and proper-
ties of CNT-NAF ﬁlm, including very large speciﬁc area, strong
adsorptive ability, and subtle electronic properties. The potential
difference of 720 mV between the two peak potentials of ROP
and L-dopa at the CNT-NAF/GCE is large enough to determine the
concentration of both drugs individually and simultaneously.
3.2. Optimisation of experimental conditions
Different supporting electrolytes, including sulfuric acid, hydro-
chloric acid, acetic acid and BR buffer pH 2.0–6.0, were tested in
order to develop a new electroanalytical method for simultaneous
Fig. 2. SEM images of the NAF/GCE (a), the CNT/GCE (b) and the CNT-NAF/GCE (c). Scale bar: 100 nm.
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Fig. 3. Effect of supporting electrolyte on ropinirole voltammetric response at the
CNT-NAF/GCE: 0.1 M H2SO4 (a), 0.01 M H2SO4 (b), Britton-Robinson buffer pH 4 (c),
0.01 M HCl (d) and 0.1 M CH3COOH (e). Scan rate: 100 mV s1; c = 5  105 M.
Inset: Cyclic voltammograms of levodopa at the CNT-NAF/GCE (solid line) and
together with ropinirole (doted line) and blank at CNT-NAF/GCE (dashed line).
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determination of ROP and L-dopa at the CNT-NAF/GCE. The exper-
iments showed that well-deﬁned voltammetric response of ROP
was obtained only in strong acid media and beyond pH 2 the peak
current started to deteriorate, as shown in Fig. 3. A maximum cur-
rent intensity was obtained in 0.1 M H2SO4 solution and conse-
quently, it was employed for further studies.
Since ROP oxidation was observed at relatively high potential
and this drug was found in lower concentration limits then L-dopa
in real samples, the effect of modiﬁer amount on the performance
of the CNT-NAF/GCE was investigated using SWV in order to obtain
the most favourable response of ROP. Therefore, when varying pro-
portions of CNTs dispersed in NAF solution (1–9 lL) were casted
onto the GCE surface, 5 lL of homogenous suspension served as
the optimum amount for NAF-CNT ﬁlm coating on the electrode
because maximum current of ROP was obtained, and thereafter,
the oxidation peak current conversely showed gradual decline.
The thickness of the composite ﬁlm was determined by the volume
of NAF-CNT suspension applied on the GCE surface. When the
thickness of the ﬁlm increased, there were more –SO3 sites that
conducted ion-exchange with the ROP molecules leading to an
increment of accumulation capacities, and similarly, more CNTs
dramatically promoted electron transfer reaction. These two
aspects resulted in a corresponding increase in the peak current.
The SWV response of ROP was increased up to 0.5% of NAF concen-
tration in the immobilizing suspension. Then, the NAF ﬁlm became
thicker and lowered the electrical conductivity of CNTs and, conse-
quently, retarded the electron transfer rate of ROP oxidation as
well as the analyte mass transportation through the ﬁlm resulting
in the higher electric resistance.
To obtain a much more sensitive peak currents for analytical
studies, the variation of the peak currents recorded at the CNT-
NAF/GCE was monitored while changing instrumental SWV
parameters, i.e. frequency (10 Hz 6 f 6 130 Hz), pulse amplitude
(10 mV 6 a 6 70 mV) and potential step (2 mV 6 DEs 6 10 mV).
The most favourable response was achieved using a combination
of a frequency of 50 Hz, pulse amplitude of 25 mV and a potential
step of 8 mV. Additionally, according to the square-wave theory
[34], the slope of 0.069 V obtained from the Ep versus log f plot
was used to calculate the value of an as 0.86. Taking the value of
0.53 for the charge transfer coefﬁcient, the number of electrons
transferred in the oxidation process of ROP was estimated to be
1.71, again a value of approximately 2, which was in agreement
with the result obtained by CV experiments conﬁrming the two-
electron mechanism of ROP electrooxidation at the CNT-NAF/GCE.
3.3. Adsorption properties of ROP and L-dopa on CNT-NAF/GCE
Since the modiﬁcation of the electrode surface with CNT-NAF
layer led to a strong interfacial accumulation of positively charged
drug molecules, possibility of effective analyte preconcentration
before voltammetric measurement was examined. To achieve the
optimum conditions for the maximum adsorption, the inﬂuence
of accumulation potential on the stripping peak current was
evaluated from 1.0 to 1.0 V. A maximum was observed at 0 V,
so this deposition potential was selected in all subsequent studies.
Square-wave voltammograms with increasing accumulation times
(between 0 s and 360 s) were recorded for solutions containing
ROP and L-dopa at concentration level of 2.5  106 M. Fig. 4
shows square-wave voltammograms for solution without accumu-
lation and after a 240 s accumulation step at the CNT-NAF/GCE.
The accumulation time signiﬁcantly affected the voltammetric
response of both drugs at the CNT-NAF/GCE. The peak current of
ROP increased up to 360 s, however, the accumulation time of
240 s provided the largest peak current in the linearity range
revealing a constant adsorption of drug molecules attracted on
the surface of the CNT-NAF/GCE. Further increment of deposition
time period showed a deviation of the peak current from linearity
suggesting saturation of the surface coverage. On the other hand,
the peak current of L-dopa enhanced greatly within 30 s indicating
faster adsorption then ROP, as shown in inset of Fig. 4. The voltam-
metric response of L-dopa increased up to a maximum at 120 s and
then remained almost constant. However, the value of 240 s was
considered as the optimum for simultaneous quantiﬁcation of both
drugs because the peak current of L-dopa slowly increased up to
240 s which was selected as the optimal value for ROP to achieve
the highest possible sensitivity in acceptable analysis time.
3.4. Simultaneous analysis and validation studies
The use of an electrochemical sensor for ROP determination has
not been reported in the literature and in addition, this work is the
ﬁrst report for simultaneous determination of ROP and L-dopa
used in combination to treat advanced Parkinson’s disease. The
electrocatalytic peak currents of ROP and L-dopa at 1.24 and
0.52 V, respectively, obtained at proposed sensor were used for
determination of both drugs in solution, involving SWV and
adsorptive stripping square-wave voltammetry (AdSWV) for drug
quantitation at low levels.
When all parameters that affect ROP and L-dopa quantiﬁcation
had been studied, variation of the current response with the drug
concentration was performed. In the case of a square-wave scan
without any accumulation step, the oxidation peak showed a linear
response in the concentration range of 1  106–5  105 M for
ROP and 1  106–1  105 M for L-dopa. By using drug accumula-
tion at the CNT-NAF/GCE prior to SWV measurement, higher sensi-
tivities were achieved. Fig. 5 shows the SWV responses from the
electrochemical oxidation of ROP and in 0.1 M H2SO4 solution after
a 240 s preconcentration step. Calibration graph using AdSWV
showed two linear segments for ROP detection. The ﬁrst linear
range was from 1  107 to 1.5  106 M and the second linear
dynamic range was between 1.5  106 and 1  105 M (inset of
Fig. 5). The break in the calibration curve of ROP adsorptive strip-
ping current reﬂected the formation of a sub-monolayer in the ﬁrst
range of calibration and formation of a monolayer in the second
range. Since the presence of L-dopa in solution may affect the
quantiﬁcation of ROP due to competitive adsorption and therefore,
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Fig. 4. Square-wave voltammograms of ropinirole (2.5  106 M) and L-dopa
(2.5  106 M) at the CNT-NAF/GCE in 0.1 M H2SO4 after preconcentration time of
240 s (a), without preconcentration (b) and blank solution (c). SWV settings:
frequency of 50 Hz, amplitude of 25 mV and potential step of 8 mV, Eacc = 0 V. Inset:
Effect of the accumulation time on the oxidation peak current for ropinirole (circles)
and L-dopa (squares).
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the interference of each analyte in the simultaneous determination
of its pairs was performed by changing one analyte concentration
and keeping the other unchanged. The variation of adsorptive
stripping SWV peak current versus ROP concentration in the pres-
ence of L-dopa at the ﬁxed concentration of 2.5  106 M gave the
sensitivities of the CNT-NAF/GCE towards the ROP oxidation of
4.75  107 and 2.96  107 lA M1 for lower and higher concentra-
tion ranges, respectively. The values obtained are very close (rela-
tive errors 1.43% and 2.31%) to the values observed in the absence
of L-dopa (Table 1), indicating independent adsorption of both
drugs in the accumulation step at the proposed electrochemical
sensor. Therefore, simultaneous determination of ROP and L-dopa
is possible without interferences. Fig. 6 shows the voltammetric
responses for the solutions containing various concentrations of
L-dopa and constant concentration of ROP (1  106 M). The
relation between the stripping peak current and concentration of
L-dopa was found to be linear over the range 2.5  107–1 
105 M (inset of Fig. 6). The analytical characteristics and the
related validation parameters of developed methods are given in
Table 1. The detection and quantiﬁcation limits of were calculated
from the calibration curves as 3s/m and 10s/m, respectively, where
s is the standard deviation of the intercept andm is the slope of the
calibration curve [35].
For validation of the proposedmethod, the intra-day precision of
the voltammetric response using the CNT-NAF/GCE was evaluated
by six replicate measurements of 1.5  106 M ROP and L-dopa
solution yielding unchanged oxidation peak potentials for ROP
and L-dopa and the RSD values of 1.4% and 1.7% for ROP (mean
ip = 70.4 lA) and L-dopa peak currents (mean ip = 33.5 lA),
respectively. These results indicated that proposed electrochemical
sensor was stable in repeated measurements for selective determi-
nation of ROP and L-dopa. The inter-day precision of the electrode
response was characterized by three replicate measurements of
2.5  106 M ROP and L-dopa over three days, each time using a
freshly prepared CNT-NAF/GCE and standard solutions. The RSDs
values of the anodic stripping currents for ROP (mean ip = 96.4 lA)
and L-dopa (mean ip = 53.8 lA) were 2.5% and 2.9%, respectively,
while the RSDs of peak potentials for both drugs were no greater
than 0.7%, indicating excellent fabrication reproducibility.
The proposed electrochemical sensor can be stored in air or kept
in distilled water for several weeks without the loss of activity. The
stability of the CNT-NAF/GCE was evaluated by measuring the cur-
rent response of 2.5  106 M ROP and L-dopa solution over a per-
iod of three weeks. The modiﬁed electrode was used daily and
stored in the air at room temperature. Before measurements, the
modiﬁed electrode was scanned between 0.5 and 1.4 V in the solu-
tion of supporting electrolyte until the SWV response was stable.
The experimental results indicated that the CNT-NAF/GCE could
retain 97.5% and 98.3% of initial response after two weeks for
ROP and L-dopa, respectively, revealing that sensor fabricated pos-
sesses long-term stability. Thereafter, the voltammetric signal
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Fig. 5. Adsorptive stripping square-wave voltammograms of ropinirole at the CNT-
NAF/GCE recorded in 0.1 M H2SO4 at different concentrations (1  10 7–
1  105 M). SWV settings and accumulation conditions same as in Fig. 4. Inset
shows a calibration graph for the quantiﬁcation of ropinirole.
Table 1
Analytical parameters for the voltammetric determination of ROP and L-dopa by SWV and AdSWV using CNT-NAF/GCE.
ROP L-dopa
SWV AdSWV SWV AdSWV
Linearity range (M) 1  106–5  105 1  107–1.5  106 1.5  106–1  105 1  106–1  105 2.5  107–1  105
Slope (lA M1) 2.22  106 4.81  107 3.04  107 1.46  107 1.89  107
Intercept (lA) 0.20 0.28 26.78 4.45 2.64
Sx/y
a 2.16 1.86 7.40 5.62 3.52
Sb
b 4.63  104 1.62  106 1.05  106 6.99  105 3.55  105
Sa
c 0.19 0.27 1.30 0.79 0.33
Correlation coefﬁcient 0.999 0.998 0.998 0.995 0.999
Detection limit (M) 2.6  107 1.6  108 1.3  107 1.6  107 5.2  108
Quantitation limit (M) 8.7  107 5.5  108 4.3  107 5.4  107 1.7  107
a Standard deviations of residuals.
b Standard deviations of the slope.
c Standard deviations of the intercept.
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Fig. 6. Adsorptive stripping square-wave voltammograms of the mixture contain-
ing levodopa at different concentrations (2.5  107–1  105 M) and ropinirole
(1  106 M) recorded at the CNT-NAF/GCE in 0.1 M H2SO4. SWV settings and
accumulation conditions same as in Fig. 4. Inset shows a calibration graph for
levodopa.
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started to decrease indicating the need for re-depositing of a new
nanostructured ﬁlm.
3.5. Interference studies
Prior to the analysis of samples, the selectivity of the proposed
electrochemical sensor for quantiﬁcation of ROP and L-dopa was
also evaluated. The addition of possible interference compounds
commonly present in the analyzed pharmaceutical dosage forms
or biological samples was investigated in a standard solution
containing ROP and L-dopa at 1  106 M concentration. The toler-
ance limit was taken as the concentration of foreign substances
which gave an error less than ±5% in the determination of the
drugs. According to the analysis of the obtained voltammetric
responses, Na+, Cl (2000-fold), K+, Zn2+, SO42, NO3 (1000-fold),
Ca2+, Mg2+, Cu2+, lactate (500-fold), HPO42, citric acid, L-glycine,
L-alanine, L-aspartic acid, L-glutamic acid (400-fold), Fe3+, starch
(300-fold), lactose, sucrose, L-cysteine (200-fold) did not show
interference in the determination of both drugs. Also, the interfer-
ence of ascorbic acid, glucose and uric acid was examined because
theses endogenous substances are always present in complex
matrices such as biological ﬂuids. It was observed that the adsorp-
tive stripping peak current of ROP and L-dopa did not change after
adding 400-fold of ascorbic acid and 300-fold of glucose. In the
presence of uric acid, new well-deﬁned oxidation peak appeared
at the potential around +0.69 V. The results showed that 50-fold
concentration of uric acid did not cause a positive or a negative
error greater than 5% in the determination of L-dopa. However, uric
acid did not inﬂuence the peak current of ROP even up to 200-fold
excess. As expected, the interferences from negatively charged oxi-
dizable ions were eliminated by prevention their accumulation
using application of a Naﬁon-coated membrane. Also, dopamine
at the concentration ratio 2:1 (interferent: drug standard solution)
did not interfere with ROP voltammetric response, but showed
interference with L-dopa quantiﬁcation due to dopamine oxidation
at +0.48 V, very close to L-dopa potential. However, normal plasma
levels of endogenous free dopamine (26 pg/mL) [36] did not affect
L-dopa voltammetric response at the CNT-NAF/GCE.
3.6. Analytical applications
To evaluate the validity and practical utility of the proposed
method for individual quantiﬁcation of ROP and L-dopa, two com-
mercially available pharmaceutical products containing ROP
(Requip, GlaxoSmithKline) as well as L-dopa and benserazide
(Madopar, Hoffmann-La Roche) were analyzed using the standard
addition method in order to eliminate matrix effects. Due to the
high concentration of active ingredients in their dosage forms
(2 mg per ROP tablet and 100 mg per L-dopa tablet), no accumula-
tion time was needed and the tablets assay was carried out using
direct anodic SWV technique. Results summarized in Table 2
shows that the content of assayed tablets obtained by utilizing
the CNT-NAF/GCE are in good agreement with those declared in
the label of the pharmaceutical products. The effect of excipients
upon the voltammetric response of ROP and L-dopa at the
CNT-NAF/GCE was studied by adding different known amounts of
standard to the formulation solution samples. The recoveries of
99.2% for ROP and 99.4% for L-dopa were obtained from this type
of matrix, indicating adequate accuracy of the proposed analysis
procedures. The obtained recoveries revealed that excipients did
not interfere with the assay avoiding a separation step, and thus
corroborating the suitability of the proposed sensor for this
purpose. Also, the data indicate that benserazide present in com-
bined pharmaceutical dosage form with L-dopa had no interfer-
ence effect on L-dopa determination in real sample using the
CNT-NAF/GCE.
The results obtained with the proposed sensor were compared
with those obtained by developed reverse-phase HPLC method
for ROP and ofﬁcial HPLC method described in USP for L-dopa tab-
lets [30]. Recovery tests were also performed for chromatographic
methods. Statistical comparison were performed on data obtained
using both voltammetric and HPLC procedures. The results of the
student t-test and variance ratio F-test show that there are no sig-
niﬁcant differences between the techniques with regard to accu-
racy and precision (Table 2). Therefore, the modiﬁed electrode
can be efﬁciently used for individual determination of ROP and
L-dopa in pharmaceutical preparations. The newly developed
methods using the CNT-NAF/GCE can be successfully applied in
controlling the quality of active pharmaceutical ingredient and
dosage forms as a selective method that is very precise, rapid
and inexpensive.
To check the analytical applicability of the proposed electro-
chemical sensor for simultaneous quantiﬁcation of ROP and
L-dopa, the AdSWV method was applied to the determination of
both drugs in human serum samples. Pharmacokinetic studies
found in the literature suggest that the sensitivity of the proposed
sensor complies with the expected serum concentration level in
Parkinson patients treated with usual recommended daily dose.
The average plasma concentration of L-dopa ranged from
4.4  106 to 11  106 M [32]. However, the maximum plasma
concentration of ROP at steady state is much lower [31] and the
quantitation of ROP in human serum at the therapeutic concentra-
tion range could not be feasible without preconcentration step on
the modiﬁed electrode surface. The recovery studies of both drugs
in serum samples were performed using the standard addition
method. The mean recovery of 99.6 ± 2.2% for ROP and 98.8 ±
Table 2
Application of the CNT-NAF/GCE for individual determination of ROP and L-dopa in pharmaceutical dosage forms by the proposed SWV.
Samples ROP L-dopa
SWV HPLC SWV HPLC
Label value (mg) 2 2 100 100
Determined value (mg)a 2.02 2.06 95.23 95.04
RSD% 1.16 0.49 1.25 0.06
Bias% 0.95 2.85 4.77 4.96
Added (M) 5.00  106 5.00  105 2.50  106 1.00  103
Found (M)a 4.96  106 5.03  105 2.48  106 1.02  103
Recovery% 99.2 100.6 99.4 101.8
RSD% 1.65 0.28 2.23 0.44
Bias% 0.76 0.64 0.72 1.80
Fb 5.41 – 4.21 –
tb 1.54 – 1.99 –
a n = 3.
b The theoretical values of F and t-test at 95% conﬁdence limit are 6.39 and 2.31, respectively.
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2.3% for L-dopa was achieved (Table 3). Using the proposed electro-
chemical sensor, no sample pre-treatment was required, other
than precipitation of the serum proteins with acetonitrile and a
dilution step with the selected supporting electrolyte. The possibil-
ity of monitoring ROP and L-dopa concentration expected after
therapeutic dose could make the method proposed useful for phar-
macokinetic purposes.
3.7. Comparison of analytical methods
The analytical characteristics observed during validation of the
proposed methods were compared with those obtained in earlier
reported electroanalytical methods for the determination of ROP
and L-dopa (Table 4). The electrochemical behaviour of ROP has
not been investigated to date at modiﬁed electrodes, while many
electrochemical sensors have been developed for the L-dopa deter-
mination. Very recently, we have developed SWV and differential-
pulse voltammetric method (DPV) for ROP determination using a
bare GCE [15]. Compared with those methods (slope of the calibra-
tion graph was 4.08  106 lA M1 for SWV and 1.92  105 lA M1
for DPV), the better sensitivity of adsorptive stripping analytical
procedure was obtained at the CNT-NAF/GCE for measurement of
ROP (Table 1). Also, the LOQ values obtained at proposed sensor
using AdSWV are lower than that obtained at the GCE [15]. One
of the most important attributes of the CNT-NAF/GCE is its remark-
ably improved reproducibility without the need for additional and
time-consuming mechanical polishing of the electrode surface
before each measurement as in the case of GCE.
Additionally, the quantiﬁcation limits of ROP obtained at
developed electrochemical sensor are comparable to some HPLC
methods with UV detection [6,7] and are better than that obtained
in capillary electrophoresis [9], spectrophotometry [10] and high
performance thin layer chromatography [8], but the detection lim-
its are higher than LODs reported for chromatographic methods
coupled to mass spectrometry [3,4,13] and spectroﬂuorimetric
method reported previously [11]. However, spectroﬂuorimetric
method additionally require derivatization of ROP with 4-chloro-
7-nitrobenzofurazan before detection step, while LC-MS analytical
procedures demand expensive and sophisticated equipment that
could not be available in many laboratories. In addition, the pro-
posed electroanalytical methods offer several advantages over
chromatographic techniques applied only to the quantiﬁcation of
drug, including short analysis time, simplicity of operation and
lower running cost.
The comparison between the analytical performance of the
CNT-NAF/GCE and other electrochemical sensors described in
the literature in recent two years for determination of L-dopa
is also presented in Table 4. The proposed electrochemical sensor
exhibited wide linear working range and appreciable detection
limit compared to previously developed sensors for L-dopa
quantiﬁcation. The LOD obtained with adsorptive accumulation
at CNT-NAF/GCE is similar or even better than those found with
some other electrochemical sensors described in the literature.
However, in comparison with most others it can be easily
constructed in a simple procedure and the surface of electrode
is also easily renewable. Moreover, the developed methods were
applied for both pharmaceutical formulations and biological
ﬂuids whereas the reported literature methods [17,19,20,23,24]
have been applied either for pharmaceutical or biological
samples.
Table 3
Results on recovery tests for serum samples by proposed AdSWV method for simultaneous determination of ROP and L-dopa using CNT-NAF/GCE.
Samples found/R.S.D., average Added 106 c (M) Found 106 c (M) Recovery (%) RSDa (%)
ROP 0.10 0.099 98.66 2.47
0.25 0.247 98.93 2.44
0.50 0.505 101.07 1.84
L-dopa 10.00 9.873 98.73 2.79
15.00 14.653 97.69 2.25
20.00 19.983 99.92 1.86
a Average of three measurements.
Table 4
Comparison of various voltammetric methods for the determination of ROP and L-dopa with the present work.
Analyte Technique Electrode Concentration range (M) LOD (M) Reference
ROP DPV GCE 1  106–2  105 2.5  107 15
SWV GCE 5  107–2  105 1.1  107 15
SWV CNT-NAF/GCE 1  106–5  105 2.6  107 This work
AdSWV CNT-NAF/GCE 1  107–1  105 1.6  108 This work
L-dopa DPV Cumarine derivative/TiO2 NPa/ILb/CPEc 1  107–9  104 4.1  108 16
AdDPV Ni(OH)2 NPa/MWCNT/GCE 1  107–1  104 7.6  108 17
AdSWV Cu(II) complex/Ag NPa/CPEc 7.8  109–9.1  106 2.4  109 18
AdDPV Poly(methyl orange) CPEc 2  105–8  104 3.7  106 19
SWV Co(III) complex/MWCNT/BPPGEd 3  106–1  104 8.6  107 20
DPV Quercetin/ MWCNT/GCE 9  107–8.5  105 3.8  107 21
DPV Co-porphyrin/TiO2 NPa/CPEc 1  107–1  104 6.9  108 22
DPV SWCNT/chitosan/ILb/GCE 2  106–4.5  104 1.6  107 23
DPV Au NP/Naﬁon/CPEc 2  107–2  105 1.5  109 24
5  105–3  103 2.8  106 24
DPV Nanosized mesoporous molecular sieves/CPEc 1.3  107–1.25  103 7.2  108 25
DPV Co-hexacyanoferrate/large mesopore carbon/GCE 1  107–1.9  103 1.7  108 26
SWV CNT-NAF/GCE 1  106–1  105 1.6  107 This work
AdSWV CNT-NAF/GCE 2.5  107–1  105 5.2  108 This work
a Nanoparticles.
b Ionic liquid.
c Carbon paste electrode.
d Basal plane pyrolytic graphite electrode.
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4. Conclusion
The result of this investigation shows that developed electro-
chemical sensor based on carbon nanotubes embedded into the
polymer Naﬁon matrix is high sensitive and selective analytical
tool for voltammetric determination of ROP and L-dopa. For the
ﬁrst time, the analytical method for simultaneous determination
of ROP and L-dopa was developed. The large separation of the peak
potentials at the CNT-NAF/GCE allows fast simultaneous quantiﬁ-
cation of trace amounts of both drugs in human serum samples.
The very high sensitivity of the modiﬁed electrode can be related
to very large surface area, low resistance, electrocatalytic effect
and strong adsorption ability of the CNTs-NAF nanocomposite.
The proposed sensor is also a feasible alternative for direct mea-
surements of ROP and L-Dopa individually in pharmaceutical sam-
ples by SWV. The prepared modiﬁed electrode shows several
advantages such as simple preparation procedure, high sensitivity
and stability, ease of the electrode surface regeneration with excel-
lent reproducibility. We believe that the proposed method would
be a potential step forward in the development of a reverse-phase
HPLC procedure with electrochemical detection for simultaneous
trace determination of ROP and L-dopa co-administrated in
advanced Parkinson’s disease patients.
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a b s t r a c t
A rapid analytical method without the time-consuming separation step was developed to simultaneously
determine mesalazine and its N-acetylated metabolite. A simply designed electrochemical sensor with
functionalized carbon nanotubes in a Naﬁon matrix was constructed for this purpose. The presence of the
nanocomposite modiﬁer on the electrode surface signiﬁcantly affects the voltammetric response of
target analytes. The morphology of the modiﬁed surface was investigated by scanning electron micro-
scopy. The effect of modiﬁer amount on the sensor performance was investigated in order to obtain the
most favorable response of mesalazine since it was found in lower concentration limits in real samples
then its metabolite due to the rapid drug elimination and the slightly slower renal metabolite excretion.
Under optimal conditions, the anodic peak currents measured by square-wave voltammetry increased
linearly after short accumulation of 30 s in the range of 5.0108–2.5106 M and
1.01075.0106 M for drug and metabolite, respectively. In addition to stable response, the sensor
has excellent performance associated with high sensitivity (2.33107 and 8.37106 mA M1 for drug
and metabolite, respectively). The synergistic effect of the carbon nanotubes and Naﬁon polymer ﬁlm
yielded detection limit of 1.2108 M for mesalazine and 2.6108 M for its metabolite that is com-
parable to known chromatographic methods. Due to the easy preparation and regeneration, the pro-
posed sensor opens new opportunity for fast, simple and sensitive analysis of drug and its metabolite in
human serum samples as well as direct quantiﬁcation of mesalazine in delayed-release formulations.
& 2015 Elsevier B.V. All rights reserved.
1. Introduction
Mesalazine (5-aminosalicylic acid, 5-ASA) is an anti-inﬂammatory
drug widely prescribed for the therapy of ulcerative colitis and Crohn's
disease (Scheme 1). It may also provide protection against the devel-
opment of colorectal cancer in patients suffering from inﬂammatory
bowel diseases [1]. In addition, 5-ASA inhibits cell injury in the in-
ﬂamed mucosa by scavenging reactive oxygen metabolites, thus sup-
pressing their toxicity. The drug is absorbed quickly from the small
intestine when administrated orally and therefore, modiﬁed-release
dosage forms are designed to deliver drug in the terminal ileum and
colon [2]. After absorption, 5-ASA is metabolized by N-acetyltransfer-
ase to its N-acetyled-5-ASA derivative (Ac-5-ASA) in the liver and in-
testinal mucosa. This compound is the major metabolite present in
blood with a half-life of up to 10 h. In plasma, both 5-ASA and Ac-5-
ASA are found 40–50% and 80%, respectively bound to proteins.
Various analytical methods were described in the literature for
the determination of 5-ASA, such as liquid chromatography coupled
to mass spectrometry for drug quantiﬁcation in plasma samples [3],
HPLC with UV detection for stability-indicating assays [4] and
analysis in pharmaceutical formulations [5], capillary electrophor-
esis for drug impurity proﬁling [6], spectrophotometry [7], ﬂuor-
escence spectroscopy [8], automated chemiluminescence [9] and
ultra-performance liquid chromatography [10]. At present, several
HPLC methods with a ﬂuorescence [11–13], electrochemical [14,15]
and mass spectrometry detection [16,17] were developed for si-
multaneous quantiﬁcation of 5-ASA and its N-acetylated metabolite.
The satisfactory results were obtained with excellent selectivity and
low detection limit. However, the developed chromatographic
methods require derivatization of drug and metabolite before de-
tection step, tedious sample preparations, consumption of large
solvent volumes and time-consuming procedures. In developed
HPLC methods the analytical run time per sample took about 10–
40 min.
The electroanalytical methods have proved to be useful for
sensitive and selective determination of many pharmaceuticals
owing to fast response, low instrument and analysis cost as well as
simplicity of samples preparation [18,19]. In spite of that, no at-
tempt has been made to this date to determine 5-ASA and its
metabolite by an electroanalytical method. There are only a few
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reports available on the electrochemical determination of 5-ASA.
The sonolinear sweep voltammetric method was developed for
determination of drug in tissue culture medium [20]. 5-ASA was
quantiﬁed using glassy carbon electrode (GCE) [21] and pencil
graphite electrode [22], however both methods were applied only
to analysis of pharmaceutical formulations. The abrasive stripping
voltammetry was used for identiﬁcation of 5-ASA in commercial
dosage forms [23], but proposed method was not quantitative. The
amperometric catalase-peroxidase based biosensor was developed
for measurement of 5-ASA concentration by indirect method
monitoring dissolved oxygen level [24]. The high cost of enzymes
used in the kit limits widespread application of the method for
routine purpose. The oxidative behavior of 5-ASA was studied on
the surface of GCE modiﬁed with nanoporous ﬁlm and subse-
quently, electrochemically deposited polypyrrole using 1,5-naph-
talenedisulfonic acid as dopant [25], however the developed
method was designed only for quantitation of 5-ASA. Due to
prolonged therapy and maintenance of remission in inﬂammatory
bowel diseases, as well as the need for clinical and bioequivalence
studies after the administration of newly developed delayed-re-
lease formulations, a simple, inexpensive and highly sensitive
electroanalytical method is in great demand for simultaneous
determination of 5-ASA and its metabolite.
Carbon based electrodes are commonly used in electro-
analytical chemistry because of their low cost and wide avail-
ability. On the other hand, carbon nanotubes (CNTs) have attracted
scientiﬁc interests in recent years owing to unusual mechanical
strength and electrical conductivity, unique structure with huge
surface area and excellent electrocatalytic activity [26]. Theirs
exceptional properties offered versatile platform to employ them
as the active material for the preparation of various composite
electrode materials. CNTs-based sensors generally have higher
sensitivities at low concentration levels or in the complex matrix,
lower detection limits and faster electron transfer kinetics than
traditional carbon electrodes. However, many factors need to be
investigated in order to create an optimal CNTs-based sensor.
In the present study, the composite material based on the
coupling of multi-walled CNTs and Naﬁon as cation exchange
polymer was used to develop a fast and simple method for si-
multaneous measurement of 5-ASA and its metabolite without a
separation step. The developed electrochemical sensor was suc-
cessfully applied for simultaneous determination of 5-ASA and Ac-
5-ASA metabolite at trace levels in serum samples using ad-
sorptive stripping square-wave voltammetry (SWV). In addition,
the proposed sensor was used to develop inexpensive and rapid
method for direct measurement of active ingredient in different
5-ASA delayed-release formulations.
2. Experimental
2.1. Apparatus
Voltammetric measurements were performed using a μ-Auto-
lab potentiostat (Eco Chemie, Utrecht, The Netherlands) controlled
by GPES 4.9 software. A three-electrode cell system was used. The
multi-walled CNTs and Naﬁon polymer modiﬁed GCE (CNTs-N/
GCE) and a bare GCE (3-mm diameter, Metrohm, Switzerland)
were used as a working electrode, a platinumwire and an Ag/AgCl/
3 M KCl (Metrohm) were used as the counter and reference elec-
trodes, respectively. In preliminary measurements, a bare gold
electrode (2-mm diameter, Metrohm, Switzerland) and gold elec-
trode modiﬁed in the same way as GCE were also employed as the
working electrode. Prior to modiﬁcation, the working electrode
was polished with aqueous slurry of 0.05 μm alumina powder on a
smooth polishing cloth, thoroughly rinsed with water and then
ultrasonically cleaned in water for 30 s. Finally, the electrode was
washed with puriﬁed water and dried. All electrochemical ex-
periments were carried out at room temperature (2371 °C).
When required, stirring was applied using a computer-controlled
stirrer at ca. 300 rpm.
Scanning electron microscopy (SEM) measurement was pe-
formed on a Jeol JSM-7000F microscope (Jeol Ltd., Tokyo, Japan).
2.2. Chemicals
5-ASA supplied by Merck (Darmstadt, Germany) was used
without further puriﬁcation. Ac-5-ASA metabolite, the multi-wal-
led CNTs (498%, O.D. 6–13 nm, length 2.5–20 mm) and Naﬁon
(5 wt% solution in a mixture of lower aliphatic alcohols and water)
were obtained from Sigma-Aldrich (Steinheim, Germany). All
other chemicals were of analytical grade quality. Ultra pure water
used for the preparation of standard solutions and buffers was
obtained by a Milli-Q system (Millipore, Bradford, USA). Salofaks
(Dr. Falk Pharma, Germany) and Pentases (Ferring GmbH, Ger-
many) delay-released tablets containing 500 mg of 5-ASA were
supplied from local pharmacy.
Stock solution of 5-ASA (1103 M) was prepared by dissol-
ving appropriate amount of the compound in puriﬁed water with
addition of a drop of 1 M HCl to minimize the risk of 5-ASA oxi-
dation [21] and stored in the dark under refrigeration. Stock so-
lution of Ac-5-ASA (1103 M) was prepared by dissolving its
adequate amount in methanol. Standard solutions were prepared
daily by diluting the stock solutions with a supporting electrolyte
just before use. Britton–Robinson (BR) buffer solutions (0.04 M in
each of acetic, phosphoric and boric acids) adjusted to the desired
pH with addition of a 0.2 M NaOH were used as supporting
electrolytes.
2.3. Preparation of CNTs-N/GCE
To generate carboxylic acid-functionalized surface the multi-
walled CNTs (50 mg) were added to plentiful concentrated nitric
acid and then sonicated for about 4 h. The suspension was ﬁltered
and washed with redistilled water to neutral. The solid powders
were dried under vacuum at room temperature. One milligram of
acid-treated CNTs was dispersed in 0.3% Naﬁon ethanol solution to
give a 1.0 mg mL1 black suspension with the aid of ultrasonic
agitation. The nanocomposite ﬁlm modiﬁed electrode was fabri-
cated by dropping 3 μL of black suspension on cleaned working
electrode surface and evaporating the solvent at room temperature.
To obtain a stable cyclic voltammogram as well as strength CNTs
adhesion to the electrode surface, the modiﬁed electrode was
scanned prior to ﬁrst measurement by two successive cyclic vol-
tammetric sweeps between 0 and 1.5 V at 100 mV s1 in a blank
solution of BR buffer pH 2.0. The surface area of modiﬁed electrode
was obtained by cyclic voltammetry (CV) using 1.0103 M K3Fe
(CN)6 in 0.1 M KCl electrolyte at different scan rates (v) between
0.2 and 0.7 V. From the slope of the anodic peak current versus
v1/2 relation, the surface area of the CNTs-N/GCE was calculated to
be 0.156 cm2, which was about three times greater than the surface
of the bare GCE. For comparison, the carbon nanotubes modiﬁed
NH2HO
COOH
NHCOCH3HO
COOH
5-ASA Ac-5-ASA
Scheme 1. Chemical structures of mesalazine (5-ASA) and its N-acetylated meta-
bolite (Ac-5-ASA).
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GCE (CNTs/GCE) and the Naﬁon modiﬁed GCE (NGCE) were also
prepared in the same way as described but without the addition
Naﬁon and CNTs, respectively.
2.4. Electrochemical measurement procedures
The oxidative behavior of 5-ASA and Ac-5-ASA was investigated
by CV in the range from 0 V to 1.0 V with the scan rate varying
from 10 to 500 mV s1. Before the square-wave voltammetric
determination of drug and its metabolite in the adsorptive strip-
ping procedures, the CNTs-N/GCE was immersed in the sample
solution with 30 s accumulation at 0.1 V under stirring condition.
After 5 s equilibrium period, the voltammogram was recorded by
applying a SWV potential scan from 0.3 to 1.0 V. The CNTs-N/GCE
was applied for direct SWV measurement of 5-ASA in delay-re-
leased dosage forms. Operating instrumental conditions for SWV
were: pulse amplitude of 50 mV, frequency of 70 Hz and scan in-
crement of 2 mV. The analytes adsorbed on the modiﬁed electrode
surface after measurement were readily removed by applying
single positive-going CV potential scan from 0 to 1.5 V in blank
supporting electrolyte.
2.5. Determination in samples
Serum samples were obtained from healthy volunteers and
stored frozen until assay. Samples were fortiﬁed with appropriate
aliquot volume of 5-ASA and Ac-5-ASA standard solutions to
achieve ﬁnal concentrations (2.5107 and 1.0106 M) that are
found in serum after treatment with recommended daily dose of
2 g [16,27]. To remove serum proteins a 500 mL aliquot of serum
sample containing drug and its metabolite was mixed with acet-
onitrile (1:1). After vortexing for 60 s, the mixture was centrifuged
for 6 min at 6000 rpm. Appropriate volumes of clear supernatant
were transferred into the volumetric ﬂask and diluted with sup-
porting electrolyte before voltammetric measurements. Analysis of
human serum samples were performed using the standard addi-
tion method to reduce the matrix effect by adding three successive
aliquots of standard solutions.
To prepare the solutions of 5-ASA delay-released dosage forms,
10 tablets were weighted and crushed to a ﬁne powder. A quantity
of ﬁnely ground material equivalent to 1.5 mg of 5-ASA was
transferred into a calibrated 10.0 mL ﬂask and dispersed in water.
The content of the ﬂask was sonicated for 10 min to provide
complete dissolution of active ingredient and then completed to
the volume with water. Tablet solution was then ﬁltered through
0.45 μm Acrodisc GHP ﬁlters (Gelman, Ann Arbor, USA). An aliquot
of ﬁltrate was transferred into a calibrated ﬂask and diluted with
water to yield a ﬁnal drug concentration of 1.0104 M. A series
of dilutions were made with supporting electrolyte to cover the
working concentration range. Solutions were subjected to direct
SWV measurements and the content of 5-ASA in the commercial
pharmaceutical products was determined by standard addition
method. For recovery studies, aliquots of the 5-ASA standard so-
lutions were added to real samples prepared from tablets.
3. Results and discussion
3.1. Electrochemical behavior of 5-ASA and its metabolite on devel-
oped sensor
To improve the sensor response we examined in preliminary
measurements the inﬂuence of the working electrode material,
glassy carbon and gold, on oxidation peak heights of 5-ASA and its
metabolite. As sensitivity did not improve when using gold elec-
trode (the inset of Fig. 1), the GCE were used in subsequent
experiments due to their signiﬁcantly lower cost. The cyclic vol-
tammograms of 5105 M 5-ASA solution in BR buffer pH
2.0 obtained at the bare GCE, the NGCE, the CNTs/GCE and the
CNTs-N/GCE using a scan rate of 100 mV s1 are presented in
Fig. 1. As can be seen, 5-ASA shows one well-deﬁned voltammetric
oxidation peak in aqueous solutions and moving from the bare
GCE to CNTs-N/GCE it becomes well-deﬁned with enhanced peak
current. Due to the presence of the primary aromatic amino group
(pKa¼6), carboxylic group (pKa¼3) and phenolic group
(pKa¼13.9) in the molecule [28], 5-ASA was completely in cationic
form in experimental conditions used in the voltammetric mea-
surements. Naﬁon as a cation-exchanger attracted positively
charged drug molecules through electrostatic interaction from the
bulk solution to enhance the anodic signal (ip¼7.25 mA). However,
the voltammetric response of 5-ASA was remarkable increased at
the CNTs-N/GCE with a current of 13.9 mA at peak potential of
0.54 V compared with that of using a bare GCE (ip¼2.85 mA). The
synergistic effect of CNTs and cation-exchange polymer combina-
tion leads to a considerable improvement in the analytical sensi-
tivity. To obtain information regarding the adsorptive behavior of
5-ASA at the CNTs-N/GCE, the inﬂuence of the scan rate on the
electrochemical response of drug molecule was investigated by CV.
The oxidation peak current of 5-ASA increased with scan rate in-
creasing and a linear relationship was observed in the range 10–
500 mV s1 following the relation ip (μA)¼0.071 v (mV s1)þ
5.14. The oxidation peak current was signiﬁcantly suppressed in
second cyclic scan. Those results indicated that the electrode
process of 5-ASA at the developed electrochemical sensor is con-
trolled by an adsorption step.
5-ASA showed at slow scan rates an irreversible oxidation
wave, while in the reverse scan a single reduction wave was ob-
served at much more negative potential (0.43 V) than would be
expected for reversible process. This indicated that the initial
oxidation product underwent a chemical reaction to yield a second
product that was reduced at more negative potentials. With scan
rate increase the oxidation of 5-ASA became quasi-reversible.
Furthermore, the electrochemical behavior of 5-ASA at developed
sensor was studied over pH range of 2.0–5.0 in buffered aqueous
media. A linear shift of the peak potential towards less positive
values was observed while increasing the pH. The slope value
obtained was 65.0 mV pH1. The oxidation pattern of 5-ASA mo-
lecule observed at the CNT-N/GCE was well-consistent with our
previous studies at the GCE [21], thus, we can corroborate that the
oxidation of drug at the nanocomposite ﬁlm involves the initial
2e/2Hþ oxidation of 5-ASA to the quinone imine, followed by
hydrolysis to produce the corresponding quinones.
In this paper, the redox behavior of Ac-5-ASA was studied for
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Fig. 1. Cyclic voltammograms of 5-ASA (5105 M) at a bare GCE (a), the NGCE
(b), the CNTs/GCE (c) and the CNTs-N/GCE (d) in BR buffer pH 2.0. Inset: compar-
ison of gold electrode (dashed line) and GCE (solid line) modiﬁed with CNTs/Naﬁon
composite ﬁlm in the same conditions. Scan rate: 100 mV s1.
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the ﬁrst time. The cyclic voltammograms of Ac-5-ASA in BR buffer
pH 2.0 obtained at the bare GCE, the NGCE, the CNTs/GCE and the
CNTs-N/GCE using a scan rate of 100 mV s1 are depicted in Fig. 2.
When the bare GCE surface was coated with Naﬁon ﬁlm, the
voltammetric response of metabolite did not change signiﬁcantly.
The metabolite molecule has a pKa of 2.7 and 12.9 [28]. Therefore,
83.4% of the metabolite was in unionised form under used vol-
tammetric condition and cannot not be attracted through elec-
trostatic interaction with cation-exchange polymer. Upon mod-
iﬁcation with multi-walled CNTs, remarkable enhancement effect
to the current response of metabolite was observed due to very
larger surface area of the modiﬁed electrode. However, the CNTs
were tightly ﬁxed in the Naﬁon matrix onto GCE surface in a re-
producible way enhancing the stability of proposed electro-
chemical sensor and improving the measurement precision.
Hence, the CNTs-N/GCE exhibited convenient electroanalytical
performance for simultaneous measuring of 5-ASA and Ac-5-ASA.
The potential difference of 200 mV between the two peak poten-
tials at the CNTs-N/GCE is large enough to determine the con-
centration of drug and its metabolite simultaneously.
A well-deﬁned anodic current response of Ac-5-ASA was ob-
served at 0.74 V at the CNTs-N/GCE. On the reverse potential scan,
there was no corresponding reduction peak, suggesting that the
electrode reaction is irreversible. The electrochemical oxidation of
Ac-5-ASA was studied using CNTs-N/GCE in aqueous solutions
with different pH values in the range of 2.0–5.0. The peak poten-
tials were shifted to less positive values with increasing pH and a
linear relationship was observed following the equations: Ep (V)¼
0.860.057 pH (r¼0.999). The linear dependence implies that the
protonation reaction occurred in the overall electrode process. A
slope of 0.059 V pH1 is characteristic for the oxidation poten-
tial as a function of the pH in the 2e/2Hþ process corresponding
to the oxidation of the hydroxyl group in metabolite molecule to
the corresponding ketone. The cyclic voltammetric behavior was
further examined as a function of the scan rate in the range of 10–
500 mV s1. The signal for Ac-5-ASA was linearly dependent on
the scan rate with relation ip (μA)¼0.048 v (mV s1)þ2.21 and
together with the observed positive potential shift of the oxidation
signals with increasing the scan rate indicate that the electrode
process is an adsorption-controlled irreversible oxidation.
The surface morphology of the CNTs-N/GCE was characterized
by SEM. As shown in Fig. 3a, the nanocomposite ﬁlm deposited
formed unique bundle structures. The SEM image of composite
ﬁlm (Fig. 3b) showed a uniform coating of CNTs well dispersed in
polymer matrix making the surface rough with a high accessible
area improving the preconcentration of 5-ASA molecules through
electrostatic interaction with negatively charged sulfonate group
in Naﬁon polymer structure as well as metabolite molecules
caused by the increase in working electrode efﬁcient area due to
CNTs incorporation. On the other hand, the large surface area of
the CNTs/GCE had the tubes irregularly placed in thread-like
formations.
3.2. Optimization studies
To get more insights into the electroanalytical performance of
the CNTs-N/GCE and in addition, to optimize its performance with
respect to nanocomposite ﬁlm deposition, SWV was used for fur-
ther electrochemical measurement of 5-ASA and its metabolite.
The mean steady state plasma levels of unchanged 5-ASA are ra-
ther lower (range 0.02–1.2 μg mL1) whereas those of Ac-5-ASA
are always higher (range 0.1–2.9 μg mL1). This is due to the rapid
elimination of 5-ASA (t1/2¼0.4–2.4 h) and the slightly slower renal
excretion of the Ac-5-ASA (t1/2¼6–9 h) [27]. Since the drug was
found in lower concentration limits then its metabolite in real
samples, the effect of modiﬁer amount on the performance of the
CNTs-N/GCE was investigated in order to obtain the most favorable
response of 5-ASA.
Firstly, when varying different amounts of multi-walled CNTs
dispersed in Naﬁon ethanol solution, the concentration of
1 mg mL1 was selected as optimum. The SWV response of 5-ASA
was increased up to 0.5% of Naﬁon concentration in the im-
mobilizing suspension due to more – SO3
− sites in polymer ﬁlm that
conducted ion-exchange with drug molecules leading to an in-
crement of accumulation capacities. At higher concentrations, the
polymer ﬁlm became thicker and lowered the electrical con-
ductivity of CNTs. Furthermore, the Naﬁon polymer retarded the
electron transfer rate of Ac-5-ASA oxidation as well as its mass
transportation through the ﬁlm resulting in the lower current
response. The SWV response of both analytes in simultaneous
analysis reached the optimal value when the composite ﬁlm was
uniformly coated on the electrode surface using 0.3% Naﬁon con-
centration for preparation of homogenous CNTs suspension. The
thickness of the composite ﬁlm was determined by the volume of
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Fig. 2. Cyclic voltammograms of Ac-5-ASA (5105 M) at a bare GCE (a), the NGCE
(b), the CNTs/GCE (c) and the CNTs-N/GCE (d) in BR buffer pH 2.0. Scan rate:
100 mV s1.
Fig. 3. The surface image of the CNTs-N/GCE obtained by scanning electron microscopy (a) and same surface at high magniﬁcation (b). Scale bar: 100 nm.
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CNTs-Naﬁon suspension coated onto the GCE surface. When the
volume of suspension increased up to 3 μL, the oxidation peak
current enhanced notably for both analytes due to increment of
effective surface area and more CNTs dramatically promoted
electron transfer reaction, but with further increase the oxidation
peak currents showed gradual decline owing to the higher electric
resistance.
Additionally, various types of the supporting electrolytes, in-
cluding 0.01 and 0.1 M sulfuric acid, 0.01 M hydrochloric acid,
acetate buffer pH 3.5 and BR buffer pH 2.0–5.0, were tested in
order to obtain better sensitivity for simultaneous determination
of drug and its metabolite. A maximum current intensity and
lower background current was achieved in BR buffer solution at
pH 2.0 and consequently, it was employed for further studies.
To obtain much more sensitive peak currents for analytical
studies, the variation of the current response recorded at the
CNTs-N/GCE was monitored while changing instrumental SWV
parameters, i.e. frequency (20 Hzr fr110 Hz), pulse amplitude
(10 mVrar60 mV) and potential step (2 mVrΔEsr10 mV).
The most favorable responses were achieved using a combination
of a frequency of 70 Hz, pulse amplitude of 50 mV and a potential
step of 2 mV. Compared to other voltammetric techniques, the
SWV offers several advantages such as a high speed in analysis, a
wide dynamic concentration range, low consumption of electro-
active compounds and reduced problems with electrode surface
blocking, a high signal-to-noise ratio and a low detection limit
because of its efﬁcient discrimination of capacitance current [29].
To obtain lower detection limits the possibility of 5-ASA and its
metabolite preconcentration before SWV measurement was in-
vestigated because the modiﬁcation of the electrode surface led to
a strong interfacial accumulation of both analytes. To achieve the
optimum conditions for the maximum adsorption, the inﬂuence of
accumulation potential (between 1.0 and 0.9 V) and deposition
time (between 10 s and 120 s) on the voltammetric responses of
both analytes was evaluated in solution containing 5-ASA and Ac-
5-ASA at concentration level of 1106 M. A maximum was ob-
served at 0.1 V, so this accumulation potential was selected in all
subsequent studies. The deposition time signiﬁcantly affected the
voltammetric responses of both analytes at the CNTs-N/GCE. The
peak current of 5-ASA enhanced greatly within 30 s due to elec-
trostatic interactions of positively charged drug molecules with
negatively charged sulfonate groups in Naﬁon polymer structure
(Fig. 4). The voltammetric response increased up to 60 s and then
became constant at higher accumulation times. On the other hand,
the peak current of Ac-5-ASA increased slowly up to 120 s re-
vealing a constant adsorption of metabolite molecules attracted on
the large surface of the CNTs-N/GCE. The increment of accumula-
tion time period above 60 s showed a deviation of the metabolite
peak current from linearity, thus indicating surface adsorption
saturation. The value of 30 s was considered as optimal value to
achieve the highest possible sensitivity of both analytes in a more
short analysis time.
3.3. Simultaneous determination of 5-ASA and its metabolite
The peak currents of 5-ASA and Ac-5-ASA at 0.53 and 0.74 V,
respectively, obtained at proposed sensor were used for simulta-
neous determination of drug and its metabolite involving ad-
sorptive stripping SWV. The SWV measurement in the potential
range from 0.3 to 1.0 V takes only 5 s using the pulse frequency of
70 Hz with 2 mV potential step. Since the presence of metabolite in
solution may affect the quantiﬁcation of drug, and vise versa, the
interference of each analyte in the simultaneous determination of
its pairs was performed by changing one analyte concentration and
keeping the other unchanged. Fig. 5 shows the SWV responses
obtained for solutions of increasing drug concentration in the pre-
sence of metabolite at the ﬁxed concentration of 2.5106 M. The
relation between the stripping peak current and concentration of
5-ASA was found to be linear over the range 5.0108–
2.5106 M (the inset of Fig. 5). The variation of adsorptive
stripping SWV peak current versus 5-ASA concentration in the ab-
sence of metabolite gave the sensitivities of the CNTs-N/GCE to-
wards drug oxidation of 2.33107 mA M1. The value obtained is
very close (relative error is 1.1%) to the values observed in the
presence of metabolite (Table 1), indicating independent adsorption
of both analytes in the accumulation step at the surface of the
proposed electrochemical sensor. Fig. 6 shows the voltammetric
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Fig. 4. Effect of the accumulation time on the oxidation peak current for 5-ASA
(squares) and its metabolite (circles). SWV settings: frequency of 15 Hz, amplitude
of 25 mV and potential step of 4 mV, c¼1106 M.
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Fig. 5. Square-wave voltammograms of 5-ASA at the CNTs-N/GCE recorded in BR
buffer pH 2.0 at different concentrations (5.0108–2.5106 M) in the presence
of its metabolite (2.5106 M). tacc¼30 s, SWV settings same as in Fig. 4. Inset
shows a calibration graph for the quantiﬁcation of 5-ASA.
Table 1
Validation data for determination of 5-ASA and its N-acetylated metabolite using
developed electrochemical sensor.
Parameter Adsorptive stripping SWV SWV
5-ASA Ac-5-ASA 5-ASA
Linearity range (M) 5.0108–
2.5106
1.0107–
5.0106
5.0107–
1.0105
Slope (μA M1) 2.33107 8.37106 1.75106
Intercept (μA) 2.79 0.15 0.56
Sx/y 0.964 0.662 0.386
SD of slope (Sb) 4.37105 1.61105 4.57104
SD of intercept (Sa) 0.100 0.072 0.063
Correlation
coefﬁcient
0.999 0.999 0.999
Limit of detection (M) 1.2108 2.6108 1.1107
Limit of quantitation
(M)
4.2108 8.7108 3.6107
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responses for the solutions containing various concentrations of
metabolite and constant concentration of 5-ASA (1106 M). An
excellent linear response in the concentration range of 1.0107–
5.0106 M was obtained for Ac-5-ASA (the inset of Fig. 6). The
response of CNTs-N/GCE was also followed for successive increase
of the metabolite concentrations in the absence of drug. The sensor
revealed the sensitivity of 8.37106 mA M1 with relative error of
0.7% in comparison to the slope observed in the absence of 5-ASA
conﬁrming independent preconcentration and oxidation of both
analytes. Therefore, simultaneous determination of drug and its
metabolite is possible without interferences. Since drug monitoring
plays important role in drug quality control and has a great impact
on public health, it is very important to quantify of active ingredient
in pharmaceutical dosage forms. Due to the high concentration of
5-ASA in its dosage forms (500 mg per tablet), the variation of the
current response at the CNTs-N/GCE with the drug concentration
was monitored by direct SWV measurements. In the case of a
square-wave scan without any accumulation step, the oxidation
peak showed a linear response in the concentration range of
5.0107–1.0105 M. The analytical characteristics and the re-
lated validation parameters of developed methods are given in Ta-
ble 1. The detection and quantiﬁcation limits were calculated from
the calibration curves as 3s/m and 10s/m, respectively, where s is
the standard deviation of the intercept and m is the slope of the
calibration curve [30].
3.4. Selectivity, reproducibility and stability of developed sensor
The selectivity of the CNTs-N/GCE was investigated in solutions
containing 5-ASA and Ac-5-ASA at 2.5106 M concentration.
The inﬂuence of potential interfering species, commonly present
in biological samples or co-formulated with active ingredient, on
the voltammetric responses of both analytes was examined. The
tolerance limit was deﬁned as the maximum concentration of the
interfering substance that caused an error less than 75% in the
voltammetric responses. The experiments displayed that the oxi-
dation peak current of 5-ASA and its metabolite at the CNTs-N/GCE
did not change after adding 300-fold of glucose and 500-fold
concentration of ascorbic acid indicating that the selectivity of the
method may be adequate for the quantiﬁcation in biological ﬂuids
where these endogenous substances are always present. In the
presence of uric acid, new well-deﬁned oxidation peak appeared
at the potential around þ0.66 V. However, uric acid did not in-
ﬂuence on the peak current of 5-ASA and its metabolite up to
5-fold excess. According to the analysis of the obtained voltam-
metric responses, Naþ , Cl (2000-fold), SO4
2− (1000-fold), Kþ , NO3
−,
HPO4
2− (500-fold), Zn2þ , Ca2þ , Mg2þ , Cu2þ , lactate (50-fold), Fe3þ
(10-fold), L-glycine, L-alanine, L-aspartic acid, L-glutamic acid
(500-fold) and L-cysteine (200-fold) did not show interference in
the determination of both analytes. The presence of citric acid,
starch, lactose, sucrose (500-fold) had no inﬂuence on the peak
current of 5-ASA.
The repeatability of the voltammetric response was evaluated
by six replicate measurements of 1.0106 M 5-ASA and Ac-5-
ASA solution yielding unchanged oxidation peak potentials for
both analytes and the RSD values of 1.7% and 1.3% for the peak
currents of 5-ASA (mean ip¼26.6 μA) and Ac-5-ASA (mean
ip¼8.1 μA), respectively. These results indicated that proposed
electrochemical sensor was stable in repeated measurements for
selective determination of 5-ASA and its metabolite. The re-
producibility of the electrode response was characterized by three
replicate measurements of 1.0106 M 5-ASA and Ac-5-ASA over
three days, each time using a freshly prepared the CNTs-N/GCE
and standard solutions. The RSDs values of the anodic stripping
currents for 5-ASA and As-5-ASA were 2.6% and 2.8%, respectively,
while the RSDs of peak potentials for both drugs were no greater
than 0.9%, indicating excellent fabrication reproducibility.
The proposed electrochemical sensor can be stored in air at
room temperature or kept in distilled water for several weeks
without the loss of activity. The stability of the CNTs-N/GCE was
checked by measuring the voltammetric response in 2.5106 M
of 5-ASA and Ac-5-ASA solution over a period of four weeks. Be-
fore measurements, the modiﬁed electrode was scanned by CV
between 0 and 1.5 V in the solution of blank supporting electrolyte
until the response was stable. The experimental results indicated
that the peak potential for both analytes was unchanged and the
current response of drug and its metabolite decreased after two
weeks by about 3.2% and 3.5%, respectively. Repeating the ex-
periments after longer time, it was found that the current re-
sponses decreased about 20% in four weeks for both analytes. The
experiments revealed that the prepared multi-walled CNTs-Naﬁon
composite ﬁlm has good stability and durability due to high me-
chanical strength of the CNTs incorporated into polymer matrix
and strong adherence to electrode surface enabling long-term
electrochemical sensing applications.
3.5. Analytical applications
The CNTs-N/GCE was applied for simultaneous determination
of 5-ASA and its metabolite in human serum samples (Fig. 7). The
expected serum concentration level for drug and its metabolite
after treatment with the therapeutic daily dose recommended for
ulcerative colitis and Crohn’s disease are within the linear con-
centration range of the newly developed method using proposed
electrochemical sensor. The quantitation of drug and metabolite in
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Fig. 6. Square-wave voltammograms of Ac-5-ASA at the CNTs-N/GCE recorded in
BR buffer pH 2.0 at different concentrations (1.0107–5.0106 M) in the pre-
sence of 5-ASA (1.0106 M). tacc¼30 s, SWV settings same as in Fig. 4. Inset
shows a calibration graph for the quantiﬁcation of As-5-ASA.
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Fig. 7. Square-wave voltammograms of 5-ASA and its metabolite at the CNTs-N/
GCE recorded in spiked human serum for increasing concentrations together with
corresponding background recordings. tacc¼30 s, SWV settings same as in Fig. 4.
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human serum at the therapeutic concentration range is not fea-
sible without analyte accumulation on the CNTs-N/GCE surface. On
the other hand, the Naﬁon-coated membrane contains sulfonate
groups and such surface layer prevents accumulation of negatively
charged oxidizable ions found in biological ﬂuids onto the elec-
trode surface. The recovery studies of both analytes in serum
samples were performed using the standard addition method to
nullify any remaining interference. The mean recovery of
100.172.7% for 5-ASA and 99.372.8% for Ac-5ASA was achieved
from this type of matrix (Table 2). From the experimental results, it
is obvious that the proposed electrochemical sensor has great
potentials for practical analysis of biological samples and bioe-
quivalence studies when a new drug formulation is prepared. The
knowledge of the pharmacokinetic proﬁle of 5-ASA from the dif-
ferent controlled-released formulations is important for the ef-
fective therapy of inﬂammatory bowel diseases.
The determination of 5-ASA content in pharmaceutical for-
mulations was carried out using the direct SWV measurements. To
eliminate matrix effects 5-ASA was quantiﬁed in delay-released
tablets using the standard addition method. The analysis of 5-ASA
in its pharmaceutical formulations exhibited mean recoveries of
100.7% and 99.8% with relative standard deviations of 0.8% and
0.7% for Salofaks and Pentases, respectively, indicating adequate
precision and accuracy of the SWV method as well as the suit-
ability of the developed sensor for this purpose. The effect of ex-
cipients on the voltammetric response of 5-ASA was studied by
adding of known amount of drug standard solution (2.5107 M)
to the different pre-analyzed formulation solution samples. The
recoveries in the range of 98.4–101.6% indicated that excipients did
not interfere with assay of active ingredient. The results obtained
with the described method were compared with those obtained
by the reported HPLC methods [4,5]. No signiﬁcant differences
were found between the performances of those methods regard-
ing the accuracy and precision. Moreover, the electroanalytical
method does not require separation, sophisticated instrument and
expensive solvents that are needed for HPLC procedures and only
5 s is necessary for direct SWV measurement.
3.6. Comparison with other analytical methods
The analytical characteristics of the CNTs-N/GCE were com-
pared with those obtained by HPLC methods for the simultaneous
determination of 5-ASA and its metabolite (Table 3.). The detection
limits of both analytes at the CNTs-N/GCE are comparable to
chromatographic methods reported previously, moreover, the
achieved values are better than those reported for HPLC methods
with ﬂuorescence [12] and electrochemical detection [15]. Com-
pared with HPLC method coupled to mass spectrometry [17], the
LODs obtained with CNTs-N/GCE for both examined analytes were
in a higher concentration range. However, the LOQ values obtained
at the CNTs-N/GCE as 6.3 and 16.9 ng/mL for 5-ASA and Ac-5-ASA,
respectively, are adequate to quantify concentration levels of
5-ASA and its main metabolite generally found in human plasma
samples collected during clinical and pharmacokinetic studies in
which delay-released formulations are administered at ther-
apeutic dosage. In comparison with the previously developed
chromatographic methods, the present electroanalytical method
offers undoubted advantages including short analysis time, sim-
plicity of operation and lower running cost. The HPLC methods
require a high percentage of organic solvent making them less
environmental friendly. Additionally, HPLC method with ﬂuores-
cence detection require derivatization reaction of analytes before
detection step, while LC–MS analytical procedures demand ex-
pensive and sophisticated equipment that is not available in many
laboratories.
The electrochemical behavior of Ac-5-ASA has not been in-
vestigated to date, while only few electroanalytical methods were
developed for the determination of 5-ASA. The comparison be-
tween the analytical performance of the CNT-N/GCE and other
electrochemical sensors described earlier in the literature for the
quantiﬁcation of drug is also presented in Table 4. The LOQ value
for 5-ASA obtained in this work is almost two orders of magnitude
better than that obtained at bare GCE [21]. However, the most
important advantage of the CNT-N/GCE is its remarkable im-
provement in the reproducibility, with no requirement for tedious
mechanical maintenance by polishing the substrate surface before
each measurement as in the case of GCE. Also compared with
other methods, the linearity range obtained at proposed electro-
chemical sensor for 5-ASA was in the lower concentration range.
The CNT-N/GCE with adsorptive accumulation of 30 s exhibited a
similar linear range as GCE modiﬁed with nanoporous ﬁlm and
electrochemically deposited polypyrrole after 90 s accumulation
step (slope of the calibration plot was 1.36105 mA M1) [25], but
the improved sensitivity was obtained in the case of CNT-N/GCE
(slope of the calibration plot was 2.33107). In relation to other
electroanalytical methods for determination of 5-ASA, the LOD
obtained with direct SWV measurement at CNT-N/GCE is similar,
Table 2
Quantiﬁcation of 5-ASA and its N-acetylated metabolite in serum samples by ad-
sorptive stripping SWV.
Samples Added 106 c (M) Found 106 c (M) Recovery (%) RSDa (%)
5-ASA 0.25 0.253 101.28 2.65
0.50 0.501 100.27 2.96
0.75 0.745 99.33 2.28
1.00 0.995 99.47 2.70
Ac-5-ASA 1.00 0.989 98.91 3.34
2.00 1.964 98.22 3.11
3.00 2.988 99.61 2.82
4.00 4.019 100.47 2.06
a Average of three measurements.
Table 3
Comparison of HPLC methods for the simultaneous determination of 5-ASA and its N-acetylated metabolite with the present work.
5-ASA Ac-5-ASA
Detection Concentration range LOD Concentration range LOD Reference
Fluorescence 5–10,000 ng/mL 5 ng/mL 5–10,000 ng/mL 5 ng/mL [11]
Fluorescence 100–8000 ng/mL 20 ng/mL 100–8000 ng/mL 20 ng/mL [12]
Fluorescence 3.2107–4.9106 M 5.0108 M 1.3107–4.9106 M 2.0108 M [13]
Electrochemical 1–300 ng/mL 1 ng/mL 10–1000 ng/mL 1 ng/mL [14]
Electrochemical 50–3200 ng/mL 5 ng/mL 50–3200 ng/mL 10 ng/mL [15]
Mass spectrometry 50–4000 ng/mL 15 ng/mL 50–4000 ng/mL 15 ng/mL [16]
Mass spectrometry 2–1500 ng/mL 1 pg/mL 10–2000 ng/mL 2 pg/mL [17]
CNTs-N/GCE 5.0108–2.5106 M 1.2108 M 1.0107–5.0106 M 2.6108 M This work
(7.5–375 ng/mL) (1.8 ng/mL) (19.5–975 ng/mL) (5.1 ng/mL)
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or even better using adsorptive accumulation of drug molecules on
the porous thin ﬁlm at its surface, than those found with other
electrodes. The lower LOD value showed only the GCE modiﬁed
using layer by layer procedure with nanoﬁlm deposition and
subsequently electropolimerization of pyrrole in the presence of
aromatic anion dopant [25], however, the CNT-N/GCE can be easier
fabricated in a simple and fast procedure and the surface of elec-
trode is also easily renewable.
4. Conclusions
In the present work, we have developed for the ﬁrst time
analytical method for simultaneous determination of 5-ASA and
its metabolite without the need for prior time-consuming se-
paration step using electrochemical sensor with functionalized
CNTs. A simple approach was applied for the modiﬁcation of
electrode surface. The presence of the nanocomposite modiﬁer on
the surface of the GCE signiﬁcantly affects the response sensitivity
of target analytes. Additionally, the proposed electrode showed
long-term stability and very easy surface regeneration. The ob-
tained results reveal that the CNT-N/GCE in combination with the
proposed pulse voltammetric method is reliable and extremely
selective tool with short response time for sensing conveniently
low concentration levels of 5-ASA and its metabolite in biological
samples. The reported results also imply a promising application of
the CNT-N/GCE for rapid and direct measurement of 5-ASA in
pharmaceutical samples providing signiﬁcant advantage over
previously developed methods.
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Electrochemical sensor based on carbon nanotubes decorated with zirconium oxide nanoparticles was 
developed for the determination of nebivolol at the potential of +1.05 V (vs. Ag/AgCl). Nanomaterials 
were dispersed in an anionic polymer and deposited by simple one-step casting method on glassy 
carbon electrode. Scanning electron microscopy and energy dispersive X-ray spectroscopy were used 
to study the surface morphology and structure characterization of deposited film. The sensor has a 
strongly improved sensitivity (9.29  10-6 μA M-1). The electrocatalytical peak current of nebivolol 
shows a linear response from 100 nM to 10 mM with detection limit of 12 nM. Low-cost analysis of 
drug in serum samples was carried out after adsorption of nebivolol at the nanocomposite using 
differential pulse voltammetry. In comparison with HPLC method, the electrochemical method ensures 
faster and simpler quantification of nebivolol in pharmaceutical samples. 
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1. INTRODUCTION 
Nebivolol (NBV) is a recently approved beta(1)-selective blocker drug for the treatment of 
hypertension. According to the World Health Organization, hypertension is one of the leading causes 
of premature death worldwide. Hypertension increases the risk for a variety of cardiovascular diseases, 
including stroke, coronary artery disease, heart failure, atrial fibrillation and peripheral vascular 
disease [1]. NBV has additional mechanism besides beta-blocking effects that contribute to its unique 
pharmacologic profile. It has an endothelium dependent vasodilator property mediated via L-arginine-
nitric oxide pathway [2]. Nitric oxide also inhibits platelet and leucocyte adhesion to vascular 
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endothelium, prevents smooth muscle hyperplasia following vascular injury and scavenging 
superoxide anion activity. 
The development of sensitive analytical methods for determination of NBV is highly required 
due to the important role of the drug in treatment of  chronic diseases. In addition, an official method 
for its quantification in bulk form and pharmaceutical formulations has not been approved in any 
pharmacopoeia. Several analytical methods were reported for drug quantification in biological samples 
and pharmaceuticals including LC-MS methods [3,4], HPLC methods with UV detection [5-7], high 
performance thin layer chromatography [8], spectrophotometry [9] and spectrofluorimetry [10] Among 
these methods, electrochemical techniques usually provide greater sensitivity, in addition to its other 
outstanding features such as rapid response, low cost, easy operation, short analysis time and excellent 
potential for miniaturization and portable equipment construction [11, 12].  
At present, in the literature only three methods were published on the voltammetric behaviour 
of NBV. The poorly defined voltammetric response was obtained on an electrode modified with 
undoped silver oxide nanoparticles using two-electrode system [13]. The proposed method was not 
fully validated and it was not applied to real samples of bulk drug or its pharmaceutical dosage forms. 
We used unmodified boron-doped diamond electrode for rapid square-wave voltammetric 
determination of NBV [14], but the working range of the method is suitable for quantification of NBV 
in its pharmaceutical dosage forms. Very recently, graphene nanocomposite modified electrode was 
employed for determination of NBV at relatively high potential of 1.33 V versus Ag/AgCl [15]. 
One of the most widely used nanostructure materials for electrode surface modification is 
carbon nanotubes (CNTs) [16]. The CNTs are very attractive in the field of sensor development due to 
their advantageous properties for electroanalysis, such as enhanced electronic properties, high 
electrical conductivity, excellent chemical stability and high surface-to-volume ratio [17]. Therefore, 
the CNTs-based sensors generally have higher sensitivities and lower detection limits than traditional 
carbon electrodes [18]. Also, CNTs have the ability to support metal nanoparticles (NPs). The 
combination of metal NPs with CNTs can provide a promising way for fabrication of novel sensors 
with significantly improved performance [19]. Metal exhibits very important physical, optical and 
electrocatalytic properties that can be improved by mixing with CNTs without losing any of the 
electronic properties of CNTs. There are several methods of preparing metal NPs-CNT 
nanocomposites including electrochemical deposition method, electroless deposition, dispersion of 
metal NPs on the functionalized CNTs and physical methods. For successful external decoration of 
CNTs, metal NPs could be obtained from bulk metals or the interaction of CNTs with already prepared 
suspensions of metal NPs [20, 21]. 
In recent years, the use of zirconium dioxide nanoparticles (ZrO2 NPs) is rapidly growing in 
biomedical fields. They are widely used as drug delivery carriers for controlled release of medicines, 
as gene delivery vehicles with target specificity for some tissues, biocompatible matrix for protein 
immobilization as well as in orthopedics for improving the properties of traditional bone cements [22]. 
ZrO2 NPs have also been employed for construction of various electrochemical sensors and biosensors 
due to their large surface area, chemical inertness, thermal stability, mechanical strength and lack of 
toxicity [23-25]. ZrO2 is naturally available, environmentally friendly and neutral bioceramic material 
with good potential to be extensively used in pharmaceutical and medical applications.  
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In this paper, glassy carbon electrode modified with carbon nanotubes and ZrO2 nanoparticles 
(ZrONP-CNT/GCE), obtained by simple one-step modification, was used to provide sensitive method 
for the voltammetric determination of NBV. Nafion is a useful material to enhance the adsorption of 
the drug molecules onto the electrode [26, 27] and therefore, the nanomaterials were dispersed in a 
Nafion matrix to ensure high sensitivity. The developed adsorptive stripping differential-pulse 
voltammetric (AdDPV) method was used for NBV analysis in serum samples. The modified electrode 
showed excellent performance for direct measurements of NBV in pharmaceutical dosage forms with 
good accuracy. The voltammetric data were estimated with those obtained by validated HPLC method.  
 
 
 
2.  EXPERIMENTAL 
2.1 Chemicals  
Nebivolol hydrochloride was obtained by the Agency for Medicinal Products and Medical 
Devices (Zagreb, Croatia). Nibel

 tablets (Belupo, Croatia) containing nebivolol hydrochloride, 
equivalent to 5 mg of NBV, were supplied from a local pharmacy. ZrO2 nanoparticles (purity 99.95%, 
crystal phase monoclinic), average particle size 20 nm, were purchased from US Research 
Nanomaterials, Inc. (Houston, USA, http://www.us-nano.com). The multi-walled CNTs (>98%, O.D. 
6-13 nm, length 2.5-20 µm), Nafion (5 wt % solution in a mixture of lower aliphatic alcohols and 
water) and propranolol hydrochloride were obtained from Sigma-Aldrich (Steinheim, Germany). 
Bisoprolol fumarate, carvedilol and atenolol were supplied from Pliva (Zagreb, Croatia). 
Hydrochlorothiazide was purchased from Fluka (Laramie, USA).  
Stock solutions of NBV (1.0 × 10
-3
 M) for voltammetric measurements were prepared in ultra-
pure water and stored at 4 C. The standard solutions were prepared by appropriate dilution of these 
stock solutions with the selected electrolyte just before use. The supporting electrolytes were 0.5, 0.1 
and 0.01 M H2SO4, 0.1 and 0.01 M HCl and Britton-Robinson buffer adjusted to the desired pH with 
0.2 M sodium hydroxide solution. 
 
2.2 Equipment and Conditions 
Voltammetric measurements were taken at room temperature using a computer-controlled -
Autolab potentiostat (Eco Chemie, Utrecht, The Netherlands) with GPES 4.9 software. A three-
electrode configuration was used with a bare or modified GCE (3-mm diameter, Metrohm, 
Switzerland) as working electrode, Ag/AgCl (KCl 3M, Metrohm) reference electrode and a platinum 
counter electrode. Cyclic voltammetry (CV) was carried out from 0.5 to 1.5 V with the scan rate from 
10 to 350 mV s
-1
. Differential pulse voltammetry (DPV) was used for determination of NBV in the 
potential range from 0.6 to 1.4 V. The accumulation of NBV was carried out at 0 V with a 240 s step 
using a computer-controlled stirrer. The pulse amplitude of 50 mV, pulse width of 75 ms and scan rate 
of 20 mV s
-1 
were used. After each measurement, the modified electrode was refreshed in blank 
electrolyte by one CV scan from 0.5 to 1.4 V until the peak of NBV disappeared completely.  
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The structure and morphology of nanocomposite was characterized by a field emission 
scanning electron microscope Jeol JSM-7000F coupled with an energy dispersive X-ray spectroscopy 
(Jeol Ltd., Tokyo, Japan). HPLC analysis were performed using an Agilent 1100 Series LC system 
(Agilent Technologies, Waldbronn, Germany) equipped with a diode array detector, controlled by 
ChemStation software. 
 
2.3 Preparation of the ZrONP-CNT/GCE    
Before modification, the working electrode was polished with 0.05 m alumina slurry, rinsed 
with water and then cleaned ultrasonically for 30 s in water and dried. The suspension (1 mg/mL) was 
prepared by dispersing the ZrO2 NPs and functionalized CNTs in 0.5% Nafion ethanol solution to 
obtain mixture containing a ratio in weight of 1:1 (ZrO2 NPs-CNTs) under ultrasonic stirring for 2 h 
prior to use. The carboxylic acid functionalized CNTs were prepared according to the previously 
described method [28]. The GCE was modified by casting 5 μL of suspension on an electrode surface 
and dried at room temperature. To obtain a stable cyclic voltammogram and strength adhesion to the 
electrode surface, the ZrONP-CNT/GCE was scanned prior to the first measurement by two successive 
cyclic voltammetric sweeps between 0 and 1.5 V at 100 mV s
-1
 in a blank solution of 0.1 M H2SO4. To 
measure the electroactive surface area of the ZrONP-CNT/GCE, the cyclic voltammograms of 1.0 × 
10
-3
 M K3Fe(CN)6 as redox probe were recorded. According to the Randles-Sevcik equation the 
electroactive area was calculated to be 0.311 cm
2
, nearly 5.5 times greater than GCE [16]. For 
comparison of electrochemical performance, the ZrO2 modified GCE (ZrONP/GCE), the carbon 
nanotubes modified GCE (CNT/GCE) and the Nafion modified GCE (Naf/GCE) were also prepared in 
the same way as described but without the addition of CNTs, the ZrO2 NPs and both nanomaterials, 
respectively. 
 
2.4 Application of the ZrONP-CNT/GCE  
To prepare the sample of NBV dosage forms, a quantity of finely ground tablets equivalent to 
4.4 mg of NBV was dispersed into a calibrated 10.0 mL flask. The mixture was sonicated for 10 min. 
The mixture was filtered through 0.45 m Acrodisc GHP filters (Gelman, Ann Arbor, USA) and was 
diluted with supporting electrolyte to prepare the solutions in certain concentrations. Solutions were 
analysed by direct DPV measurements. The content of NBV in the commercial pharmaceutical 
products was determined by standard addition method. For recovery studies, aliquots of the NBV 
standard solutions were added to samples prepared from tablets. The NBV determination by HPLC 
was carried out according to procedure described earlier [14]. 
Serum samples were collected from healthy volunteers and stored at -20°C until assay. Samples 
were fortified with aliquot volume of NBV standard solution to achieve concentrations (1.0 × 10
-7
 M) 
found in serum after treatment with recommended dose of 10 mg [29]. A 500 µL aliquot of serum 
sample containing drug was vortexed with acetonitrile (1:1) for 60 s and than centrifuged for 6 min at 
6000 rpm. The suitable volumes of supernatant were transferred into the volumetric flask and diluted 
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with supporting electrolyte before AdDPV measurements. Analysis of human serum samples were 
performed using the standard addition method.  
 
 
 
3.  RESULTS AND DISCUSSION 
3.1 Morphological characterization of ZrO2 NPs-CNTs nanocomposite 
        
 
 
 
Figure 1. SEM images of the ZrONP-CNT/GCE with different magnifications (A, scale at 100 m and 
B, scale at 100 nm) and its corresponding EDS spectra (C). 
 
The surface morphology of the ZrONP-CNT/GCE was examined by a field emission scanning 
electron microscopy (FE-SEM). As shown in Fig. 1a, low-magnification FE-SEM image indicates that 
homogeneous film is very uniformly deposited onto the whole surface. The compact coating reveals 
ZrO2 NPs observed as white dots well dispersed in CNTs-Nafion matrix. Generally, coating was well 
adherent to the substrate. The Fig. 1b displays the same surface at high magnification. The unique 
structure of CNTs with tubes placed in the bundle reveals a large surface area of the coating with ZrO2 
NPs entrapped into the matrix. The ZrO2 NPs are in uniform spherical shape with average diameter of 
about 20 nm. 
A B 
C 
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The structure characterization of the ZrO2 NPs-CNTs nanocomposite was examined using the 
energy dispersive X-ray spectroscopic (EDS) pattern (Fig. 1c). EDS analysis shows presence of 
zirconium at 2.10 keV and oxygen at 0.54 keV. The EDS pattern presents carbon peak at 0.26 keV 
attributed to the carbon nanotubes. The oxygen signal detected also originates from carboxyl and 
hydroxyl groups introduced onto the CNT surfaces in performed functionalisation procedure [16]. The 
fluor detected at 0.66 keV is present from Nafion. The peak corresponding to the copper appears at 
0.90 keV and comes from the supporting copper grid. The composition of nanomaterial on electrode 
surface was calculated using the EDS measurement and presented 34.86% of carbon, 18.10% of 
oxygen, 16.95% of fluor and 30.12% of zirconium.  
 
3.2 Electrochemical properties of NBV on ZrONP-CNT/GCE  
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Figure 2. Cyclic voltammograms of NBV (1.0 × 10
-4
 M) in 0.1 M H2SO4 recorded on different 
electrode surfaces: bare GCE (a), ZrO/GCE (b), CNT/GCE (c) and ZrONP-CNT/GCE (d). 
Scan rate: 100 mVs
-1
. Inset: Chemical structure of NBV. 
 
As can be seen in Fig 2, NBV exhibits a weak irreversible voltammetric response (5.6 A) at 
1.28 V using a bare GCE. When the GCE surface is modified with ZrO2 NPs in Nafion matrix, the 
response is increased with a current of 18.1 A. The oxidation peak potential is shifted to less positive 
values by 110 mV. To enhance sensitivity towards drug molecule, the GCE functionalized with CNTs 
was also tested under the same condition [16]. After modification of electrode surface, the oxidation 
peak current intensity on the CNT/GCE is about 7.8-fold higher than that on the bare GCE. Finally, the 
ZrONP-CNT/GCE reveals a remarkable increase of the voltammetric response of NBV obtained from 
the combined effects of CNTs and ZrO2 NPs. Compared with the response obtained at bare GCE, the 
oxidation peak current is increased up to 88.7 A at the ZrONP-CNT/GCE with a well-defined 
response at 1.13 V shifted by 152 mV to less positive potential. This finding is due to increased 
O
F
N
H
OHOH
O
F
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electroactive surface area of the ZrO2 NPs-CNTs nanocomposite as well as the the electronic 
conductivity and electrocatalytic activity of CNTs modifying layer [16]. Nafion polymer was used to 
fix the nanomaterials tightly onto GCE [30]. Additionally, the sulfonate groups in Nafion have ability 
to attract positively charged NBV prior to quantification in order to increase sensitivity. 
The effect of scan rate on the oxidative peak currents at the ZrONP-CNT/GCE was also 
evaluated. In the range of 10 - 350 mV s
-1
 a linear relationship between the peak current and the scan 
rate was obtained. This result indicates adsorption-controlled process at the ZrONP-CNT/GCE. The 
dependence of the peak potential is linear with logarithm of the scan rate with a slope of 82.6 
mV/decade, indicating n = 0.72. Using the calculated value of the charge transfer coefficient (0.40), 
the number of electrons exchanged was found to be n=1.8.  
It is known that alcohols are oxidised in many cases in 2e
-
/2H
+
 process to ketones as stable 
intermediates 31. The voltammetric response observed at ZrONP-CNT/GCE corresponds to the 
oxidation of one of the secondary hydroxyl groups to the corresponding C=O group in drug molecule 
(inset of Fig. 2). The same mechanism was proposed for electrooxidation of NBV at boron-doped 
diamond electrode 14 and graphene nanocomposite modified electrode 15 as well as for other beta-
blocker drugs such as propranolol [32] and atenolol whose oxidation product was isolated and 
characterized by 
1
H NMR [33].  
 
3.3 Optimisation of ZrONP-CNT/GCE preparation 
The relationship between voltammetric signal of NBV at the ZrONP-CNT/GCE and different 
concentration ratios of ZrO2 NPs : CNTs (1:1, 2:1) and Nafion concentration (0.3-0.7% v/v) in 
suspension for surface modification was studied by DPV. The most favorable peak current was 
achieved at concentration ratio of 1:1 (ZrO2 NPs : CNTs) with the ZrO2 NPs concentration of 1 mg 
mL
-1
 in 0.5% Nafion ethanol solution. The peak current decreased with the increase of ZrO2 NPs 
applied on the electrode surface over the concentration of 1 mg mL
-1
. The decrease of peak current at 
higher amount of ZrO2 NPs may be due to lower adhesion between the nanocomposite film and the 
electrode surface as well as the agglomeration of the nanoparticles [34]. The 0.5% Nafion 
concentration was the optimized loading of nanomaterials. The film became thicker at higher 
concentrations hindering the conductivity of nanomaterials doped in polymer. 
To obtain a much more sensitive peak current for analytical studies, the variation of NBV 
current response was examined at the ZrONP-CNT/GCE in different supporting electrolytes, such as 
sulfuric acid, hydrochloric acid and Britton-Robinson buffer (pH 2-6) [28]. The comparison of 
voltammograms indicates that NBV exhibits higher peak current at lower pH values. The NBV 
(pKa=8.9) is completely protonated on the nitrogen atom in acidic media and therefore, more 
effectively attracted to the modified electrode surface. Analysing the current response, 0.1 M sulfuric 
acid was chosen as the optimum supporting electrolyte for subsequent analytical measurements.  
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3.4 Adsorption properties of NBV and analytical performance  
Since CV detected some adsorption of NBV at the ZrONP-CNT/GCE, the possibility of analyte 
preconcentration at electrode surface before DPV measurements was investigated. The differential 
pulse voltammograms without accumulation and after a 240 s accumulation step at the ZrONP-
CNT/GCE are shown in Fig. 3. The improved sensitivity is achieved due to adsorption of NBV 
through electrostatic interaction with sulfonate group in Nafion matrix [30]. To maximise the DPV 
signal, the influence of accumulation potential and preconcentration time was estimated in solution 
containing NBV at 5  10-7 M concentration. A maximum enhancement of the voltammetric response 
was observed at accumulation potential of 0 V. The peak current magnified linearly up to 300 s 
preconcentration time (inset of Fig. 3), however to achieve the highest sensitivity in shorter analysis 
time, the value of 240 s was taken as the optimum for NBV quantification. 
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Figure 3. Differential-pulse voltammograms of NBV (5.0 × 10
-7
 M) at the ZrONP-CNT/GCE in 0.1 M 
H2SO4 after preconcentration time of 240 s (a) and without preconcentration (b). DPV settings: 
pulse amplitude of 50 mV, pulse width of 75 ms and scan rate of 20 mV s
-1
, Eacc = 0 V. Inset: 
Influence of the preconcentration time on the NBV oxidation peak current.  
 
Table 1. Analytical parameters for the calibration curves of nebivolol determination using ZrONP-
CNT/GCE  
 
Parameter DPV AdDPV 
Linearity range (M) 1.5 × 10-6 – 1.0 × 10-4 1.0 × 10-7 – 6.0 × 10-6 
Slope (μA M-1)  4.36 × 105 9.29 × 106 
Intercept (μA) -0.37 0.79 
Sx/y 16.21 16.85 
SD of slope (Sb) 1.39 × 10
4 2.01 × 105 
SD of intercept (Sa) 0.072 0.058 
Correlation coefficient 0.996 0.998 
Limit of detection (M) 5.5 × 10-7 1.8 × 10-8 
Limit of quantitation (M) 1.6 × 10-6 6.2 × 10-8 
0 50 100 150 200 250 300
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The electrocatalytic peak current of NBV obtained at 1.05 V using the ZrONP-CNT/GCE was 
employed for determination of drug in aqueous solution. In the case of a DPV scan without 
preconcentration, the oxidation peak showed a linear response in the concentration range of 1.5 × 10
-6 
– 1.0 × 10-4 M. By using drug accumulation at the ZrONP-CNT/GCE prior to DPV measurement (Fig. 
4), the current response after 240 s accumulation showed linear relationship in the range of 1.0 × 10
-7
 – 
6.0 × 10
-6
 M (inset of Fig. 4). The analytical parameters are given in Table 1. The detection limit 
(LOD) and the quantification limit (LOQ) were estimated as LOD = 3s/b and LOQ = 10s/b, where s is 
the standard deviation of the intercept and b is the slope of the calibration curve [35]. 
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Figure 4. Adsorptive stripping differential-pulse voltammograms of NBV at ZrONP-CNT/GCE in 0.1 
M H2SO4 recorded at different concentrations (1 × 10
-7
 – 6 × 10-6 M) after preconcentration 
time of 240 s with corresponding background recording. DPV settings same as in Fig. 3. Inset: 
calibration graph for NBV quantification.  
 
3.5 Selectivity, precision and stability of ZrONP-CNT/GCE  
The effect of different possible interfering species in the analysis of NBV was studied in the 
mixed solutions of these species with 2.5  10-6 M NBV using AdDPV method. The tolerance limit 
was calculated as molar ratio of NBV/interference which gave an error less than ±5% in the 
determination of the drug [36]. It was found that some ions such as Na
+
, K
+
, Cl
-
, HPO4
2-
 had no 
influence on NBV response at concentration of about 1000-fold of NBV. The experiments also 
revealed that NBV response did not change after adding 500-fold of ascorbic acid, lactose and citric 
acid as well as 400-fold of glucose. In the presence of uric acid, new well-defined oxidation peak was 
registered at the potential +0.49 V. However, the results showed that 100-fold concentration of uric 
acid did not cause an increase in the NBV current as well as dopamine present in equal concentration. 
However, the interference effect was observed with equal concentrations of other beta-blockers like 
atenolol, carvedilol, propranolol and bisoprolol. In the presence of propranolol and carvedilol, new 
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oxidation peaks were found in the voltammograms (+0.75 V for propranolol and +0.96 for carvedilol) 
with a significant influence on the distortion of the NBV response (-10.1% and -38.9%, respectively). 
On the other hand, atenolol and bisoprolol did not display well-developed voltammetric response in 
investigated potential range; however, these substances caused a positive error (+9.3% and +25.4%, 
respectively) in the NBV current. Furthermore, the interference studies showed that the equal 
concentration of hydrochlorothiazide caused an increase of 46.4% in the NBV current response. 
Hydrochlorothiazide is used for the treatment of hypertension, separately or together with NBV in a 
combined pharmaceutical formulation. Its oxidation potential (+1.02 V) is very close to that of NBV, 
resulting in overlapping voltammetric responses (Fig. 5).  
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Figure 5. Comparison of voltammetric responses of NBV (line a), hydrochlorothiazide (line b) and 
their mixture (1:1) (line c) recorded at ZrONP-CNT/GCE in 0.1 M H2SO4. DPV settings same 
as in Fig. 3. Inset: voltammetric responses recorded in BR buffer pH 4. 
 
To obtain the differentiation of the responses, the influence of supporting electrolyte pH value 
(0.1 M sulfuric acid and BR buffer pH 4) on peak potentials was studied on a mixture containing both 
drugs. With the increase of pH, the peak potential of hydrochlorothiazide was shifted to less positive 
value (inset of Fig. 5). Unfortunately, the potential difference obtained at the ZrONP-CNT/GCE was 
not large enough to overcome this problem. Therefore, the ZrONP-CNT/GCE cannot be applied to 
simultaneous analysis of NBV and hydrochlorothiazide as well as studied beta-blockers. 
For method validation, the precisions of the electrode response were evaluated by adsorptive 
stripping DPV measurements of 2.5  10-6 M NBV solutions. Unchanged oxidation peak potential and 
the RSD value of 1.1% for peak current (mean ip = 23.2 A) were estimated for intra-day 
measurements with the same modified electrode. The inter-day precision of the electrode response was 
tested by three replicate measurements over three days [16], each time using a freshly prepared 
ZrONP-CNT/GCE. The RSD value of the peak current was 2.8%, while the RSD of peak potential for 
was 0.4%, indicating excellent fabrication reproducibility. 
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The stability of the ZrONP-CNT/GCE was examined by recording the voltammetric response 
over the course of two weeks. The modified electrode was kept at room temperature between 
experiments. The peak potential was unchanged, while the drug current response decreased after a 10-
day use by 4.1%. After this period the signal decreased progressively. To explore a reusable 
application of electrochemical sensor the renewability of the ZrONP-CNT/GCE was examined 
considering the adsorption of NBV or its oxidation product on the modified surface. A simple 
electrochemical approach to clean the used sensor was used by running CV between 0.5 and 1.4 V in 
blank supporting electrolyte. The voltammetric responses obtained at regenerated ZrONP-CNT/GCE 
after CV scan were compared with the ones obtained during its first-time use. The regenerated sensor 
exhibited similar responses (recovery of 99.1±2.5% based on three measurements) indicating that the 
adsorbed molecules were successfully removed through the cleaning process. 
 
3.6 Analytical applications 
The ZrONP-CNT/GCE in combination with the DPV was applied for direct measurement of 
NBV in pharmaceutical formulations using the standard addition method in order to eliminate matrix 
effects. The assay showed that drug content of pharmaceutical product is in good agreement with the 
declared value (Table 2).  
 
Table 2. Analysis of NBV in pharmaceutical dosage forms by the proposed DPV method at ZrONP-
CNT/GCE and HPLC method 
 
 DPV HPLC 
Label value (mg) 5 5 
Determined value 
(mg)
a
  
4.92 4.91 
Recovery % 98.3 98.2 
RSD % 1.15 0.64 
Bias % -1.60 -1.80 
Added (M) 1.00 × 10
-5
 3.00 × 10
-5
 
Found (M)
 a
 0.98 × 10
-5
 2.96 × 10
-5
 
Recovery % 98.1 98.7 
RSD % 1.28 0.87 
Bias % -2.00 -1.33 
F
 b
 3.21 - 
t
 b
 0.85 - 
a
  n=5 
b
 The theoretical values of F and t-test at 95% confidence limit  
 are 6.39 and 2.31, respectively.  
 
The recovery study was carried out by adding known concentration of standard to the 
formulation solution to define the accuracy of the new method using ZrONP-CNT/GCE. In addition, 
the results obtained with the voltammetric method were compared with those obtained by developed 
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reverse-phase HPLC method [14] for NBV (Table 2). The results of the student t-test and variance 
ratio F-test show that there are no significant differences between the methods regarding the accuracy 
and precision. This finding revealed that the ZrONP-CNT/GCE can be used as a reliable and 
inexpensive electrochemical platform for quantification of NBV in pharmaceutical preparation. 
Moreover, the method developed at the ZrONP-CNT/GCE is faster and simpler in comparison with 
HPLC (the retention time of NBV was 17.6 min) [14]. 
The serum concentration of NBV administered in therapy of hypertension and cardiovascular 
diseases, the leading cause of the death in the world, can be monitored only after preconcentration of 
the drug on the modified electrode surface. To check the potential of ZrONP-CNT/GCE for use in 
analysis of NBV at trace level, the AdDPV method was applied to drug determination in human serum. 
NBV is on the list of prohibited substances in certain sports according to list of several anti-doping 
agencies. Therefore, the ZrONP-CNT/GCE was also tested for screening of drug intake or abuse. The 
standard addition method was used for the recovery studies in serum samples. The results are 
presented in Table 3.  From mean recovery of 100.8±1.7%, it is obvious that the ZrONP-CNT/GCE 
has potential to determine of NBV in serum samples. 
 
Table 3. Quantification of NBV in serum samples at ZrONP-CNT/GCE by adsorptive stripping DPV  
 
Added 10
7
 c (M)  Found 10
6
 c (M)   Recovery (%) RSD
a
 (%) 
1.50 1.51 100.67 1.99 
2.50 2.52 100.80 2.21 
5.00 5.09 101.87 2.16 
7.50 7.49   99.87 0.61 
 
a
 average of three measurements 
 
3.7. Comparison of analytical methods 
The ZrONP-CNT/GCE was compared with other electrochemical sensors developed for the 
determination of NBV (Table 4). The higher sensitivity was obtained at the ZrONP-CNT/GCE for 
measurement of NBV and wider linear range was achieved allowing the use of method for both 
applications, pharmaceutical products and biological samples. The LOD value obtained at the ZrONP-
CNT/GCE using adsorptive stripping DPV is in lower concentration range than that obtained at other 
electrodes, except for the electrode modified with undoped silver oxide nanoparticles [12]. However, it 
is unclear whether the current response at this electrode has changed with concentration, and the 
method was not fully validated. The method developed using unmodified boron-doped diamond 
electrode is faster but obtained sensitivity is lower compared to the ZrONP-CNT/GCE.  
In relation to the other developed analytical methods for determination of NBV, the linearity 
obtained at the ZrONP-CNT/GCE is in a lower concentration range compared to the previously 
reported HPLC methods with UV detection [6,9]. The LOQ value obtained by AdDPV is better than 
those found with HPLC using UV detector [6,9], high performance thin layer chromatography [8], 
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spectrophotometry
 
[9] and comparable with spectrofluorimetry [10]. The LOD value is higher than 
LODs reported for LC-MS method [4,5], but this technique is not widely available.  
 
 
Table 4. Comparison of various voltammetric methods for the determination of NBV with the present 
work  
 
Technique Electrode Concentration range 
(M) 
Sensitivity 
(μA M-1) 
LOD 
(M) 
Referenc
e 
I-V
a
 Undoped AgO 
NPs/GCE 
5.5 × 10
-9  – 9.9 × 10-
5
 
3.48 × 10
3
 0.9 × 10
-
9
 
12 
SWV
b
 BDDE 2.5 × 10
-7  – 1.5 × 10-
5
 
3.46 × 10
5
 3.2 × 10
-
8
 
13 
AdDPV Graphene-
Nafion/GCE 
5.0 × 10
-7 – 2.4 × 10-
5
 
4.52 × 10
5
 4.6 × 10
-
8
 
14 
DPV ZrONP-CNT/GCE 1.5 × 10
-6 – 1.0 × 10-
4
 
4.36 × 10
5
 5.5 × 10
-
7
 
This 
work 
AdDPV ZrONP-CNT/GCE 1.0 × 10
-7 – 6.0 × 10-
6
 
9.29 × 10
6
 1.8 × 10
-
8
 
This 
work 
a
 I-V measurement in two electrode system 
b
 Square-wave voltammetry 
c
 Boron-doped diamond electrode 
 
 
 
 
4. CONCLUSION 
A simple modification of a GCE with ZrO2 NPs and carboxylic acid functionalized multi-
walled CNTs was examined and elaborated. Nanocomposite film displayed high electrocatalytic 
activity to oxidation of NBV. DPV and AdDPV were used to investigate the sensitivity of ZrONP-
CNT/GCE to drug molecule oxidized at 1.03 V. The modified electrode showed a wide linear range 
for NBV with high sensitivity. The ZrONP-CNT/GCE is able to detect NBV in serum samples. This 
modified electrode can be used with short response time for direct measurements of NBV in 
pharmaceutical dosage forms with satisfactory results in comparison with HPLC method. 
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6. GENERAL DISCUSSION
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Due to strict and highly demanding requirements regarding the quality of 
pharmaceuticals, imposed by the pharmacopoeias, pharmaceutical industry and quality control 
laboratories, there is an ever-present challenge of developing reliable, more robust and 
selective methodologies with short analysis times, minimizing the influence of excipient 
substances and matrix effects and also allowing low LOD and LOQ to be obtained as newly 
developed drugs are often more physiologically active and therefore can be administrated in 
smaller amounts [9,117]. Due to their considerable advantages, electroanalytical techniques 
have been proved to meet all the above-mentioned requirements. Voltammetric techniques are 
the most frequently used electroanalytical techniques in pharmaceutical analysis. Since the 
development of electrochemical sensors is currently one of the most active areas of 
electroanalytical research [9], the main focus is finding a novel material in fabrication of 
sensors in order to make the developed methods more selective and sensitive. Seeing that the 
recent developments in nanotechnology have provided excellent opportunities in design and 
construction of novel electrochemical detection tools [5], we have chosen carbon nanotubes 
(CNTs) as the basis of electrochemical sensors developed in this doctoral thesis. 
The fact that there are two groups of CNTs, SWCNTs and MWCNTs, raised a 
challenging question: which type is right for targeted analytical investigations? Although 
there are many examples in the literature describing benefits of both types of nanotubes in 
pharmaceutical analysis, in the end, we have chosen to use the MWCNTs in our research. 
Moreover, the low production yield of SWCNTs compared to that of MWCNTs makes it 
rather challenging to obtain in large quantities and at affordable prices [81]. Bulk synthesis of 
MWCNTs is easier than that of SWCNTs and MWCNTs can be produced without a catalyst 
because their purity level is much higher [118]. The synthesis of SWCNTs requires higher 
quality control process than MWCNTs and hence it is more costly to produce large amounts 
of SWCNTs than MWCNTs [113], which results in their higher price. The commercial cost of 
SWCNTs is much higher, but with lower purity. Also, MWCNTs are achiral and therefore 
always regarded as metallic conductors, a highly attractive property for an electrode, whereas 
SWCNTs' conductivity depends on their chirality and diameter [80]. 
The aim of our research was to develop new electroanalytical methods for direct 
quantification of selected pharmaceutically active substances (active pharmaceutical 
ingredients, API) in their dosage forms using novel electrochemical sensors with MWCNTs. 
Furthermore, those same sensors were also applied for the simultaneous determination of 
selected pharmaceuticals in trace amounts with other co-administered drugs in therapy or their 
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metabolites in very complex media, such as biological fluids, using adsorptive stripping 
voltammetry. The selection of pharmaceuticals to be investigated followed few criteria. 
Although derivatisation can be used to introduce an electroactive group into the structure of 
compound in order to determine it electrochemically [7], instead we have chosen to use drugs 
that are electroactive by its nature. Fortunately, it was shown that most of the drugs are 
electrochemically active [42]. By avoiding the derivatisation step, the developed methods are 
cheaper and simpler. In contrast, spectrophotometric and chromatographic techniques often 
aquire some form of derivatisation step prior to analysis [27]. Another criterion that was 
considered was the lack of available analytical methods described in the literature for the 
selected drugs, with emphasis on the lack of electroanalytical methods.  The choice of drugs 
depended also on their wide use in clinical medicine. Selected drugs are often prescribed by 
physicians, very often as the first line of therapy. Despite the extensive use in approved 
indications, some of the selected drugs are also being widely studied in numerous new 
indications and therefore the development of new reliable methods for evaluation of the 
quality of their pharmaceutical products or determination drug concentrations in biological 
fluids is highly required.  
The first drug that was investigated as a part of this doctoral thesis was the antiemetic 
drug ondansetron (OND), a selective 5-HT3 antagonist. We started our research with this 
particular drug because its redox behaviour and electrochemical determination in 
pharmaceutical formulations or human fluids have not been reported in the literature at all. It 
was investigated electrochemically for the first time as a part of our research. Ondansetron 
often coexists with morphine (MOR) in biological fluids as these drugs are co-administered 
for control of pain, nausea and vomiting in patients undergoing surgery or chemotherapy. 
Furhermore, in recent years ondansetron has been successfully used in prevention of 
morphine-induced pruritus and postoperative nausea and vomiting in patients receiving 
neuraxial injections of morphine as postoperative analgesia [119,120]. Despite of that, there is 
no electroanalytical method for the simultaneous determination of OND and MOR in 
biological fluids, which is why we applied the proposed electrochemical sensor for their 
simultaneous quantification in human serum samples. Up to now, only one analytical method 
has been reported in the literature regarding their simultaneous determination in injections and 
not in biological fluids. Two analytes were separated within 20 minutes by HPLC method 
with UV detection [121].  
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Ropinirole (ROP) is a novel nonergoline dopamine agonist indicated for the treatment  
of early and advanced Parkinson's disease. The only report for electroanalytical determination 
of ROP found in the literature up to that time was published by our group [122] at the 
Department of Pharmaceutical Analysis of Faculty of Pharmacy and Biochemistry. However, 
employment of the bare GCE for ROP determination had its drawbacks. Therefore, one of the 
goals of this doctoral thesis was to construct for the first time an electrochemical sensor for 
ROP determination with the aim of improving some deficiencies of previously developed 
methods on the bare GCE. Not only that the electrochemical behaviour of ROP at modified 
electrodes has not been investigated up to that time, but also the official method for 
quantification of ROP in the Ph. Eur. has not yet been approved at the time of our research of 
ROP. The monograph of ROP was reported for the first time in the Ph. Eur. just recently with 
its edition 8.7 that was implented on 1 April, 2016, while during our research of ROP, the 7
th
 
edition was in use [44]. After publishing our work on ROP, the awareness of practical utility 
of electroanalytical methods and the importance of development of new sensors for ROP 
determination has been recognised by other researchers [123–125]. ROP often coexists with 
L-dopa in biological fluids as these drugs are co-administered in advanced Parkinson's disease 
patients but surprisingly, up to now, no study has been published in the literature reporting the 
simultaneous determination of ROP and L-dopa.  
Mesalazine (5-aminosalicylic acid, 5-ASA) is an anti-inflammatory drug widely 
prescribed for the therapy of chronic inflammatory bowel diseases (IBDs), such as ulcerative 
colitis and Crohn's disease. Although it has been used in therapy for some time now and there 
are few reports [126–131] available on the electrochemical determination of 5-ASA, still no 
attempt has been made to determine 5-ASA and its major N-acetylated metabolite (Ac-5-
ASA) by an electrochemical method. The electrochemical behaviour of Ac-5-ASA was 
investigated for the first time as a part of this doctoral research. The knowledge of 
pharmacokinetics and metabolism of 5-ASA from mesalazine-containing drugs is mandatory 
when new drug formulations are developed for the treatment of IBDs, and therefore validated 
analytical methods are needed for bioequivalence studies [132]. Development of the method 
for simultaneous determination of the drug and its metabolite can be quite a challenge due to 
high selectivity of the method required in order to simultaneously determine structurally very 
similar compounds. Furthermore, we have employed proposed sensor for fast and reliable 
determination of 5-ASA content in two different delayed-release formulations which enabled 
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us to compare the qualities of two pharmaceutical products with the same active ingredient 
present on our market. 
Nebivolol is a third-generation, long-acting and highly selective beta(1) blocker (β1-
blocker) with a pharmacological profile that differs from those of other drugs in its class. In 
addition to cardioselectivity mediated via β1 receptor blockade, NBV induces nitric oxide-
mediated vasodilation by stimulating endothelial nitric oxide synthase. Its unique 
pharmacological profile, based on the highest cardioselectivity and additional vasodilatory 
effect, provides NBV the highest efficacy and tolerability for the treatment of hypertension 
and chronic heart failure among others of its class [133]. Due to its important role in treatment 
of chronic cardiovascular diseases and the fact that an official method for its quantification in 
bulk form and pharmaceutical formulations has not been approved in any pharmacopoeia, we 
have recognized the need to develop new sensitive analytical method for NBV determination. 
NBV has already been investigated [134] at bare boron-doped electrode (BDDE) as well as 
other β1-blockers [104], by our group at the Department of Pharmaceutical Analysis. Studies 
have been shown that metal NPs supported on the MWCNTs may provide much improved 
electrocatalytic activity [135]. Therefore, in order to take full advantage of the two kinds of 
nanomaterials, our idea was to construct a simple and sensitive electrochemical sensor based 
on both NPs and MWCNTs, so that the individual properties of each material can be 
integrated and the interactions between the two components may bring out novel properties. 
No electrochemical studies on NBV determination using this kind of nanocomposite film 
were reported in scientific literature. However, during the preparation of the manuscript, a 
paper dealing with the electrochemical determination of NBV appeared, but it is based on 
oxidation of drug at GCE modified with graphene as another type of nanomaterial [136]. 
Once obtained, MWCNTs were purified and activated before use. The most common 
pretreatment step with nanotube modified electrodes is to purify the tubes in strong acid 
which gives an improvement in the electron transfer rate. Solutions of sulfuric, nitric and 
hydrochloric acids, either concentrated or diluted, alone or mixed have been used at room 
temperature or under refluxing, with or without sonication for different times [92]. Sonication 
of dispersion of MWCNTs in concentrated HNO3 for 4 hours showed to be suitable protocol 
for activation of nanotubes for our purposes. 
To take advantage of the remarkable properties of MWCNTs in electrochemical 
sensing applications, the MWCNTs should be properly functionalized and uniformly 
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immobilized at electrode surface. For that purpose, we chose Nafion as the dispersing agent. 
Not only did Nafion homogenously disperse MWCNTs, fixing them onto the electrode 
surface tightly and enhancing the stability of proposed electrochemical sensor, but it also 
enhanced the electrochemical response together with MWCNTs thanks to their synergistic 
effect. The investigated drugs are all weak basic compounds that were completely protonated 
in the experimental conditions under which voltammetric measurements were performed and 
Nafion as a cation-exchanger attracted them from the bulk solution. The electrode that was 
employed in performed voltammetric measurements was GCE, which is not untypical for this 
type of investigation. Selected drugs (except for 5-ASA) were oxidized at relatively high 
potential values on the bare GCE, and MWCNTs, due to their electrocatalytic activity, made 
that oxidations more facile, and thus placing them outside the solvent window. Modification 
of GCE with either MWCNTs or Nafion led to advantageous electroanalytical performance, 
while a remarkable enhancement effect on electrochemical responses of all investigated drugs 
was obtained from the combined contribution of MWCNTs and Nafion. The analytical 
performance of the modified electrodes, besides for the drugs in our primary focus, was also 
evaluated for the co-administered drugs and metabolite. The results also showed a 
considerable improvement of their voltammetric responses. The differences between the two 
peak potentials were large enough for the development of simultaneous methods in all cases, 
even for the structurally very similar 5-ASA and its metabolite. Furthermore, implementing 
the ZrO2 NPs for NBV determination enabled even more enhanced voltammetric response 
obtained from the combined effects of ZrO2, MWCNTs and Nafion.  
During the preliminary investigations and before constructing electrochemical sensors 
based on MWCNTs, different modifiers and different types of electrodes were studied to find 
the most favorable electrochemical response. Since the redox behaviour of OND was studied 
for the first time as a part of this doctoral thesis, the investigation of the electrochemical 
oxidation of drug molecule was started at a bare GCE. The preliminary results indicated that 
the voltammetric response of OND at bare GCE was not satisfactory for the analytical 
purposes because of slow heterogeneous electron transfer, electrode fouling problems, 
unstable analytical signal and reduced sensitivity due to the fact that adsorption of drug 
molecule could not be purposely used as a preconcentration step. In light of these findings, it 
was a challenge to find a new electrode material for determination of OND using 
voltammetric technique.  
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One common approach for incorporating a modifier onto the solid surface is to cover it 
with an appropriate polymer film [76]. Polymer-modified electrodes are often prepared by 
casting a solution containing the dissolved polymer onto the surface and allowing the solvent 
to evaporate or via electropolymerization in the presence of the dissolved monomer. Polymer-
modified electrodes prepared by electropolymerization have received extensive interest in the 
detection of analytes, not only due to their high sensitivity and selectivity, but also because of 
the film homogeneity attained in electrochemical deposition, its chemical stability and strong 
adherence to the electrode surface [137]. So, for the initial modification of GCE for the 
investigation of OND behaviour, 2-hydroxy-5-[(4-sulfophenyl)azo]benzoic acid (SPAB) was 
chosen. The electrochemical properties of SPAB were investigated at GCE [138,139] and 
hanging mercury drop electrode (HMDE) [140,141] in previously published papers. Getting 
the insight into the electrochemical behaviour of SPAB enabled the application of 
electrooxidation of its monomer to generate polymer layer on GCE with incorporated 
polyanions that can show cation selectivity and adsorption of positively charged drug 
molecules [137]. The electrochemical sensor based on SPAB was developed for the first time 
to determine analytes by voltammetry at the Department of Pharmaceutical Analysis by our 
group. Based on excellent experience with poly(SPAB) as a novel sensor for sensitive and 
selective determination of antipsychotic drug quetiapine, we tested it in preliminary studies of 
OND using experimental conditions (Supplemental data 1, Figure 1) that were previously 
selected as optimum (SPAB, c = 1 x 10
-3
 M in Britton-Robinson (BR) buffer pH 4, between -
0.1 and 1.6 V, ν = 100 mV/s, 10 cycles).  
Because of the presence of the charged carboxylic and sulfonate groups in the 
structure of SPAB, the adsorption of positively charged OND molecules onto the modified 
electrode due to the electrostatic interactions was expected. Nevertheless, the electrode 
modified with SPAB did not give much better results than that of bare GCE as it was the case 
for quetiapine. The peak potential of OND was shifted to less positive values by 20 mV, 
indicating weak electrocatalytic activity of immobilized film towards OND, but there was 
clearly no enhanced effect of SPAB on peak current (Supplemental data 1, Figure 2). The 
adsorption of drug molecules could not be obtained on GCE modified with poly(SPAB) under 
such experimental conditions, and therefore higher sensitivity could not be achieved which 
was needed for the application of the sensor to determine trace amounts of OND found in 
biological fluids after the therapeutic doses. It is possible that some steric factors limit the 
good electrostatic interaction between positively charged nitrogen atom in OND structure and 
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negatively charged carboxylic and sulfonate groups in SPAB structure. On the other hand, 
functional groups of SPAB may not be charged enough under the acidic conditions of the 
experiments; however, a maximum current intensity was obtained in 0.1 M H2SO4 during the 
preliminary investigation on bare GCE. Therefore, it was employed as optimum supporting 
electrolyte for further studies. 
SPAB belongs to the same class of compounds as two azosalicylic acids, sulfasalazine 
and olsalazine, which are employed in clinical praxis as precursor of 5-ASA [137]. SPAB was 
also proposed as potential novel prodrug of 5-ASA by the earlier investigations [138]. 5-ASA 
is identified as an active component in the therapy of IBDs and a novel sensor has been 
proposed for its determination as a part of this doctoral thesis. However,  due to its similarity 
with SPAB, which was applied as a modifier, we investigated the possible use of 5-ASA for 
synthesis of polymer film for sensitive determination of ROP. Also, Eriksson et al. (142) 
proposed possible way of 5-ASA polymerization during its electrooxidation on GCE and Mu 
(143) performed the copolymerization of aniline and 5-ASA by CV to introduce pH 
functional groups (-OH and –COOH) with 5-ASA in order to improve the pH dependance of 
redox activity of polyaniline, which is also used for electrochemical sensing due to its 
conductivity and redox activity. The assumption was that 5-ASA could attract positively 
charged ROP molecules from the bulk solution by its negatively charged carboxylic groups. 
Voltammetric response of ROP turned out to be much better on GCE modified with poly(5-
ASA) than that obtained at the bare GCE, so we proceeded with the optimization of 5-ASA 
polymer film in order to get the most favorable response for ROP (Supplemental data 2, 
Figure 3). 
Parameters that could affect electropolymerization of 5-ASA and therefore the 
voltammetric response of ROP on GCE modified with poly(5-ASA) were optimized: potential 
window, number of cycles, scan rate, as well as concentration and pH of 5-ASA solution. The 
efficiency of the film growth was the highest when an electrode was cycled in the 
modification solution between -0.2 and +0.9 V. The wider potential window resulted in lower 
peak currents of 5-ASA and the preparation of the polymer film was longer. Also, peak 
current for ROP was sharper and higher when shorter potential range of cyclization was 
applied. When 10 cycles with ν = 100 mV/s were used for the deposition of the polymer film, 
voltammetric responses of ROP were sharper and higher in comparison with 20 cycles with ν 
= 200 mV/s. Poly(5-ASA) was prepared in BR buffer. In order to find optimum conditions for 
its electropolymerization, the pH value of BR buffer was varied between 2 and 6. Although 
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the pH had great effect on 5-ASA oxidation, it did not seem to affect the voltammetric 
response of ROP that much. BR buffer pH 2.0 was finally chosen as optimum because it 
resulted in the highest 5-ASA peak current and therefore the highest film growth. On the other 
hand, concentration of 5-ASA solution appeared to be the critical parameter for ROP 
voltammetric response. Its peak current significantly increased with the increase of 5-ASA 
concentration and the value of 1 x 10
-3 
 M was selected as optimum (Supplemental data 2, 
Figures 1 and 2). 
Although the sensor with poly(5-ASA) looked very promising compared to SPAB that 
has similar structure, we were not able to achieve the accumulation of ROP on that film. It 
might have been that carboxylic groups where not charged enough to concentrate ROP 
molecules by electrostatic interaction. Since one of the imperatives of our research was to 
develop methods that would be sensitive enough to be able to quantify very low 
concentrations of drugs in biofluids, GCE modified with poly(5-ASA) proved to be 
unsatisfactory for this purposes. However, some other type of investigation, such as the 
determination of drug content in pharmaceutical dosage forms where such high sensitivities 
are not necessary, could possibly benefit from this type of sensor. In order to achieve 
accumulation we tried to construct an electrochemical sensor based on both 5-ASA and 
MWCNTs. Instead on bare GCE, electropolymerization of 5-ASA was performed on the GCE 
surface on which was previously casted a suspension of MWCNTs in DMF, but we did not 
achieve satisfactory results with that modification either. Later, we found in the literature a 
publication concerning a novel solid-phase extractor based on MWCNTs with 5-ASA for 
preconcentration of Pb
2+ 
[144]. To construct such an extractor, the covalent bond was 
established between carboxylic groups of functionalized MWCNTs and amino group of 5-
ASA. In our electroanalytical studies we did not use those covalent types of MWCNTs 
functionalisation, but rather non-covalent, which are simpler. Future investigations could 
perhaps try to employ such covalent functionalisation with 5-ASA for electrochemical 
sensing. 
BDDE have found many applications as electrode material in electroanalysis due to 
their outstanding properties, such as very wide electrochemical potential window, low 
background current [145], exceptional chemical inertness and mechanical strength, negligible 
adsorption of organic compounds [146], and thus reduced fouling [147], extreme hardness 
and applications in aggressive media such as strong acids [42]. These properties make BDDE 
particularly suitable for electrochemical studies of analytes with a high oxidation potential 
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[148] and ROP is one of them. Furthermore, previous work on ROP by our group at the bare 
GCE [122] revealed fouling effect of ROP oxidation product. The sp
3
 surface of BDDE is less 
vulnerable to surface oxidation and fouling than sp
2
, such as GCE [78], which is why we 
investigated the electrochemical behaviour of ROP on modified and bare BDDE as well. 
Modification of BDDE with MWCNTs and Nafion led to similar results as observed on GCE 
in terms of synergistic effect from MWCNTs and Nafion (Supplemental data 2, Figure 5).  
When compared to MWCNTs/Nafion-GCE (Supplemental data 2, Figure 6), 
MWCNTs/Nafion-BDDE did not provide much better results (BDDE: ip = 128 μA at 1.26 V 
vs. GCE: ip = 110 μA at 1.24 V for c (ROP) = 5 x 10
-5
 M). However, it is more expensive and 
more difficult to maintain as it cannot be cleaned by severe polishing because of its surface 
doping [77]. It is usually pretreated cathodically [148,149] or anodically [77], which can last 
even for a few minutes. Also, it has been reported that repeated electrochemical cleaning of 
the BDDE surface can decrease the electrode activation [77]. The fouling effect of ROP and 
its oxidation product was decreased on MWCNTs/Nafion-GCE anyway, and so it was not 
necessary to use expensive BDDE for such a small progress in peak current. 
To improve the sensor response we examined in preliminary measurements, once 
again, the influence of the working electrode material, this time glassy carbon and gold (Au), 
on oxidation peak height of 5-ASA. Au is together with platinum (Pt) the most used solid 
metal electrode material [11]. They are commonly considered to be inert [76], but their 
inertness should be considered as relative [42] because under certain electrochemical 
conditions these electrodes are highly active [76]. At certain applied potentials, oxides are 
formed by reaction between the electrooxidised metal and oxygen and electrodes' otherwise 
highly active surface can be covered by a surface oxide film over a broad range of positive 
potentials. This will influence the electrode oxidation processes since the electrochemical 
charge transfer reactions will occur at the surface oxide rather than the metal surface [42]. 
Such films can also strongly alter the kinetics of the electrode reaction, leading to 
irreproducible data [11]. Since the Au electrode in aqueous electrolyte at potentials higher 
than +0.8 V is covered by an Au oxide film, making its use in the positive potential range 
reduced [42], this type od metal electrode could only be applied in our research for 5-ASA as 
its oxidation occurs below +0.8 V. For other investigated drugs oxidation happens at 
potentials higher than +1.0 V. As sensitivity did not improve when using gold electrode 
(Supplement data 3, Figures 1-4), the GCE was used in subsequent experiments due to its 
significantly lower cost. 
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For fabrication of novel nanosensor based on both metal nanoparticles and carbon 
nanotubes, we investigated NPs that were not so commonly used for sensing of 
pharmaceuticals. Noble metal nanoparticles (NPs) such as gold, platinum and silver were 
mostly used in this area [5], but a wide variety of metal NPs, which are not typically used 
materials such as those mentioned above, have been studied in electroanalysis [109]. Bismuth 
NPs represent innovative material in sensing applications. They have attracted growing 
attention recently [150] and so we tried them in combination with carbon nanotubes that have 
already proven to be an excellent tool for sensing. However, the results obtained from 
combining those two modifiers were unexpected. The peak potential of NBV shifted to less 
positive values, while the peak current was higher at the electrode modified only with 
nanotubes. There was no synergistic effect observed from those two types of nanomaterials 
(Supplemental data 4, Figures 1 and 2). Lee et al. [151] reported the formation of 
agglomerates with petal shape, observed by SEM, emerging from well-connected spherical 
NPs with Nafion, which existed at the beginning of the measurement process. It is believed 
that they decreased due to chemical reaction of Bi with ions in electrolyte solution and Bi 
oxidation. X-ray diffraction (XRD) patterns confirmed that most of the Bi oxidized to BiOCl 
at pH 3.0 and the agglomerates observed by SEM are thought to be BiOCl. Thus, it is 
suggested that the pH of the solution significantly influences the phase stability of bismuth 
and that the phase transition of pure bismuth into the other forms leads to a considerable 
decrease in sensitivity of the nano-bismuth fixed electrode. Our preliminary study on NBV 
oxidation has shown that the best voltammetric response was obtained in very acidic media 
due to NBV protonation and interaction with Nafion, which is why it was not feasible to apply 
this nanosensor with Bi NPs for NBV determination in this selected conditions. On the other 
hand, ZrO2 NPs proved to be a useful material for enhancing sensitivity together with 
MWCNTs and Nafion. Since only few papers on its use in sensing of pharmaceuticals have 
been reported [152–154], it is considered as a very attractive and innovative nanomaterial in 
this field. Although some sensors based on both ZrO2 NPs and MWCNTs have been reported, 
the sensor that would combine ZrO2 NPs and MWCNTs together with Nafion, to our 
knowledge, has not yet been reported in pharmaceutical and biomedical field. 
Although various modifiers and types of electrodes were explored in our search for a 
novel electrochemical sensor, those based on MWCNTs dispersed in Nafion, decorated with 
ZrO2 NPs in case of NBV, proved to give the most favorable voltammetric responses for all 
drugs investigated. Therefore, the next step was optimisation of all experimental conditions 
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and parameters that could affect the electroanalytical performance of that sensor. The surface 
morphology and structure characterization of the modified electrodes was examined by 
scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDXS) and CV. 
Since the modification of the electrode with nanomaterials and Nafion led to such great 
improvement in electrochemical responses of all drugs, it was necessary to optimize the 
amounts of modifiers in suspension. An increase of the amounts of nanomaterials in polymer 
film was expected to result in enhanced peak currents due to their unique properties; however, 
too high MWCNTs or ZrO2 NPs concentrations led to large background currents and lower 
stability of the nanocomposite film due to lower adhesion on the electrode surface as well as 
the agglomeration of nanomaterials. The optimum concentration ratios for our investigations 
appeared to be 1:1 (MWCNTs : Nafion) and 1:1:1 (MWCNTs : ZrO2 : Nafion) for NBV 
sensing. Nafion concentrations were also studied in the range of 0.1-0.7 %. The optimum 
value was 0.5 % for all selected pharmaceuticals, except for the Ac-5-ASA. The metabolite 
could not have been effectively attracted by the cation-exchange polymer, which is why 0.3 % 
Nafion concentration was chosen as optimal value for simultaneous analysis of 5-ASA and its 
acetylated metabolite. Finally, the volume of suspension, which determines the thickness of 
the cast film, was varied between 1 and 9 μL. The maximum responses were achieved when 
electrode surface was coated with 5 μL, except for simultaneous analysis of 5-ASA and Ac-5-
ASA where 3 μL were casted. The smaller amount of Nafion used in this method (0.3 %) 
resulted in less viscosity of the suspension and therefore the better adhesion at the electrode 
surface and better stability of the immobilised film were obtained with smaller suspension 
volume. 
The choice of the supporting electrolyte is very important in method development. If 
no information is found in the literature for the given electroactive compound or related 
compounds, a number of various supporting electrolytes must be used to find one in which the 
best developed and easy measurable waves are obtained [42]. First, to obtain better sensitivity 
for analytical studies, the electrochemical oxidation of selected drugs was examined using CV 
in different supporting electrolytes, including BR buffer and acetate buffer with different pH 
values, as well as the sulfuric acid, hydrochloric acid and acetic acid in different 
concentrations. For analyses of electroactive organic components that are most frequently 
present in drugs, the supporting electrolytes are usually buffers, solutions of a strong acid or 
of a strong base [31]. The experiments have shown that well-defined voltammetric response 
of selected drugs was obtained only at lower pH values. A 0.1 M H2SO4 was chosen as the 
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optimum electrolyte for sensitive determination of NBV, as well as for selective simultaneous 
determination of OND with MOR and ROP with L-dopa. On the other hand, in BR buffer 
solution pH 2.0 a maximum current intensity together with lower background current was 
achieved for simultaneous determination of 5-ASA and its metabolite. These supporting 
electrolytes were employed in further studies. As was already mentioned, all of these drugs 
are weak basic compounds and in this kind of acidic media they were completely protonated 
and thus effectively attracted by Nafion to the electrode surface.  
For evaluating the redox reaction character of selected drugs on modified electrodes, 
the CV measurements with different scan rates (ν) were performed and the effects of scan rate 
change on peak potentials and peak currents were evaluated. For all drugs peak currents 
linearly increased with the scan rate, and a plot of anodic peak current versus the scan rate 
gave the linear relationship, indicating that the eletrooxidation of drug molecules at modified 
electrodes was an adsorption-controlled process. Therefore, to obtain the highest sensitivity of 
the method, the adsorption of drug molecules was used in subsequent analytical 
measurements as an effective accumulation step prior to the voltammetric quantification of 
drugs. In cases of all drugs, peak potentials shifted positively when increasing scan rate and 
dependance of the peak potential was linear with logaritm of scan rate, as expected for an 
irreversible electrode process. This established relation allowed, using the appropriate 
equations, to calculate the number of electrons exchanged during the oxidation process on 
modified electrodes. The slopes of the plots of peak potentials versus pH demonstrated that 
equal number of protons participated in redox processes of ROP, 5-ASA and NBV. As for 
OND, the peak potential remained almost constant with the pH change, indicating that protons 
did not participate in its oxidation process. 
To obtain a much more sensitive peak currents for analytical studies, the variation of 
the peak currents recorded at the modified electrodes was monitered while changing 
instrumental SWV parameters for OND, ROP and 5-ASA and DPV parameters for NBV 
determination. The pulse amplitude and the potential scan rate were optimized to acquire 
voltammograms of relatively high sensitivity and well-shaped waves with a relatively narrow 
peak width. Selection of these parameters is very important for sensitivity, resolution and 
analysis time [9]. Because of its speed, SWV was employed in most cases for sensitive and 
fast determinations in our research. The effective scan rate is given by f ΔE [11]. For example, 
the optimisation of SWV parameters for OND determination resulted in f = 75 Hz and ΔE = 8 
mV, which gave the value of effective scan rate of 600 mV/s. Since the SWV voltammograms 
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were recorded in potential scan from 0.7 to 1.4 V, it took only 1.17 seconds to obtain the 
entire voltammogram for OND determination. Analysis time is, therefore, drastically reduced 
by the careful choice of SWV parameters. 
CV studies revealed surface-controlled processes at the modified electrodes; therefore, 
the possibility of effective analyte preconcentration before voltammetric measurement was 
examined. To achieve the optimum conditions for the maximum adsorption, the influence of 
accumulation potential and deposition time on voltammetric responses of investigated drugs 
were evaluated. Our observations of the influence of accumulation potential on the stripping 
peak currents were in accordance with the Langmuir isotherm in voltammetric studies, which 
means that the peak currents increased, for such electroactive molecules oxidized at positive 
potentials, as the accumulation potential shifted to more negative values. As it is common, 
accumulation potentials were not close to the oxidation potentials of investigated drugs [49]. 
The accumulation time significantly affected voltammetric responses of all selected drugs 
with enhanced increase of their oxidation peak currents with the increase of tacc until surface 
adsorption saturation occured. However, the adsorption kinetics appeared to be quite different 
for simultaneously determined drugs. Although, MOR showed much faster adsorption at the 
modified electrode surface than OND, as well as L-dopa opposed to ROP, a little longer tacc 
was chosen as optimum in order to achieve the highest possible sensitivity in the linearity 
range for quantification of the targeted drugs of this research in biological fluids (OND and 
ROP) in acceptable analysis time. As for 5-ASA and its metabolite, an extremely short tacc 
allowed  the needed sensitivity to measure the expected serum concentrations after treatment 
with the therapeutic daily doses recommended for IBDs. 
Every analytical procedure needs to be validated to be regarded as suitable for 
intended purpose [155]. After all the experimental conditions and instrumental parameters 
that could affect voltammetric response of our investigated drugs were optimized, and before 
the applicability of proposed sensors on pharmaceutical dosage forms and human serum 
samples was examined, the developed methods were validated according to ICH guidelines 
using those optimized conditions. The validation parameters that were checked during the 
development of new methods using proposed sensors were selectivity, linear range, LOD and 
LOQ, precision as inter-day and intra-day precision, accuracy and stability. The linearity 
range was examined with pulse techniques, DPV for NBV and SWV for all other selected 
drugs, both with and without accumulation step. Obtained linear responses without 
preconcentration step allowed direct determination of these drugs in their dosage forms due to 
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high concentrations of API in tablets. Although electrochemical methods are generally 
considered to be very sensitive [156], the quantification in human serum samples where these 
drugs are basically found in trace amounts after therapeutic doses could not be feasible 
without accumulation step prior to SWV or DPV. So, linearity was also checked under 
optimum accumulation conditions, and, thus higher sensitivities were achieved.  
By changing one analyte concentration and keeping the other unchanged, obtained 
sensitivities (slopes of the calibration curves) were compared to the values observed in the 
absence of co-administered drugs or metabolite. Results  indicated independent adsorption of 
examined analytes in the accumulation step at the proposed electrochemical sensor. 
Therefore, simultaneous determination of selected drugs or drug with its metabolite was 
possible without inteferences. There are several different approaches for LOD and LOQ 
determination recommended by the official guidelines and pharmacopoeias. The most widely 
used approach in electroanalytical chemistry and also in our investigations, estimates the LOD 
and LOQ values from the standard deviation of the intercept and the slope of the related 
calibration curves [42]. LOD and LOQ values obtained with proposed sensors were 
comparable or even better than in previously reported chromatographic methods which are 
less environmentally friendly, more expensive and demand sophisticated equipment. 
ICH Q2 defines that precision of the method can be considered at three levels: 
repeatability (intra-day precision), intermediate precision (inter-day precision) and 
reproducibility (ruggedness, USP). Reproducibility is used especially for collaborative 
studies. It is employed for the standardization of an electroanalytical method, for instance, for 
inclusion of procedures in pharmacopoeias [42], but it is not normally expected as the 
mandatory validation parameter if intermediate precision is performed [156]. The intra-day 
precision of voltammetric responses using proposed sensors was evaluated by six replicate 
measurements yielding unchanged oxidation peak potentials for all investigated drugs and 
relative standard deviations (RSD) for stripping peak currents, all below 2 %. The inter-day 
precision was characterized by three replicate measurements over three days, each time using 
freshly prepared sensor and standard solutions. The RSD values for stripping currents were 
not greater then 3 % and were also less then 1 % for peak potentials. For evaluation of 
precisions of the electrode response, adsorptive stripping technique was employed, that was 
later used for trace amount assay in biological fluids. Since the precision criterion for trace 
amount assay in electroanalytical methods should be  ≤  5 %  [156], we can conclude that 
proposed sensors showed excellent precision and also great fabrication reproducibility. The 
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stability of proposed sensors was checked over a period of four weeks by evaluating the 
analytes oxidation peak potential and peak currents. 
Accuracy of the method is usually expressed as recovery and rarely as bias or relative 
bias and it can be obtained in different ways. It is not uncommon for the electroanalytical 
assay of pharmaceuticals that accuracy is determined by spiking a blank matrix with known 
concentrations of compounds [42], for example when measuring a drug active compound in a 
complex and/or unknown matrix media such as biological samples or pharmaceutical dosage 
forms. Also, in order to eliminate interferences such as excipients in tablets or endogenous 
substances in serum samples, standard addition methods can be used for quantification and 
recovery studies.  
Prior to the analysis of samples, the selectivity of the proposed electrochemical 
sensors for quantification of selected drugs and metabolite was also evaluated. Their fixed 
amounts in standard solutions were spiked with various excess amounts of interfering species 
that are likely to be found in biological samples or are co-formulated with the API. Many 
inorganic electrolytes, such as Na
+
, Cl
-
, K
+
, NO3
-
, SO4
2-
, HPO4
2-
,
 
Zn
2+
, Ca
2+
, Mg
2+
, Cu
2+
 and 
Fe
3+ 
did not intefere even when they were added in amounts much larger than usual 
physiological levels. L-alanine, L-glycine, L-aspartic acid, L-glutamic acid, L-cysteine, 
lactose, sucrose, glucose, starch, citric acid, Na2EDTA and manitol also did not cause an error 
more then ± 5 % in the voltammetric responses of investigated analytes.  
Exploring the influence of dopamine (DA), ascorbic acid (AA), uric acid (UA) and 
nitrite ions (NO2
-
) was particularly interesting for quantification of our analytes in serum 
samples as these biomolecules regularly coexist in many biological matrices and their 
simultaneous determination is one of the most important points in sensor fabrication due to 
their very close oxidation potentials at bare electrodes [157]. At bare GCE they can usually be 
seen as one overlapped and broad oxidation peak, but modifications with different MWCNTs-
based sensors allowed separation of their peaks [158,159]. Unfortunately, the separated peaks 
due to their potential values may intefere with the voltammetric determinations of some of our 
analytes. However, Nafion with its negatively charged sulfonate groups prevented the 
accumulation of negatively charged oxidizable NO2
-
, while allowing facile accumulation of 
the positively charged analytes (Supplemental data 1, Figure 4). Ascorbic acid (pKa = 4,17) is 
neutral [160] under the experimental conditions so it was not rejected by Nafion, but its 
oxidation potential on electrodes modified with MWCNTs can be seen at very low oxidation 
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potentials, outside our potential window. DA is positively charged (pKa = 8.89) under 
experimental conditions [160]  conducted in our measurements and was attracted by Nafion 
and therefore could have been showing possible competitive adsorption on this type of 
electrode surface. However, DA showed only interference with L-dopa (Supplemental data 2, 
Figure 7 a) and b)), which is actually used as DA precursor in the treatment of Parkinson's 
disease, due to their very similar structure and very close peak potentials (+0.48 V for DA vs 
+0.52 V for L-dopa). However, normal plasma levels of endogenous free DA (26 pg/mL) did 
not affect L-dopa voltammetric response at the proposed sensor. UA, although without charge 
[160] under optimized experimental conditions (pKa = 5.4), influenced on peak currents of 
MOR (Supplemental data 1, Figure 3) and L-dopa (Supplemental data 2, Figure 8), as well as 
5-ASA and its metabolite (Supplemental data 3, Figure 5) due to closeness of their potentials. 
As it was the case with DA, no interferences were seen on real samples. For NBV, additional 
inteferences studies were performed and the inteference effect was observed with equal 
concentrations of other β-blockers, like atenolol, carvedilol, propranolol and bisoprolol 
(Supplemental data 4, Figures 2-5), as well as with hydrochlorothiazide that can be combined 
with NBV for the treatment of hypertension.  
To evaluate the validity and practical utility of newly developed methods on proposed 
sensors, analytes were determined in tablets obtained from local pharmacy and in human 
serum samples obtained from healthy volunteers. Direct measurements with pulse techniques 
(DPV for NBV and SWV for others) were employed for the determination of drug contents in 
dosage forms, except for OND due to unstable analytical signal without preconcentration step. 
Otherwise, due to high concentration of API in tablets, no accumulation step was needed. 
Voltammograms were obtained by SWV within few seconds and such fast quantification in 
pharmaceutical formulations, without complicated sample preparation and with higher or at 
least of the same order sensitivity and selectivity, cannot be usually achieved with commonly 
used analytical methods for determination of drug content, such as chromatographic, 
spectroscopic and capillary electrophoretic methods. For NBV determination DPV is 
employed instead of SWV because of the much lower background current and significantly 
lower overpotential of NBV achieved in this way. It has been reported in the literature that 
SWV can lead to drawbacks with kinetically slow processes because of its high speed, when 
DPV is to be preferred [42].  
The results obtained with the proposed sensors were in good agreement with the 
claimed amount. Mean recoveries were 98.3 – 101.0 % with RSD values 0.7 – 1.3 %, 
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depending on the analyte, indicating good accuracy and precision as well as the suitability of 
the proposed sensor for this purpose. Only for L-dopa determination recoveries obtained by 
both SWV (95.23 %) and HPLC (95.04 %) were slightly outside of that narrow range, but 
were still more than acceptable. Similar recoveries were obtained with both techniques which 
is why it cannot be prescribed to the technique used for measurements but were probably 
caused by the nature of sample as L-dopa is present with another component - benzerazid in 
combined pharmaceutical dosage form. Also, the recoveries in the range of 98.1 – 99.4 % 
indicated that excipients did not interfere with assay of active ingredient in any case. The 
results obtained with newly developed methods were compared with those obtained by HPLC 
methods reported in literature (5-ASA), official HPLC methods described in USP (L-dopa), 
previously developed HPLC methods by our group (ROP, NBV) or HPLC methods 
developed as a part of this doctoral thesis (OND). Recovery tests were also performed for 
chromatographic methods. Statistical analysis of the results obtained using voltammetric and 
HPLC procedures showed no significant difference between the performance of the two 
methods regarding accuracy and precision, as revealed by the student t-test and variance ratio 
F-test. 
MWCNTs/Nafion sensor was also applied for the first time for simultaneous 
determination of OND and MOR, ROP and L-dopa, 5-ASA and its metabolite Ac-5-ASA in 
human serum samples by AdSWV. ZrO2-MWCNTs/Nafion sensor was applied for the 
determination of NBV in serum by AdDPV. The expected serum concentrations with the 
therapeutic daily doses were within linear concentration ranges of the newly developed 
method using proposed electrochemical sensors after the accumulation step in duration of 360 
s for OND and MOR, 240 s for ROP and L-dopa, 30 s for 5-ASA and metabolite and 240 s 
for NBV. The analysis time was still very short, especially when it was compared to other 
methods and there was no need for expensive and complicated extraction procedures. The 
recovery studies in serum samples were performed using the standard addition method to 
nullify any remaining interference. In this type of complex matrix, such as biological fluids, 
excellent recoveries were obtained in the range 98.7 – 102.6 % with RSD 1.5 – 2.8 %. 
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7. CONCLUSIONS 
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In present doctoral thesis new electroanalytical methods using novel 
MWCNTs/Nafion or ZrO2-MWCNTs/Nafion sensors were developed, validated and applied  
in pharmaceutical dosage forms and human serum samples for selected pharmaceuticals. 
 
 The oxidative behaviour and electrochemical determination of OND were studied for 
the first time. MWCNTs/Nafion-GCE exhibited high selectivity in the voltammetric 
measurements of OND and co-administered drug MOR with potential difference of 
430 mV. It was succesfully applied for the simultaneous determination of both drugs 
in human serum samples by AdSWV after short accumulation at the electrode surface. 
A newly developed voltammetric method was applied for quantification of OND in 
film-coated tablets.  
 The use of an electrochemical sensor for ROP determination has been reported for the 
first time by our work. The proposed nanostructured sensor was utilised for direct 
measurements of ROP, as well as co-administered drug L-dopa, individually in 
pharmaceutical formulations by SWV. In addition, the analytical method for their 
simultaneous determination was developed for the first time. The large separation of 
the peak potentials of 720 mV at the MWCNTs/Nafion sensor allowed fast 
simultaneous quantification of trace amounts of both drugs in human serum samples. 
 For the first time, an electroanalytical method was developed for selective 
simultaneous determination of 5-ASA and its major metabolite, Ac-5-ASA without the 
need for prior time-consuming separation step. The potential difference of 200 mV 
between the peaks at the MWCNTs/Nafion sensor was large enough to determine 
structurally very similar analytes in very low concentrations by AdSWV. Proposed 
sensor was also used for direct measurements of 5-ASA contents by SWV in two 
pharmaceutical formulations available on our market. 
 Proposed sensor with MWCNTs in Nafion matrix was decorated with ZrO2 NPs in 
order to improve its performance and electrochemical sensing of NBV by utilising all 
of the exceptional properties of the two nanomaterials. ZrO2-MWCNTs/Nafion sensor 
was applied for fast quantification of NBV in tablets by DPV and also for very 
sensitive analysis of NBV in serum samples by AdDPV.  
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Development of new electroanalytical methods in the present doctoral thesis represent 
an important scientific contribution of our research in the field of pharmaceutical analysis, 
especially for the drugs characterised with the lack of analytical methods for their qualitative 
and quantitative examination. It is a significant progress for drugs that have not yet been 
investigated electrochemically, particularly using novel electrochemical sensors. 
A considerable enhancement effect on voltammetric responses of selected drugs was 
observed due to synergy of remarkable properties of nanomaterials and cation-exchange 
polymer that were used to construct a promising platform for electrochemical sensing. 
Enhanced peak currents and lower potential values were obtained due to larger electroactive 
surface area and excellent electrocatalytic activity of nanomaterials together with ion-
exchange capacity and improved accumulation capability provided by Nafion matrix. 
Electrochemical sensors proposed in the present doctoral thesis, therefore, offer improved 
sensitivity and selectivity for electroanalytical methods, which is with their low cost and short 
analysis time very appealing in pharmaceutical analysis.  
The preparation of sensors was quite simple; obtained by dispersing nanomaterials in 
polymer and depositing of the homogenous dispersion by one-step casting method on GCE. 
Additionally, the proposed sensor has shown long-term stability due to high mechanical 
strength of MWCNTs and also very easy surface regeneration by applying a single SWV or 
CV potential scan in blank supporting electrolyte, thus avoiding tedious polishing as in the 
case of bare GCE before every measurement. 
The modern electroanalytical methods based on such modified electrodes have great 
potential for practical application in complex media such as real pharmaceutical and 
biological samples, not only for fundamental research in laboratories, but also for routine 
analyses. Generally, the separation and extraction procedures are not necessary, as compared 
to the chromatographic methods that usually require some type of sample pretreatment, such 
as liquid-liquid extraction (LLE) or solid-phase extraction (SPE) prior to the analysis of 
biological samples. 
Novel sensors proposed in this doctoral thesis can be used for evaluation of the quality 
of pharmaceutical products in order to achieve better medicinal effect and lower toxicity. 
They can also be successfully applied for monitoring of the therapeutic levels of drug 
concentrations in biological samples in patients in clinical medicine to prevent overdose 
toxicity or for pharmacokinetic purposes. 
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9.1. Supplemental data 1: Multi-walled carbon nanotubes/Nafion composite 
film modified electrode as a sensor for simultaneous determination of 
ondansetron and morphine  
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Supplementary Figure 1. Electrochemical polymerization of 2-hydroxy-5- [(4-
sulfophenyl)azo]benzoic acid on GCE surface for ten cycles in Britton-Robinson buffer 
solution (pH 4)  containing 1 x 10
-3
 M SPAB (scan rate 100 mVs
-1
) 
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Supplementary Figure 2. Cyclic voltammograms of OND (1 x 10
-4
 M) at a bare GCE (blue) 
and the poly(SPAB)-GCE (red) in 0.1 M H2SO4 
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Supplementary Figure 3. Square-wave voltammograms of OND and MOR (1 x 10
-6
 M) at 
the MWCNTs/Nafion-GCE with 200-fold uric acid (red) and without uric acid (blue). SWV 
settings: f = 75 Hz, Esw = 25 mV and ΔE = 8 mV (Eacc = -0.5 V, tacc = 360 s) 
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Supplementary Figure 4. Square-wave voltammograms of OND and MOR (1 x 10
-6
 M) at 
the MWCNTs/Nafion-GCE with 400-fold nitrite ions (red) and without nitrite ions (blue). 
SWV settings: f = 75 Hz, Esw = 25 mV and ΔE = 8 mV (Eacc = -0.5 V, tacc = 360 s) 
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Supplementary Figure 5. Square-wave voltammograms of OND at the MWCNTs/Nafion-
GCE recorded in tablets for increasing concentrations (1.0 x 10
-6
 M – 2.5 x 10-6 M). SWV 
settings: f = 75 Hz, Esw = 25 mV and ΔE = 8 mV (Eacc = -0.5 V, tacc = 360 s) 
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Supplementary Figure 6. Square-wave voltammograms of OND and MOR at the 
MWCNTs/Nafion-GCE recorded in spiked human serum for increasing concentrations (5.0 x 
10
-7
 M – 2.5 x 10-6 M for OND and 1.0 x 10-7 M – 1.0 x 10-6 M for MOR). SWV settings: f = 
75 Hz, Esw = 25 mV and ΔE = 8 mV (Eacc = -0.5 V, tacc = 360 s) 
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9.2. Supplemental data 2: Voltammetric determination of ropinirole in the 
presence of levodopa at the surface of a carbon nanotubes based 
electrochemical sensor in pharmaceuticals and human serum  
 
-0,2 0,0 0,2 0,4 0,6 0,8 1,0
-15
-10
-5
0
5
10
15
20
25
i 
/ 

A
E / V vs. Ag/AgCl
 
Supplementary Figure 1. Electrochemical polymerization of 5-ASA on GCE surface for ten 
cycles in BR buffer solution (pH 2)  containing 1 x 10
-3
 M 5-ASA (scan rate 100 mVs
-1
) 
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Supplementary Figure 2. The effect of pH value of BR buffer solution on 5-ASA (5 x 10
-4
 
M) electropolymerization (first cycle): pH 2 (red), pH 4 (green) and pH 6 (blue) 
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Supplementary Figure 3. Square-wave voltammograms of ROP (5 x 10
-5
 M) at a bare GCE  
(blue) and at poly(5-ASA)-GCE (red) together with corresponding background recording in 
BR buffer pH 2 (green) 
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Supplementary Figure 4. Square-wave voltammograms of ROP (5 x 10
-5
 M) in 0.1 M 
H2SO4 at poly(5-ASA)-GCE (blue) and at the MWCNTs/Nafion-GCE (red)  
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Supplementary Figure 5. Cyclic voltammograms of ROP (5 x 10
-5
 M) at a bare BDDE 
(black), the Nafion-BDDE (green), the MWCNTs-BDDE (blue) and MWCNTs/Nafion-
BDDE (red). Scan rate: 100 mVs
-1 
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Supplementary Figure 6. Square-wave voltammograms of ROP (5 x 10
-5
 M) at the 
MWCNTs/Nafion-BDDE (blue) and the MWCNTs/Nafion-GCE (red)
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Supplementary Figure 7. Square-wave voltammograms of L-dopa (1 x 10
-6
 M) at the 
MWCNTs/Nafion-GCE: (a) with equal DA concentration (red) and without DA (blue). (b) 
with plasma concentration (26 pg/mL) of DA (red) and without DA (blue). SWV settings: f = 
50 Hz, Esw = 25 mV and ΔE = 8 mV (Eacc = 0 V, tacc = 240 s) 
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Supplementary Figure 8. Square-wave voltammograms of L-dopa (1 x 10
-6
 M) at the 
MWCNTs/Nafion-GCE with 50-fold uric acid (red) and without uric acid (black). SWV 
settings: f = 50 Hz, Esw = 25 mV and ΔE = 8 mV (Eacc = 0 V, tacc = 240 s) 
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9.3. Supplemental data 3: Electrochemical sensing of mesalazine and its N-
acetylated metabolite in biological samples using functionalized carbon 
nanotubes 
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Supplementary Figure 1. Cyclic voltammograms of 5-ASA (5 x 10
-5
 M) at a bare gold 
electrode (dashed line) and a bare GCE (solid line). Scan rate: 100 mVs
-1 
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Supplementary Figure 2. Cyclic voltammograms of 5-ASA (5 x 10
-5
 M) at a gold electrode 
(dashed line) and GCE (solid line) modified with MWCNTs/Nafion composite film. Scan 
rate: 100 mVs
-1 
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Supplementary Figure 3. Cyclic voltammograms of Ac-5-ASA (5 x 10
-5
 M) at a bare gold 
electrode (dashed line) and a bare GCE (solid line). Scan rate: 100 mVs
-1 
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Supplementary Figure 4. Cyclic voltammograms of Ac-5-ASA (5 x 10
-5
 M) at a gold 
electrode (dashed line) and GCE (solid line) modified with MWCNTs/Nafion composite film. 
Scan rate: 100 mVs
-1 
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Supplementary Figure 5. Square-wave voltammograms of 5-ASA and Ac-5ASA (2.5 x 10
-6
 
M) at the MWCNTs/Nafion-GCE with 5-fold uric acid (red) and without uric acid (blue). 
SWV settings: f = 70 Hz, Esw = 50 mV and ΔE = 2 mV (Eacc = 0.1 V, tacc = 30 s) 
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9.4. Supplemental data 4: Development of electrochemical platform based on 
carbon nanotubes decorated with zirconium oxide nanoparticles for 
determination of nebivolol 
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Supplementary Figure 1. Cyclic voltammograms (a) of NBV (1 x 10
-4
 M) in 0.1 M H2SO4 at 
a bare GCE (black), the BiNP/GCE (green), the MWCNTs/Nafion-GCE (red) and BiNP-
MWCNTs/GCE (blue). Differential pulse voltammograms (b) of NBV (1 x 10
-4
 M) in 0.1 M 
H2SO4 at the MWCNTs/Nafion-GCE (blue) and BiNP-MWCNTs/GCE (red) together with 
corresponding background current (black)  
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Supplementary Figure 2. Differential pulse voltammograms of NBV (2.5 x 10
-6
 M, blue) 
and mixture of NBV with carvedilol (1:1, red) in 0.1 M H2SO4. DPV settings: pulse amplitude 
of 50 mV, pulse width of 75 ms and scan rate of 20 mV s
-1
 (Eacc = 0 V, tacc= 240 s) 
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Supplementary Figure 3. Differential pulse voltammograms of NBV (2.5 x 10
-6
 M, blue) 
and mixture of NBV with propranolol (1:1, red) in 0.1 M H2SO4. DPV settings: pulse 
amplitude of 50 mV, pulse width of 75 ms and scan rate of 20 mV s
-1
 (Eacc = 0 V, tacc= 240 s) 
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Supplementary Figure 4. Differential pulse voltammograms of NBV (2.5 x 10
-6
 M, blue) 
and mixture of NBV with atenolol (1:1, red) in 0.1 M H2SO4.  DPV settings: pulse amplitude 
of 50 mV, pulse width of 75 ms and scan rate of 20 mV s
-1
 (Eacc = 0 V, tacc= 240 s) 
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Supplementary Figure 5. Differential pulse voltammograms of NBV (2.5 x 10
-6
 M, blue) 
and mixture of NBV with bisoprolol (1:1, red) in 0.1 M H2SO4. DPV settings: pulse 
amplitude of 50 mV, pulse width of 75 ms and scan rate of 20 mV s
-1
 (Eacc = 0 V, tacc= 240 s) 
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